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Fusing different high-throughput data sources is an effective way to reveal func­
tions of unknown genes, as well as regulatory relationships between biological 
components such as genes and metabolites. Dependencies between biological 
ponents functioning in the different layers of biological regulation can be investi­
gated using canonical correlation analysis (CCA). However, the properties of the 
high-throughput bioinformatics data induce many challenges to data analysis: the 
sample size is often insufficient compared to the dimensionality of the data, and 
the data pose multicollinearity due to, for example, со-expressed and co-regulated 
genes. Therefore, a regularized version of classical CCA has been adopted. An 
alternative way of introducing regularization to statistical models is to perform 
Bayesian data analysis with suitable priors. In this thesis, the performance of a 
new variant of Bayesian CCA called gsCCA is compared to a classical ridge regres­
sion regularized CCA (rrCCA) in revealing relevant information shared between 
two high-throughput data sets. The gsCCA produces a partly similar regulatory 
effect as the classical CCA but, in addition, the gsCCA introduces a new type of 
regularization to the data covariance matrices. Both CCA methods are applied 
to gene expression and metabolic concentration measurements obtained from 
oxidative-stress tolerant Arabidopsis thaliana ecotype Col-0, and an oxidative- 
stress sensitive mutant redi as time series under ozone exposure and in a control 
condition. The aim of this work is to reveal new regulatory mechanisms in the 
idative stress signalling in plants. For the both methods, rrCCA and gsCCA, the 
thesis illustrates their potential to reveal both already known and new regulatory 
mechanisms in Arabidopsis thaliana oxidative stress signalling.
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Bioinformatiikassa eri tyyppisten mittausaineistojen yhdistäminen on tehokas tapa 
selvittää tuntemattomien geenien toiminnallisuutta sekä säätelyvuorovaikutuksia 
eri biologisten komponenttien, kuten geenien ja metaboliittien, välillä. Riippu­
vuuksia eri biologisilla säätelyt asolila toimivien komponenttien välillä voidaan 
tutkia kanonisella korrelaatioanalyysillä (canonical correlation analysis, CCA). 
Bioinformatiikan tietoaineistot aiheuttavat kuitenkin monia haasteita data- 
analyysille: näytteiden määrä on usein riittämätön verrattuna aineiston piirteiden 
määrään, ja aineisto on multikollineaarista johtuen esim. yhdessä säädellyistä ja il­
mentyvistä geeneistä. Tästä syystä usein käytetään regularisoitua versiota kanon­
isesta korrelaatioanalyysistä aineiston tilastolliseen analysointiin. Vaihtoehto re- 
gularisoidulle analyysille on bayesiläinen lähestymistapa yhdessä sopivien priori- 
oletuksien kanssa. Tässä diplomityössä tutkitaan ja vertaillaan uuden bayesiläisen 
CCA:n sekä klassisen harjanneregressio-regularisoidun CCA:n kykyä löytää oleelli­
nen jaettu informaatio kahden bioinformatiikka-tietoaineiston välillä, 
bayesiläisen menetelmän nimi on ryhmittäin harva kanoninen korrelaatioana­
lyysi. Ryhmittäin harva CCA tuottaa samanlaisen regularisointivaikutukseen kuin 
harjanneregressio-CCA, mutta lisäksi uusi menetelmä regularisoi tietoaineisto­
jen kovarianssimatriiseja uudella tavalla. Molempia CCA-menetelmiä sovelletaan 
geenien ilmentymisaineistoon ja metaboliittien konsentraatioaineistoon, jotka 
mitattu Arabidopsis thaliana:n hapetus-stressiä sietävästä ekotyypistä Col-0 ja 
hapetus-stressille herkästä redi mutantista aika-sarjana, sekä otsoni-altistuksessa 
että kontrolliolosuhteissa. Diplomityö havainnollistaa harjanneregressio-CCA:n 
ja ryhmittäin harvan CCA:n kykyä paljastaa jo tunnettuja ja mahdollisesti 
sia säätelymekanismeja geenien ja metabolittien välillä kasvisolujen viestinnässä 
hapettavan stressin aikana.
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1 Introduction
Research in molecular biology has identified cellular components such 
proteins, enzymes and metabolites which function together in a highly regulated 
manner
technologies, such as DNA microarrays and mass spectrometric methods, are widely 
used to study the abundance and expression of these biological components in living 
organisms. High-throughput technologies are used to quantify the biological com­
ponents in the whole genome or organism scale, leading to various omics data sets 
such as metabolomics and transcriptomics. The constantly increasing amount of 
various omics data types has motivated the development of sophisticated bioinfor­
matics data analysis methods to dissect these data sets [1]. However, omics data sets 
obtained by high-throughput technologies pose several challenges to data analysis: 
the measurement technologies are highly inaccurate; differences in individual organ­
isms cause variation in data; there is a difficulty in analyzing data with small sample 
size compared to the large number of features such as genes; and multicollinearity 
due to, for example, со-regulated and со-expressed genes makes the interpretation 
of the results hard.
There has been a growing interest in observing different types of high-throughput 
data sets jointly, and performing an integrated analysis on the data sets obtained 
from the same experimental units. The integrated analysis is justified because the 
regulation of the biological systems occurs on different biological components, and on 
different layers such as gene expression, translation, mRNA and protein degradation, 
enzyme activation, or the concentration levels of metabolites. Examples of this 
be found in [2].
Systems biology as a research discipline focuses on interactions between the cellu­
lar components, as well as the functional mechanisms and behaviour of living systems 
arisen from these interactions [3-5]. The ultimate goal in systems biology is to under­
stand the whole function of a cell in a systematic way, and to build in silico models 
to simulate life on computers. Computational systems biology attempts to analyse 
the regulation of a biological system as a whole by fusing different data sources, and 
by computational and statistical methods capable of handling the enormous data 
sets. In systems biology studies, the system under study is usually perturbed and 
high-throughput measurements are made to identify the components and their inter­
actions. Moreover, integration of different data sets is often done given the biologi­
cal domain knowledge that has been accumulated into the bioinformatics databases. 
An ever increasing amount of various biological high-throughput data sets is ex­
pected to emerge in the future, including single-nucleotide polymorphism (SNP) 
profiles, DNA copy number variation measured by array comparative hybridization 
methods [6], epigenetic modifications measured by chromatin immunoprécipitation 
combined with sequencing (ChIP-seq), and gene expression data measured using 
sequencing methods. Therefore, there is a growing need of computational systems 
biology and data integration methods.
The microarrays and mass spectroscopic methods used to quantify gene expres­
sion and metabolite concentrations, respectively, are probably the most widely used
as genes,
to form a complex system, life. In biological research, high-throughput
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2high-throughput methods. They are the most suitable techniques for obtaining 
genome- or organism-scale measurements, and also the most useful in the analysis 
of metabolism and its regulation. The flow of information in metabolic regulation 
begins when the genes related to a certain metabolic pathway are transcribed to 
messenger RNA molecules (mRNA). The mRNA molecules are transferred to ribo­
somes in which the protein synthesis occurs according to the instructions contained 
in the mRNA molecules. This expression of mRNA molecules is a central functional 
and regulatory layer that determines the proteins produced in a cell [7]. Some of 
the proteins are enzymes catalysing biochemical reactions in which the metabolites 
participate. These reactions constitute a complex network of interactions between 
biomolecules which can be investigated by metabolomics techniques [2,8]. Cellular 
metabolism can be seen as a result of the regulation occurring in the other layers of 
biological components such as transcripts. Therefore, understanding the metabolic 
network and its functional properties is crucial in deciphering the function of a 
cell [9,10]. The regulatory interconnection between gene expression and metabolism 
has led to the development of various methods which aim to integrate these two 
data sources [11-22].
This thesis concentrates on integrating high-throughput bioinformatics data 
ing methods derived from canonical correlation analysis (CCA). Canonical correla­
tion analysis [23] is a widely used method to fuse two or more paired data sets, i.e. 
distinct sets of features measured from the same samples. CCA seeks a linear repre­
sentation of two or several paired data sets so that the representations are maximally 
correlated with each other, thus finding the statistical dependencies between the sets 
of features. Canonical correlation analysis is a symmetric method contrasting with 
asymmetric methods such as linear regression used to predict target value from in­
put values. In CCA, both sets of variables can be considered as target and input 
variables simultaneously. Canonical correlation analysis fits to situations in which it 
can be assumed that the variation in one set of variables correlates with the variation 
in the other set and vice versa. Therefore, canonical correlation analysis suits well 
for analysing gene expression and metabolomics data because the changes in gene 
expression levels often regulate the metabolite concentration levels but, in addition, 
the metabolites might as well regulate the expression of some genes. Moreover, it is 
believed, in spite of the high dimensionality of the high-throughput data, that the 
interesting process underlying the data is in fact low dimensional. CCA performs a 
dimensionality reduction of high-dimensional data sets into lower dimensions for a 
more global view of the underlying biological process, and is thus a very attractive 
method for high-throughput bioinformatics data integration.
The noisy measurement techniques, the high dimensionality and small sample 
size, as well as the multicollinearity of the features typical to the high-throughput 
biological data pose various problems to data analysis. For example, canonical 
correlation analysis cannot be performed successfully when the number of features 
in both data sets exceeds the number of paired samples. This is because canonical 
correlation analysis requires the estimation of large covariance matrices and their 
inverses but the small sample size gives little statistical strength to obtain accurate 
estimates for the huge number of covariance parameters. As a result, the estimates
us-
3have very high variance, the covariance matrices are singular or ill-conditioned, and 
thus their inverses are unreliable, or cannot be computed at all. When the number 
of samples is low compared to the number of features, CCA model learned from the 
data overfits, i.e. starts to model irrelevant variation and noise in the data. Such 
challenges can be overcome by using classical regularization methods. For example, 
the classical ridge regression regularization has been adopted to canonical correlation 
analysis [24-27].
Applying the classical ridge regression regularization technique to canonical 
relation analysis requires the optimization of the regularization parameters using, for 
example, cross-validation procedure. However, the optimization of the regularization 
parameters can be ambiguous and computationally very tedious. An alternative ap­
proach introducing regularization into statistical analysis is to apply Bayesian data 
analysis methods. Bayesian data analysis offers a number of advantages compared 
to the classical or frequentisi regularization techniques such as addressing the 
tainty of the model parameters by assigning probability density to them; controlling 
the uncertainty in the modelling process itself; and the possibility to integrate 
uninteresting model parameters. The Bayesian data analysis methods have an inher­
ent regularization property that makes them particularly appropriate for complex 
bioinformatics data sets having small sample size and large number of features. The 
Bayesian data analysis methods have been applied in several publications to a sin­
gle high-throughput data set (see references in [28]) but few exists for data fusion 
methods. The Bayesian framework can be applied to canonical correlation analysis 
by formalizing the model in a probabilistic framework [29-31]. In the probabilistic 
interpretation of CCA, the data is assumed to arise from a probabilistic generative 
model with a shared latent space for the two observed data sets. In the Bayesian 
framework, prior distributions are introduced to the model parameters. By selec­
tion of appropriate priors, the learned models become automatically regularized. 
For example, introducing Gaussian priors for the model parameters corresponds to 
the ridge regression regularization. Moreover, instead of using a part of the data 
to learn the model and another part to determine the model complexity, as is done 
in the cross-validation procedure to find the right regularization parameters for the 
classical regularized CCA, in the Bayesian framework, the whole data set is used to 
learn the model and its complexity jointly.
Bayesian canonical correlation analysis to fuse two high-throughput data sets 
has been introduced by Huopaniemi et al. [32]. The authors solve the problems of 
high dimensionality, small sample size and multicollinearity of the data by assuming 
that the data includes clusters of highly correlated and similarly behaving variables, 
thus decreasing the dimensionality of the variables. In contrast, this thesis consid­
ers a new variant of the Bayesian canonical correlation analysis [33] which models 
the individual genes and metabolites, not the clusters of them as in [32]. In this 
new Bayesian CCA, the data covariance matrices are replaced by low-rank approx­
imations of them. This makes the rows and columns of a single covariance matrix 
dependent of each other, thus decreasing the number of effective parameters to be 
learned in the model. The low-rank approximation of the covariance matrices is 
obtained by introducing also source specific latent variables to the model, and by
cor-
uncer-
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the transformation matrix from the data set-specific latent space to the observed 
variable space. The data set-specific latent variables and the CCA components 
learnt jointly while training the model. The model is called Bayesian CCA via group 
sparsity (gsCCA), and is inferred by variational approximation techniques [33].
No canonical correlation analysis method, which imposes this type of restric­
tions to the covariance matrix, has been applied to fusing gene expression and 
metabolomics data. The problem of small sample size and large number of vari­
ables has been solved either imposing regularization or sparsity to the CCA projec­
tion matrices [35-38] or assuming that the covariance matrix of the data is diago­
nal [35,38,39]. However, assuming diagonal matrix in canonical correlation analysis 
converts the method in practise to a principal component analysis (PCA) which 
cannot correctly model the shared variation between the two data sets.
This thesis compares the performance of the ridge regression regularized CCA 
(rrCCA) and the Bayesian CCA via group sparsity (gsCCA) in revealing relevant 
information shared between two high-throughput data sets. The performance is 
investigated by studying the generalization of the methods to unseen data by com­
paring the canonical correlations obtained by the two methods, and by assessing the 
variation in the data explained by different canonical components. The two meth­
ods are applied to data from a plant biology study in which a wild type Arabidopsis 
thaliana, Columbia-0, and an ozone-sensitive mutant redi were exposed to an ox­
idative stress. The gene expression and metabolomics data were measured from the 
same biological samples, and for both genotypes in a control condition and under 
exposure at six time points starting from the exposure. The performance 
of the two CCA methods in finding interesting variation in the data is examined. 
Also a new gene-set enrichment analysis method is presented for more global anal­
ysis of the results. The study will hopefully reveal genes regulating the changes in 
metabolism (and vice versa), and suggest new hypotheses about the oxidative stress 
signalling in plants.
The thesis is structured as follows: Chapter 2 provides a necessary background of 
regulation mechanisms in biological processes, especially metabolism, and presents 
the biological research question relating to the oxidative stress signalling in plants. 
The oxidative stress signaling is presented, and the results of this thesis are analyzed 
in the light of this description. Chapter 3 introduces statistical and mathematical 
modelling concepts required in this thesis. The new Bayesian canonical correla­
tion analysis with low-rank covariance matrix approximation for integrating gene 
expression and metabolomics data is given in Chapter 4. Chapter 4 also describes 
the methods to perform the comparison between regularized CCA and Bayesian 
CCA, and describes the biological data. Results for the data analysis are presented 
in Chapter 5. Finally, Chapter 6 concludes the thesis and discusses suggestions for 
future research.
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52 Regulation of biological processes
Cellular functions result from tightly regulated biomolecular networks that control 
the cell. Biological regulation occurs at several layers of biological processes listed 
below, and some of them are shown in Figure 1:
Gene
DNA
Transcription
Primary <x/\y 
transcript
Х/Х/ Ne Nucleotides
Posttranscrtptional
processing mRNA
degradation
Mature mRNA -VX/VX/n*.
Translation
Protein
(inactive)
Amino acids
r ••••9 9Posttranslatlonalprocessing degradation
SModifiedprotein(active)
I Protein targeting and transport
Figure 1: Layers of biological regulation. [40]
synthesis of the primary messenger RNA (mRNA) transcripts, i.e. transcrip­
tion
- post-transcriptional modification of the mRNA
- mRNA degradation
- protein synthesis i.e. translation
- post-translational modification of proteins to activate or inactivate them
- protein targeting and transport
- protein degradation
- metabolic regulation of enzymes
6As can be seen in Figure 1, the genetic information to manufacture a protein is 
transferred from the nucleus to the cytosol by a transfer molecule called messenger 
ribonucleid acid (mRNA). The mRNA molecules are further translated to proteins 
that are the structural and functional units of the cell. This process is referred to 
the central dogma in molecular biology [41]. Some of the proteins are enzymes 
that catalyse biochemical reactions in a cell. The enzymes regulate the activity 
of the individual biochemical reactions, and eventually the concentration levels of 
metabolites that are the substrates and end products of the reactions. Due to 
these hierarchical layers of biological regulation, cellular functions cannot be fully 
understood by studying one type of biological components at a time, for example, 
mRNA molecules, but through a comprehensive integration of the entire molecular 
machinery controlling the cell.
This chapter concentrates on 
pecially at the level of transcription and metabolite concentrations. In addition, the 
technologies used to quantify the transcriptome and metabolome on a large scale 
introduced. Transcriptomics and metabolomics reflect the regulation occurring 
at the two extreme levels of the information flow presented in Figure 1. How­
ever, much regulation occurs between the transcript and metabolite levels, including 
post-transcriptional and post-transcriptional regulation, as well as the regulation of 
enzymes, which have not been quantified in this work. Therefore, the details of bio­
logical regulation between transcripts and metabolites are not covered in this thesis. 
Despite this simplification, the methods discussed in this thesis are expected to re­
veal regulatory relationships between metabolites and genes. It is assumed that the 
expression level of a certain gene reflects directly the activity of the corresponding 
gene product which catalyses a metabolite reaction, and thus influences the levels 
of certain metabolites. Moreover, the changes in the metabolite concentrations 
directly affect gene expression. Justification and critique of these assumptions 
further discussed in the subsequent chapters.
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2.1 Regulation of transcription
Genomics is a discipline in genetics concerning the study of genomes of organisms 
and the information contained therein. Genetics, systems biology and bioinformatics 
studies of the whole genome of an organism have given rise to various genomics 
data sets such as genome sequences, single-nucleotide polymorphism (SNP) profiles 
or DNA copy-number variation data.
The genome of an organism contains genes, the basic units of genetic informa­
tion, which determine the instructions to manufacture proteins. A gene is defined 
as a beatable region of genomic sequence, corresponding to a unit of inheritance 
which is associated with regulatory regions, transcribed regions and/or other func­
tional sequence regions [42]. A gene consists of two parts: a coding sequence, and 
regulatory regions. The coding sequence carries instructions for protein synthesis. 
Regulatory regions are sequences controlling the activity of a gene. A regulatory 
region proximal to a gene-coding region is called a promoter. Promoters are sites 
found near the transcription starting site (TSS) which is the sequence recognized
7and bound by an enzyme catalysing the mRNA transcription, the RNA polymerase. 
The regulatory regions can also be distal, i.e. thousands of base pairs away from the 
promoter, and they can be situated both upstream or downstream of a promoter; 
they can reside even within the gene-coding region itself [40].
A gene is active or expressed in a cell when transcribed to a messenger RNA 
(mRNA). The complete collection of mRNA molecules of a cell or an organism is 
called a transcriptome. The main regulation of biological processes is believed to 
occur at the level of gene expression. From the perspective of energy efficiency, syn­
thesizing mRNA molecules but not using them in protein synthesis would be a waste 
of resources. Usually the expression of multiple genes with interdependent activi­
ties is simultaneously regulated, requiring a synchronized control of transcription 
initiation. Transcripts that increase (decrease) in concentration under particular 
molecular circumstances are referred to as inducible (repressible). The process of 
increasing (decreasing) gene expression is referred to as induction (repression). For 
more details, see [40].
The activity or inactivity of the regulatory regions of a certain gene, and there­
fore the amount of expression of the gene, is determined by binding of regulatory 
proteins to the regulatory regions. The regulatory proteins include transcription 
factors (TF) of which many work by enhancing or interfering the interaction be­
tween the RNA polymerase and the promoter. Some of the transcription factors 
are repressors that impede the access of RNA polymerase to a certain promoter; 
this leads to negative regulation. On the other hand, a transcription factor can 
be activating, enhancing the RNA polymerase-promoter interaction, and hence the 
transcriptional rate. There are three types of transcription factors: sequence-specific 
factors, co-regulating factors, and factors that are part of the RNA polymerase ma­
chinery. Sequence-specific factors have DNA-binding domains that interact closely 
and specifically with the DNA. These binding domains usually include one or several 
recognizable and characteristic structural motifs. These structural motifs of TFs of­
ten recognize a certain sequence motif in the regulatory region. Sequence-specific 
factors function mainly by recruitment of transcriptional co-regulators to the regu­
latory region via protein-protein interactions that occur through specific interaction 
domains of the proteins. Co-regulators interact directly and indirectly with the 
components of RNA polymerase to regulate the activity of the RNA polymerase 
transcriptional machinery at the promoter. As a conclusion, the DNA binding tran­
scription factors interpret the genetic regulatory information, and transmit the ap­
propriate response through co-regulators to the RNA polymerase transcriptional 
machinery. More details can be found in [40,43].
The eukaryotic promoters are generally inactive in the absence of regulatory pro­
teins because the storage of DNA within the chromosomes effectively renders most 
promoters inaccessible. Moreover, the RNA polymerase usually requires an array 
of transcription factors in order to bind to a promoter and start the transcription. 
At the promoter, there is usually a cluster of sequence motifs, i.e. the recognition 
sites for multiple sequence-specific TFs. Multiple transcription factors can bind to 
a single regulatory region, and form a protein complex, and their co-operation is 
what finally determines the regulatory state. The binding of several regulatory pro-
8teins improves the specificity for transcriptional regulation. Specificity is thought 
to be required by large eukaryotic genomes, as in large genomes a single specific 
binding sequence of a certain transcription factor will occur randomly with a large 
probability [40].
Increase in the concentration levels of transcription factors in the nucleus, or 
activation of transcription factors by intracellular or extracellular signals, triggers 
their regulatory effects. The increase in the concentration level of a TF in the nucleus 
might result from the induction of the transcription factor-coding gene, or from the 
transport of transcription factors from the cytosol to the nucleus. The former 
be observed as a higher expression of TF genes. A transcription factor might, 
however, be inactive (active) just after translation but might be later activated 
(inactivated) by post-translational modifications such as phosphorylation, or binding 
of a signal molecule. TF transportation or post-translational activation 
end results of signal transduction pathways, which transfer signals from intracellular 
and extracellular parts of the cell to the nucleus where they affect the transcripti 
as a respond to the signal (examples of this 
the activity of transcription factors cannot be seen in the changes of expression of 
the corresponding genes.
Binding of specific regulatory proteins to the regulatory regions of a gene might 
switch it to a functional and active form leading to the transcription of the gene. 
Transcription starts when the double-stranded DNA is opened in the proximity of 
the gene-coding sequence, and the RNA polymerase binds to the promoter. The 
polymerase enzyme reads the protein-coding sequence of the gene, and produces 
a complementary pre-mRNA molecule. After post-transcriptional processing of the 
pre-mRNA, the mature mRNA molecule is exported from the nucleus to the cytosol. 
The complete collection of transcribed mRNA molecules in genome scale, the tran­
scriptome, is a central functional layer of the genome regulating protein production 
in a cell, and therefore also the major part of the biological processes [44]. Different 
collections of genes are active in different contexts: transcriptional activity varies 
by cell type, environmental conditions and time. It is believed that at a given time 
most genes are expressed at low concentration, perhaps only one or few copies of the 
mRNA per cell on average, whereas a small number of genes are highly expressed, 
potentially with thousands of copies per cell [45,46]. The mRNA molecules are not 
everlasting: they are degraded back to nucleotides when not needed anymore. A 
particular transcript might not ever be translated to a protein if it is chemically 
unstable or condemned to degradation. It has been shown that the degradation 
rates of transcripts are highly regulated, and affect the number of protein translated 
from mRNA molecules [47-49].
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2.1.1 Quantification of the transcriptome
Transcriptional profiling is currently the main high-throughput technique used to 
investigate gene functions at genome- and organism-wide scale [50,51]. The tran­
scriptome is measured by DNA microarrays [52-54] which allow to routinely 
the expression levels of tens of thousands of mRNA transcripts in a given biological
measure
9sample [55]; the number of mRNA abundances to be analyzed may be as large as 
40,000.
The genomic DNA in chromosomes consists of two long polymers of simple units 
called nucleotides. There axe four types of nucleotides in the DNA: thymine (T), 
adenine (A), cytosine (C) and guanine (G). The two DNA strands form a double 
helix structure in which each nucleotide on one strand interacts with just 
cleotide on the other strand. This is called complementary base pairing. Nucleotide 
A forms base pairs with T and C form base pairs with G. The two strands forming 
the double helix are called complementary to each other. The base pairing property 
of nucleotides is behind the DNA microarray technology; a microarray slide contains 
complementary sequences to the mRNA molecules residing in a biological sample. 
In the microarray analysis workflow, first mRNA from a biological sample, 
plementary DNA molecules obtained from the mRNA using reverse transcriptase 
enzyme, are marked with fluorescence labels. Then the sample is injected on a mi­
croarray slide, and the mRNA molecules contained in the sample are bound to the 
complementary nucleotide sequences on the slide, i.e. spots or probes. This is called 
hybridization. Each probe on a 
with its intended target sequence in the sample. The activity of a certain transcript 
be detected by investigating its hybridization level, reflecting the target mRNA 
concentration in the sample. The hybridization level is estimated by measuring the 
intensity of light emitted by the fluorescent labelled mRNA molecules with a laser 
scanner. For more details, see [52,54].
The DNA microarray slides can be of three different types: complementary DNA 
(cDNA) arrays, oligonucleotide arrays [52,54,56,57] or bead arrays. Oligonucleotide 
microarrays are most widely used, and they are shown to be more accurate than 
cDNA arrays [52,54]. The data analyzed in this thesis was measured using custom- 
made cDNA microarrays, so the manufacturing technology, experimental procedure, 
data pre-processing and analysis is covered in this thesis only for cDNA arrays. The 
data analyzed in this work was obtained as already pre-processed and normalized, 
so the data pre-processing is not covered in detail.
The cDNA microarrays are manufactured by attaching oligonucleotides or cDNA 
molecules on a class slide by a robotic arrayer. The robotic arrayer uses multiple 
pins to pick up solution of cDNA molecules, and then deposites them on a glass 
slide. Therefore, cDNA arrays are called contact-spotted microarrays. Other tech­
niques to produce cDNA arrays are ink-jet deposition [58], and electrophoretically 
driven deposition [59]. The probes can be synthesised, or cDNA can be generated 
via reverse-transcription of all mRNAs from an organism under study to obtain 
so-called expressed sequence tags (ESTs) which are then amplified by polymerase 
chain reaction (PGR), purified, and spotted on the microarray slides. The technique 
is versatile, and probes of several hundred to thousand base pairs in length can be 
attached to the slide. The cDNA platforms are usually two-colour microarrays, in­
dicating that RNA or cDNA obtained from differently treated samples are labelled 
with different fluorescent cyanide (Gy) markers: Cy5 being fluorescent in red region, 
and Cy3 being fluorescent in green region. Two-colour microarrays are always used 
to compare the expression ratio between differently treated samples of which the
one nu­
or com-
microarray slide is expected to uniquely hybridize
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other is usually the control sample. This direct comparison reduces the noise level 
in the final data. The cDNA microarrays tend to have a large variation in spot size, 
and morphology between spots and between arrays, thus making it more difficult 
to compare two samples hybridized on different arrays. Comparing samples directly 
the array decreases the noise due to the inefficient spot detection. Furthermore, 
the same sample labelled with different fluorescent markers may show different hy­
bridization affinity to the slide which might also vary between genes. To reduce this 
dye effect, a dye-swap is commonly performed. In dye swap, the colouring order 
of the samples is swapped to address the uncertainty associated with the binding 
affinity of differently labelled samples. For more details, see [52,54].
After the samples have been hybridized onto the microarrays, a laser scanner de­
tects the abundance of bound mRNA or cDNA molecules. For two-colour microar­
rays, the abundance of both colours is measured separately resulting in different 
channels. The quantification assigns signal intensity values to each spot or probe. 
The relative gene expression values obtained from cDNA experiment are commonly 
transformed to a logarithmic scale with base 2. The principal motivation for this 
transformation is to make variation roughly comparable among measures that span 
several orders of magnitude.
The next step in the microarray data analysis is usually normalization to 
irrelevant variation, and preserve the interesting variation. Interesting variation is 
usually the biological variation. Differences of individuals in biological samples, and 
inability to control the biological experiment also lead to irrelevant biological vari­
ation. Differences in the scale intensity between red and green channels, different 
labelling efficacy of the samples, different hybridization times and conditions, as well 
as different scanning sensitivity and laser power all lead to unwanted technical vari­
ation [60]. The normalization method to remove irrelevant biological and technical 
variation used for the data analyzed in this thesis is presented in Chapter 4.2.2.
Despite the huge advances in microarray technology and their popularity in bio­
logical research, caution is needed when applying them. In general, the microarray 
technology is still to a large extent irreproducible between microarray experiments 
done at different sites, at different platforms and between laboratories. The irrepro- 
ducibility aspect of microarray technology is addressed in the editorial [61] preceding 
the report summarizing the large-scale Microarray Quality Control Project [62]. Af­
ter 15 years of research and development, broad consensus is still lacking concerning 
best practice not only for experimental design and sample preparation but also for 
data acquisition, statistical analysis and interpretation. The microarrays 
the abundance of the mRNA molecules in a cell at a certain time instance but the 
concentrations of the mRNA molecules do not tell much about the transcriptional ac­
tivity of genes, i.e. the rate at which a gene is transcribed to a messenger RNA [63]. 
This is because microarray technology does not address the post-transcriptional 
mRNA stability, activity and degradation rate which are tightly regulated, and vary 
between genes and due to differences in cell environment. [47-49,64,65]. Moreover, it 
has also been observed that the mRNA half-lives of some genes cluster into compar­
atively tight groups [63]. This has given rise to a concern that the co-expression of 
genes observed in the results of microarray experiments might not reflect the tran-
on
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scriptional co-regulation, as is traditionally interpreted, but would instead result 
from the clustering of mRNA degradation rates [63].
2.1.2 Statistical significance of differentially expressed genes
After obtaining the normalized intensity values of the spots or probes, the signif­
icance of differentially expressed genes, for example, between control samples and 
treated samples, is determined. The genes can be differentially expressed in different 
subjects exposed to varying physical and biochemical conditions. Identification of 
genes that display tendencies of increased or reduced expression helps to discover 
the functional roles of genes in an organism, to group genes according to common 
functions, or to understand the relationships among genes in a biological system. 
Usually only genes having intensity values or fold changes in a log 2 scale compared 
to a control sample above 1 or below -1 are investigated. A standard t-test is usually 
performed for each gene to find out genes having expression significantly different 
due to a treatment compared to a control condition.
The statistical test gives p values for each gene, which can be investigated for 
statistical significance. However, obtaining p values for tens of thousands of genes 
results in a problem; for 10000 significantly expressed genes with a significance level 
of 0.05 leads to 500 false positive discoveries. This is called a multiple comparisons 
problem [66]. The large number of false positive results obtained in a multiple 
comparison test can be avoided by setting the target significance threshold much 
lower than it would be for a single test. Another way is to use a multiple-hypothesis 
testing error measure called a false discovery rate [67]. The false discovery rate 
(FDR) is the expected proportion of false positive findings among all the rejected 
null hypotheses. FDR analogue of the p value is called q value. The q value of 
individual hypothesis test is the minimum FDR at which the test may be called 
significant. The q values can be directly estimated rather than fixing a level at 
which to control the FDR [68]. The calculation of q values for genes to determine 
their statistically significant expression is today a standard procedure in microarray 
data analysis.
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2.1.3 Gene-set enrichment analysis
The microarray data analysis can be performed at three levels: at single gene level, 
at the level of multiple genes, or at the level of networks of genes [69]. The analysis 
of differential expression of a group of genes is more reasonable than the analysis 
of expression levels of single genes, because a set of multiple differentially expressed 
genes gives more statistical strength to the analysis of differences between biological 
samples than single genes. In addition, the analysis of sets of genes is well advised 
because there might be groups of genes that are со-regulated and therefore co­
expressed, or otherwise related, that are induced or repressed together due to 
stimuli. The list of differentially со-expressed genes can be further translated into 
a better understanding of the underlying biological phenomena. In particular, the 
results can be investigated in the context of gene or metabolic regulatory networks, or 
signalling pathways on the whole organism level. Methods for analyzing differentially
some
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expressed gene sets are, for example, functional class scoring [70,71], Fisher’s exact 
test and gene-set enrichment analysis (GSEA) [72,73]. In GSEA, the expression 
values of all transcripts all investigated, and the enrichment score for a gene set is 
calculated based on the order of the expression values. The statistical significance 
of the score is determined by a permutation test. GSEA finds significantly enriched 
gene sets among genes that are related to each other, although the individual genes 
might lack significantly differential expression.
Usage of gene ontology (GO) classes as predefined gene sets is a widely adopted 
method to study groups of differentially expressed genes [74,75]. However, there 
a number of limitations related to the type, quality and structure of the GO annota­
tions available. First, all types of gene-set enrichment analysis have been criticized 
of being limited by the fact that each functional GO category is analyzed indepen­
dently without a unifying analysis at a biological pathway or organism level [73,76]. 
Second, the GO class enrichment methods do not suit for a systems biology approach 
that aims to account for system level dependencies and interactions between differ­
ent biological components. An alternative way is to investigate the enrichment of 
biological pathways obtained from databases such as KEGG and BioCYC. Further­
more, there is no enrichment analysis which would take both differentially expressed 
genes and metabolites having differential concentration levels as an input, and give 
enriched pathways as a result.
Gene-set enrichment analysis gives small p values for enriched gene sets but 
if very many gene-set enrichment tests are performed, the p value correction, for 
example, using Benjamini-Hochberg method [67], is again required. In gene-set 
enrichment analysis, significantly up-regulated and down-regulated genes can be 
studied separately, or together by considering only the absolute fold changes of the 
genes. Moreover, usually only those genes belonging to at least one GO class are 
used to calculate the test statistics; this increases the p values, and leads to a smaller 
number of enriched gene sets.
Co-expressed groups of genes, if they in addition have similar functions, are likely 
to be regulated via the same regulatory mechanisms. They are most likely to have 
their promoter regions bound by a common transcription factor and share 
regulatory motifs [77]. Allocco et al. [77] have investigated data from a genome wide 
binding analysis of transcription factors in combination with mRNA expression levels 
and existing functional annotations to quantify the likelihood that co-expressed 
genes, or genes sharing the same biological function, will be bound by 
transcription factor. The authors found that this effect is present at relatively high 
levels of expression similarity. Furthermore, they estimated the probability of two 
genes being bound by the common transcription factor as a function of correlation 
between the expression values of the genes. Especially, in order for two genes to 
have a greater than 50 % change of sharing a common transcription factor binding 
site, the correlation between their expression must be greater than 84 %. Seeking 
common potential transcription factor binding motifs from со-expressed genes, such 
as genes belonging to a same GO class, is one option for further analysis of the 
results obtained by gene-set enrichment analysis.
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2.1.4 A new gene-set enrichment analysis based on area under precision- 
recall curve
A good gene-set enrichment analysis method should work even when the number 
of samples is small, and as a result it should give enriched gene sets containing 
a large number of genes. This thesis introduces a new type of gene-set enrichment 
analysis method that uses area under precision-recall curve to determine the gene-set 
enrichment score. Precision and recall are common concepts in information retrieval 
for evaluating retrieval (classification) performance [78,79]. In this new method, the 
absolute expression of all genes belonging to at least one gene-set annotation are 
listed in decreasing order, and precision and recall of each enriched gene ontology 
class are calculated on each gene in this list. While the genes in the list are gone 
through, the precision and recall for each class are calculated as follows:
Genes belonging to a class encountered thus farprecision = (1)The total number of genes encountered thus far 
Genes belonging to a class encountered thus farrecall =
The number of genes belonging to the class
The precision can be plotted as a function of the recall, and the area under the 
resulting curve (AUG) can be calculated. This area corresponds to the average 
precision of the gene-set enrichment test [80]. The obtained value could be compared 
to the distribution of AUG obtained by randomizing the order of the genes. A gene 
set could be considered significant if the AUG for that gene set is larger than 95 
% over the AUCs obtained by randomization. This gene-set enrichment analysis 
method has the property of giving high significance for gene sets including large 
number of differentially expressed genes.
Precision-recall curves have the disadvantage of having a distinctive saw-tooth 
or ”wiggled” shape. If the (k+l)i/i gene in a list do not belong to the GO class 
under study, its recall is the same as for ki/i gene but the precision drops. On the 
other hand, if the gene belongs to the class, then both precision and recall increase 
and the curve continues up and right. Solution to this is to interpolate the 
Interpolated precision PmterpM at recall r is the maximum precision over all recalls 
greater than r. The interpolated precision-recall curve is a step-curve, and area 
under it can be calculated easily. For more details, see [80-83]
curve.
2.1.5 Mutation and knock-out of a gene in microarray studies in reveal­
ing the function of the gene
Genetic studies usually rely on the assumption that disrupting the activity of a gene 
required for a process will have a specific effect on that process. Disrupting a gene 
by mutating it or by a knock-out is often used to reveal the unknown function of 
the gene. Correlations between perturbation in expression of one gene and changes 
in the activity of other genes imply that a functional interaction exists between 
them [84,85]. In a mutant organism, the concentrations of the directly affected gene 
products can be reduced or increased by variable degrees. The resulting changes 
in target gene expression are then interpreted in terms of activating or repressive
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regulatory interactions between mutated and regulated genes. Up-regulation of a 
target gene in a mutant indicates that the mutated gene represses its target; down- 
regulation indicates activation. However, interpretation of mutant expression pat­
terns is not always straightforward especially if the system is spatially distributed, 
and/or involves feedback regulation between more than two or three genes [86]. A 
specific limitation in the genetic studies is that it is often unclear from any evidence 
whether an interaction is direct or mediated via one or more intermediate regulators. 
The solution in such a situation is to mutate several genes.
2.2 Regulation of translation and protein levels
The mRNA molecules floating in the cytoplasm are used as instructions to man­
ufacture proteins, the structural and functional units of the cell. The instructions 
coded in segments of three nucleotides in the gene-coding region or the mRNA 
transcripts. These segments are called codons. The order of the codons in the 
gene-coding region or in the mRNA molecule determines the properties of the gene 
product.
A protein molecule is composed of amino acids that are arranged in a chain. 
The amino acid chain or sequence is called the primary structure of a protein, and 
the order of the amino acids in the chain is determined by the codon sequence in 
the mRNA molecule. Different codons correspond to one of 20 proteinogenic amino 
acids. There are also other amino acids which do not end up into protein sequences. 
The manufacture of the proteins, i.e. the protein synthesis or translation, occurs 
in special molecular machinery called a ribosome. In ribosome, the different amino 
acids that will be attached to each other are brought to the translating site by 
transfer-RNA molecules. When the amino acid sequence, i.e. the primary structure 
of a protein is completed, it often folds around itself to form secondary and tertiary 
structures. Moreover, different amino acid sequences can join to form multimer 
proteins; this is called a protein tertiary structure. A folded protein or enzyme may 
not be active immediately after translation; several molecules or ligands, such as 
sugars, metals, cofactors and vitamins, can bind to the protein to enable its activity 
and functionality, or the enzyme is inactive until a certain signalling molecule binds 
to it.
are
In general, translational regulation is achieved by regulating mRNA stability, 
translation initiation, elongation and termination [87,88], and the overall rate of 
protein synthesis [89,90]. The concentration level of a protein is determined by 
these mechanisms together with protein degradation. The protein degradation is 
highly specific and tightly regulated [91-94]. The abundance of protein molecules 
in a biological sample, i.e. proteomics data, can be measured by 2D gels, and by a 
western plot [95] together with mass spectrometric methods [96-98], or libraries of 
green fluorescent protein -tagged proteins can be determined [95,99-102]. However, 
the proteomics data is difficult to measure in a high-throughput manner; the best 
approach thus far for large-scale quantification of protein levels is shotgun proteomics 
[103,104].
Due to the difficulty of measuring the protein levels in a high-throughput man-
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ner, the expression levels of transcripts are assumed to reflect the concentration of 
proteins and enzymes, and therefore the activity of the corresponding biological pro­
cesses catalysed by them. Therefore, high correlation between transcriptome and 
proteome is desirable [105]. However, the mRNA concentration can only partially 
explain variation in protein concentration levels. The different processes occurring 
between transcription and appearance of proteins such as splicing; transportation of 
the mRNA molecule from the nucleus to the cytoplasm; mRNA maturation and edit­
ing; RNA interference; mRNA-binding proteins; the degradation rate of the mRNA 
molecules; the regulation of translation initiation, elongation, termination; and pro­
tein degradation raise a question whether the transcription levels reflect the 
centrations of the final gene products, the proteins. Furthermore, noise in the 
sûrement technologies, biological noise originating from the inherent stochasticity 
of biochemical processes [101,106], difference across individual cells in a population, 
and subtle environmental differences and genetic mutations [107] cause inaccuracy 
in predicting protein levels from the gene expression measurements.
In yeast and bacteria, and to a lesser extent in animals and plants, there is a 
substantial and significant correlation between protein and mRNA concentrations. 
Typically 30-85 % of the variation in protein levels can be attributed to variation 
in mRNA expression [108]. The rest can be explained by post-transcriptional and 
post-translational regulation and by measurement errors. A recent review address­
ing this issue [109] summarises the current state of knowledge about large-scale 
measurements of absolute protein and mRNA expression levels, and the degree of 
correlation between these two measurements. Authors focus particularly to the 
protein-per-mRNA (P/R) ratio. If there were no regulation in the translation or 
mRNA degradation, P/R ratio would be identical for all genes. In reality this is 
not observed; P/R ratios vary widely for genes measured from one cellular sample 
to another. Moreover, P/R is different for different genes, and might change for a 
given gene under different conditions. Protein stability is one of the major factors 
determining P/R, and P/R often depends on the type of protein. For example, in 
fission yeast, the correlation between gene expression and protein levels is strong 
for kinases, cell cycle genes, signalling and metabolic proteins but weak for proteins 
which form complexes [110].
Several large-scale studies exist in which the changes in protein concentrations 
are compared to the changes in mRNA concentrations [111-114]. Correlation coeffi­
cients between mRNA and protein levels vary widely across organisms and are often 
surprisingly low. In bacteria, the squared Pearson’s correlation coefficient between
con-
mea-
transcriptomics and proteomics ranges from 0.2 to 0.47, in yeast from 0.34 to 0.87 
and in multi-cellular organisms from 0.09 to 0.46. A recent study of yeast compared 
not only the total mRNA levels but also the translationally active transcrips, i.e. 
those that are bound to ribosomes, to protein concentration measurements [115]. 
The most significant but not the highest squared correlation between protein and 
mRNA concentrations in yeast was 0.42. All in all, squared correlation for several 
recent measurements lies around 0.4. Therefore, 40 % of the variance can be ex­
plained by changes at the transcript level, and 60 % by other means. Multicellular 
organisms display on average the lowest correlation between protein and mRNA
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Figure 2: Correlation between transcriptome and proteome in various organisms. 
[109]
2.3 Regulation of enzyme activity
Some proteins are enzymes catalysing biochemical reactions in a cell. In biochem­
ical reactions, small chemical substances, i.e. metabolites, are converted from one 
to other. Fast enzymatic transformations of metabolites cause a continuous flux of 
matter, and hence the dynamic properties of the metabolism. The rate at which 
the matter flows in a metabolic reaction, the flux, reflects the activity of an enzyme 
catalysing the reaction. The regulation of enzyme activities in metabolic pathways 
is by far the most common form of metabolic regulation. A reaction flux may sim­
ply increase by increased production of the corresponding enzyme resulting from the 
induction of the enzyme-coding gene. However, this is not the only mechanism to 
control the flux. First, the activity of a newly synthesised enzyme can be regulated 
by various processes: an enzyme may be bound by a certain molecule, making it
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levels. In multicellular organisms, the correlation is particularly poor for genes of 
signal transduction and transcriptional regulation, possibly due to extensive post- 
transcriptional control, or due to the low and error-prone concentrations of proteins 
and transcription levels. However, a study in Arabidopsis thaliana describes a good 
correlation between protein and mRNA levels, the Pearson’s correlation coefficient 
has been observed to vary between 0.52 and 0.68, similar to the correlations observed 
for C. elegans and D. melanogaster [116]. Figure about the correlations between 
transcripts and protein levels in various organisms are shown in subfigures A., B. 
and C. of Figure 2. This figure describes also the observed correlation between 
transcripts and protein levels in different studies conducted over years for several 
organisms (subfigure D). The subfigure D in Figure 2 shows that the overall correla­
tion between transcripts and proteomics in living world has in recent measurements 
been around 0.4 [109].
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active, or activation may require that a piece of enzyme is split off from it. Second, 
phosphorylation is a common mechanism either activating or inactivating an en­
zyme. Third, an enzyme can be informed of the state of the metabolic pathways by 
specific chemical signals such as the concentration of substrate, product and specific 
regulators; binding of a certain molecule to an enzyme can change the electrical and 
structural properties of an enzymes leading, for example, to altered affinity to the 
substrate molecule. Fourth, many enzymes catalysing the first steps in a metabolic 
pathway are prone to inhibitory regulation of the end products of the pathway. An 
inhibitor is any molecule that reduces the velocity of an enzymatic reaction. If 
enzyme of a metabolic pathway is inhibited by the pathway end product, the 
mechanism is called negative feedback inhibition.
The activities of enzymes are not directly available in this thesis. However, 
it is assumed that the gene expression levels reflect the activities of the proteins 
and enzymes the in metabolic pathways. Furthermore, enzymatic activities 
be partly accessed through the metabolite concentrations because the metabolite 
concentrations are ultimately the product of the complex biological regulation. An 
increase or a decrease in metabolite levels may reflect activation or inactivation 
of the pathways producing or consuming them. Moreover, if a certain enzyme is 
inhibited by a certain metabolite, this metabolic down-regulation may also lead to 
transcriptional down-regulation because synthesizing an enzyme that will anyway 
be inhibited is waste of resources.
an
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2.4 Regulation of metabolism
2.4.1 Metabolome
Metabolites are small molecules participating in the biochemical reactions, and 
required for the maintenance, growth and the normal function of a cell. The complete 
set of metabolites in an organism is denoted as a metabolome which can be partly 
identified and quantified using various metabolomics technologies. The amount of 
metabolites in a living organism can
kingdom where the estimated number of species is more than 400 000, the total 
ber of metabolites is estimated to be between 2 000 000 - 1 000 000 [117]. A single 
Arabidopsis thaliana plant is expected to produce 5000 metabolites 
A database of genetic and molecular biology data for Arabidopsis thaliana, AraCyc 
(version 6) already contains 2,632 compound entries. This number encompasses the 
documented Arabidopsis metabolites, as well as those residing in manually curated 
metabolic pathways [117-119]. The huge number of metabolites in plants originates 
from the thousands of secondary metabolites. Secondary metabolites are molecules 
not essential to survival, including flower pigments, phenyIpropanoids, flavonoids, 
terpenoids, glucosinolates and alkaloids. These have important function, for 
pie, in cellular signalling and adaptation to abiotic and biotic stresses [120]. The 
complete set of metabolites is different in different parts of a plant because there 
large differences in functions between tissues and the cells comprising them. This 
brings spatial heterogeneity to the metabolism. On the other hand, the
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tions can occur in different compartments of a plant such as plastids, mitochondria, 
peroxisomes and vacuolar compartments. Indeed, many basic pathways like tricar­
boxylic acid cycle (TCA), glycolysis, oxidative pentose phosphate pathway (OPPP) 
and organic acid metabolism are present in more than one compartment [121].
2.4.2 Metabolic reaction activities define the phenotypic state of an or­
ganism
Metabolic reaction rates or, in other words, the flux distribution, are the manifes­
tation of the regulation at enzyme and metabolite level. The rates of individual 
reactions in biochemical pathways ultimately define the phenotype of an organism. 
The production and consumption rates of the metabolites are directly connected to 
the reactions in metabolic pathways, and hence to the phenotype. The metabolites 
more directly connected to the phenotypic state of a cell than, for example, 
transcriptomics. Moreover, the metabolism represents the amplification of regula­
tion occurring in other biological layers such as transcripts and enzyme activities. 
Identifying and quantifying the metabolites under a specific condition, such as stress 
or gene knock-out, and comparing the levels to measurements obtained in a control 
condition can provide useful information of the regulatory processes in an organism. 
Indeed, metabolomics data has been used to determine the function of unknown 
genes [118,122-127]. For example, by measuring the change in relative concentra­
tions of metabolites as the result of the deletion or overexpression of a gene allows 
to locate a novel gene product on the metabolic map [128].
The guilty-by-association principle of gene expression [129] states that a set of 
genes involved in a certain process is generally со-regulated and thus co-expressed 
under the control of a shared regulatory system [118,125,126]. Therefore, if 
known gene is со-expressed with known genes of a particular biological process, it is 
assumed that this unknown gene may be involved in this process. This co-occurrence 
principle can be extended to со-regulated metabolites as well, or expression pattern 
of genes associated with a particular metabolic pathway can be combined with co­
accumulated metabolites also involved in the pathway. In this manner, regulatory 
relationships between genes and metabolites might be found.
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2.4.3 The nature of metabolism
The biological functions of metabolism are, for example, to support growth, to syn­
thesise and to turnover compounds, and to accumulate metabolites that have a role 
in coping with various stressful situations. The nature of metabolome distinguishes 
it from the other ornes such as transcriptome and proteome. Metabolism in living 
organisms operates as a highly integrated framework [130-132]. Metabolites 
not synthesised in isolation; rather, large sets of metabolites are often synthesised 
simultaneously and, therefore, the synthesis of one metabolite typically requires 
co-operation of many biosynthetical pathways. Metabolic pathways are also very 
branched. In conclusion, when the synthesis of a certain set of metabolites is up or 
down-regulated, it is often necessary to alter the fluxes and/or metabolite levels in 
several pathways. For more details, see [133].
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Metabolism is highly redundant and provides several alternative routes in synthe­
sizing a certain metabolite. Therefore, the decrease in the concentration level of one 
enzyme protein due to a knock-out of the corresponding gene or an environmental 
factor do not necessarily result on phenotypic differences in metabolome [134-138]. 
The biological reason for this might be to ensure stability of the metabolic network 
with respect to genetic mutations. Moreover, the reaction rates of pathways might 
not change in spite of the changes in the concentration levels of metabolites, or 
even changes in the activity of an enzyme catalysing the reaction. For example, 
the response to a decrease in the activity of an enzyme might be an increase in the 
concentration of substrates of that enzyme which ensures that the flux alters only 
slightly if not at all [139]. As a conclusion, metabolic networks are very robust to 
different kinds of perturbations. [140]. On the other hand, metabolome data might 
enable the detection of the phenotype of silent mutations. A silent mutation is a 
mutation in a genome which leads to no overt phenotype but which can be mapped 
by omics techniques such as metabolomics [141,142].
For certain metabolic pathways, individual reactions are organized such that the 
metabolic intermediates constituting a pathway are always bound to the enzyme 
surface, and the products are handed on as substrates for the subsequent 
tions. In such cases, intermediates of these reactions typically participate in one 
specific reaction, and are not detected in biological samples. On the other hand, 
central carbon pathways, such as glycolysis, gluconeogenesis, TCA and OPPP, are 
not organized in the same way. The intermediates of these pathways are indeed 
detectable. Moreover, the highly connected nature of metabolism requires that a 
number of compounds function as intermediates and precursors for more than one 
pathway. Such metabolites cannot be bound to enzymes because they always have 
to be available for more than one pathways, and more importantly, the rates of these 
pathways are likely to vary under different conditions [139]. These metabolites 
be observed. Because the metabolites are constantly produced and consumed, the 
quantity that is observed by metabolomics techniques for intermediate metabolites in 
pathways is the difference between produced metabolites and consumed metabolites 
in a steady-state, i.e. when the reaction rates of metabolic pathways are assumed 
to be constant [120].
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2.4.4 Metabolic regulation
The changes in the metabolite concentrations, i.e. the accumulation and depletion 
of metabolites, have several origins. For example, the accumulation of a certain 
metabolite can be due to its increased biosynthesis, or the down-regulation of the 
pathways having the accumulated metabolite as a starting compound. The accumu­
lation of the metabolites functioning as precursors of several biomass components 
may also result from impaired growth [120]. On the other hand, depletion of a 
metabolite might occur due to the down-regulation of its biosynthesis or increased 
demand of that metabolite. However, the increased demand often intensifies also 
the synthesis of the metabolite, for example, by the negative feedback regulation 
mentioned in the previous chapter [143]. Accumulation and depletion can also be
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affected by the degradation rate of the metabolite. Changes in the enzyme or path­
way activities are not always visible in the metabolite concentration levels due to 
the coupling of the metabolic network, but for the same reason, even small perturba­
tions in the proteome or enzyme activity can cause significant changes in metabolite 
concentrations. For more information, see [120].
The metabolic regulation covers the molecular mechanisms by which the activity 
of the individual enzymes or fluxes are modulated and controlled. Up- and down- 
regulation of enzymatic activities can be qualitatively estimated from the expression 
levels of enzyme genes and proteins, as well as using enzyme assays. In certain cases 
the pathway flux is controlled by the total amount of an enzyme present that is low 
enough to qualify as a rate-controlling step. In these cases, the regulation is visible 
in transcriptomics and/or proteomics data. In addition to regulation provided by 
transcriptomics and proteomics, metabolic regulation is another level of regulation 
of biological processes [144]. Metabolite levels themselves regulate various processes, 
for example, by negative feedback regulation. Therefore, certain compounds func­
tion both as metabolic intermediates and as metabolic regulators. The metabolic 
regulation can be investigated to some extent by the identification and quantification 
of metabolite levels.
The enzymatic regulation of metabolic pathways can occur in two different ways. 
First, the metabolic fluxes can be controlled by a small number of “key” regula­
tory or “rate-limiting” enzymes which function as bottlenecks in the biochemical 
pathways [145]. Second, the whole set of enzymes regulating several steps along a 
metabolic pathways can be regulated [146-148]. The bottleneck enzymes 
ally regulating the first steps in biological pathways, and they are often controlled 
by post-transcriptional and metabolic regulation. The reaction catalysed by these 
enzymes is usually irreversible indicating that the reaction proceeds only in one 
certain direction [143,149,150]. The bottleneck enzymes are common, for example, 
in amino-acid biosynthesis pathways [139]. The activity of irreversible bottleneck 
enzymes regulated, for example, by post-transcriptional modifications, negative feed­
back loops or other metabolic regulation cannot be accessed directly by the data 
acquirement methods covered in this thesis.
The regulation of the whole set of enzymes along a metabolic pathway has b 
proposed to be the most effective way to alter flux. These enzymes often catalyse 
reversible reactions that can easily proceed forward and backward. Nevertheless, 
they can have a large effect on 
result from coordinated changes in gene expression, parallel post-transcriptional 
modifications of many enzymes, or recruitment of enzymes into complexes [131,154]. 
Therefore, the regulation of these enzymes could be observed in the expression of 
corresponding genes. Moreover, if several enzymes along a metabolic pathway or 
belonging to several related pathways show similar response to perturbation in gene 
expression, it would give evidence of the co-regulation of these enzymes already in 
the transcriptional level.
The co-regulation of genes encoding the enzymes synthesizing reactions along a 
metabolic pathway may result from the binding of some transcription factors to the 
promoter regions of the genes. This type of a regulation is a common regulatory
are usu-
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tif in gene regulatory networks called single-input module (SIM) [155,156]. The SIM 
network motif is a simple pattern in which one master transcription factor controls 
a group of target genes. SIMs often occur in sensory transcriptional networks, and 
they control a group of genes according to the signal sensed by the master transcrip­
tion factor. In bacteria Escherichia coli, the SIM motifs often generate temporal 
programs of expression in which target genes are turned on one by one in a defined 
order, and these temporal programs are found to match the functional order of the 
gene products; the proteins are 
quentially to synthesise a desired metabolite atom by atom, in a kind of molecular 
assembly line. This pattern has been observed in the arginine biosynthesis system 
in Escherichia coli [157]. The target genes in a SIM always have a common bio­
logical function. Therefore, SIMs often regulate genes that participate in a specific 
metabolic pathway. Other SIMs control groups of genes that response to
made just when needed. These proteins work se-
a spe­
cific stress. These genes produce proteins that repair the different forms of damage 
caused by the stress. Such stress response systems usually have subgroup of genes 
that specialize in certain aspects of the response. So if genes coding a set of enzymes 
along a metabolic or stress-related pathway show similar response to perturbation 
in gene expression, and there is a TF having high expression before or at the co­
expression, it would give evidence of the co-regulation of these enzymes already in 
transcriptional level by the transcription factor. For more details, see [131,155].
When studying correlations between gene expression and metabolite 
tration levels, the traditional interpretation is that the metabolism is regulated by 
changes in the gene expression levels. However, the correlations between metabolites 
and transcripts may often be due to the regulation of transcript levels by metabolic 
status [120]. An evidence of this comes from a study of Arabidopsis thaliana in 
which diurnal variation of gene expression, metabolite concentration levels and 
zyme activities were measured in a wild type, and in a starchless phosphoglucomu- 
tase mutant (pmg) [158]. The pmg-mutant accumulates large amounts of sugars 
in the light but experiences carbon starvation in the night. The transcript levels 
undergo marked and rapid changes during diurnal cycles in both genotypes, and 
further enhanced in pmg compared with the wild type plants. Enzyme activities in 
both the wild type and the mutant do not show large diurnal changes. Majority 
of the metabolites show slow changes in the wild type plant. The authors claim 
that the enzyme activity profile and the metabolite profile change slowly because 
they represent an integration over time of faster but more transient changes in tran­
script levels. The slow response of enzyme activities, and the resulting time delay 
between changes in transcript levels and metabolite levels implies that the correla­
tion between transcripts and metabolites are likely to reflect a regulatory impact of 
metabolites on gene expression. The amplitudes of the diurnal changes in metabo­
lite levels in the mutant are small, except for sugars in the pmy-mutant. The larger 
diurnal changes in sugar levels in the mutant lead to exaggerated diurnal changes 
in the levels of more than 4000 transcripts. Many metabolite-transcript correlations 
found, and the proportion of transcripts correlated with sugars increased dra­
matically in the starchless mutant. These results suggests that correlations between 
metabolites and transcripts may often be due to the regulation of transcript levels by
concen-
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metabolic status, and are not the result of the regulation of metabolism by changes 
in gene expression as traditionally interpreted in the literature [120].
2.4.5 Quantification of the metabolome
Two completely different technologies are available for metabolome detection and 
quantification, namely a mass spectroscopy (MS) and a nuclear magnetic 
(NMR) spectroscopy [124,159-161]. In addition to quantifying the proteome, the 
mass spectroscopic methods are used to determine the metabolome of an organ­
ism [140,162,163]. This thesis will focus on mass spectrometric technologies in 
metabolic profiling that can be used, for example, to classify healthy and diseased 
samples, or to understanding the effects of environmental, genetic or other induced 
changes on organism’s metabolism. There are three types of metabolomic anal­
ysis: metabolic profiling, metabolic fingerprinting and metabolic footprinting. In 
metabolic profiling, i.e., targeted metabolomics, quantitative analysis of a prede­
fined set of metabolites is performed. The predefined set can be a selected biochemi­
cal pathway or a specific class of compounds, i.e. amino acids. The advantage of the 
metabolic profiling is the maximization of specificity and sensitivity of the applied 
methods. The goal in the targeted metabolomics is often to determine metabo­
lite fragmentation patterns and construct calibration curves for absolute metabolite 
quantification.
On the other hand, metabolic fingerprinting, i.e. untargeted global metabolomics, 
is a global screening approach aiming to maximize the coverage of analyzed metabo­
lites. Metabolic fingerprinting has been used to classify samples based on metabolite 
patters that change in response to disease, environmental or genetic perturbations. 
In metabolic fingerprinting, the goal might just be obtaining a good classifier to 
classify samples into healthy and diseased classes without further identification or 
quantification of metabolites. Metabolic fingerprinting can be used to address the 
success of treatment strategies by monitoring if the metabolic phenotype shifts back 
to the healthy state after drug treatment. Metabolic fingerprinting does not di­
rectly contribute to the biochemical knowledge and understanding of the underlying 
biological mechanisms because it compromises with the sensitivity and specificity 
for any particular metabolite. Metabolite fingerprinting requires usually more data 
analysis, and interpretation of the hundreds to thousands of resulting compounds 
is challenging due to a large number of unknowns and experimental uncertainties. 
Hence analysis depends extensively on computational tools, statistical methods and 
metabolite databases.
The third type of metabolic analysis, metabolic footprinting, denotes an anal­
ysis of extra-cellular metabolites in cell culture medium as a reflection of metabo­
lite excretion or uptake by cells. [164—166]. In this thesis, the technique to obtain 
metabolomics data is an intermediate form of metabolic profiling and metabolic fin­
gerprinting: only certain types of metabolites are investigated but instead of their 
absolute levels, only relational levels of metabolites are obtained.
Mass spectrometric (MS) technologies are increasingly used methods to identify 
and quantify metabolites in biological samples [140,166]. The application of MS to
resonance
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metabolite analysis is providing new insights into the biochemical functions, and the 
cellular physiology of living organisms. MS methods have been used for biomarker 
discovery, and for systematic investigation of metabolic dynamics, for instance. The 
metabolome represents a vast number of components that belong to a wide variety of 
compound classes such as amino acids, lipids, organic acids, sugars and nucleotides. 
These metabolites in living organisms have very diverse physicochemical properties 
and occur at different abundance levels. There is no single-instrument platform that 
currently can analyze all metabolites. Furthermore, the comprehensive investigation 
of the metabolome is being complicated by its enormous complexity and dynamics.
Mass spectrometric methods are based on ionization of the sample metabolites, 
and accelerating the charged molecules in an electromagnetic field, resulting to the 
separation of molecules having different mass and charge. Generally 
trometry measures the mass-to-charge ratio of the charged molecules, m/z. The m 
denotes to the mass of an ion and the z is the number of elementary charges 
the ion. MS procedure consists of five parts: first, a sample is loaded to the MS 
instrument, and it is vaporized; second, the sample molecules are ionized by one of a 
variety of methods, e.g. by bombarding the molecules with an electron beam, which 
results in the formation of charged particles. Third, the ions are separated accord­
ing to their mass-to-charge ratio by an electromagnetic field; fourth, the ions 
detected, typically using a microchannel plate or photomultiplier tube, and quanti­
fied, and fifth, the ion signal is processed into mass spectra. The mass spectrometric 
data analyzed in this thesis were measured using Thermo Finnigen’s LC-LTQ high- 
resolution MS instrument which ionizes the samples using electrospray ionization, 
and isolates and fragments the ions using linear ion-trap. Only techniques used to 
obtain the data are described in this section
Before loading the sample to the MS instrument, different metabolites 
ally separated by a chromatographic method such as gas chromatography (GC) or 
liquid chromatography (LC) [167]. Combination of MS instrument with a separation 
technique reduces the complexity of the mass spectra due to metabolite separation in 
a time dimension, provides isobar (different metabolites having the same elemental 
structure) separation, and delivers additional information about the physicochem­
ical properties of the metabolites. The different metabolites are separated in the 
chromatographic columns by their different adhesion properties to the column mate­
rial or the attachment to the small pores. The columns are manufactured from silica 
with various attached groups. Therefore, the metabolites come out of the column, 
and enter the MS instrument at different times. The time a solute takes to travel 
through the column is denoted as a retention time. When using GC-MS technique, 
the compounds in a sample are dissolved to a mobile gas phase, and separated by 
a gas chromatograph. The GC-MS method is the most widely used MS method. 
However, the compounds used in GC-MS need to be volatile and thermostable. In 
contrast, LC suited better for non-volatile metabolites separates compounds chro- 
matographically using liquid mobile phase, usually a mixture of water and organic 
solvents. For more information, see [165,166].
MS requires formation of gas phase ions that can be resolved through the 
nipulation of electromagnetic field. The ionization method used in this work, the
mass spec-
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electrospray ionization (ESI), is suitable for non-volatie molecules separated by LC 
as it allows desorption and ionization of a wide range of molecules directly from
on the formation and drying of charged liquid 
droplets. Fine droplets are formed through a charged nebulizer needle. As sol­
vent evaporates, the charges are concentrated on the surface. When surface charge 
repulsion exceeds surface tension, droplets break up into smaller droplets. This 
secutive concentration process continues until gas phase ions are ultimately formed. 
The ESI produces even-electron pseudo molecular ions [M + H]+ or [M-H]- usually 
without fragmentation. Therefore additional fragmentation techniques are required 
such as tandem MS methods discussed in the subsequent paragraphs [166].
Mass analyzers separate ions according to their mass-to-charge ratio. In order to 
distinguish between compounds with the same nominal mass, high-resolution 
spectrometers are the instrument of choice. High-mass resolution instruments allow 
accurate mass measurement, as well as the calculation of empirical molar masses, 
and thus the elemental formulas of the molecules. There exists several types of 
analyzers with a static or dynamic field. Moreover, the field can be magnetic, 
electric or both. An example of a mass analyzer is a quadrupole mass filter that 
uses oscillating electrical fields to selectively stabilize or destabilize the paths of ions 
passing through a radio frequency quadrupole field created between 4 parallel rods. 
Only the ions in a certain range of m/z -ratios are passed through the system at 
any time and detected. The mass analyzer used in this work is the ion trap which is 
closely related to the quadrupole mass analyzer [168]. In the ion trap, the ions 
trapped by a quadrupole and subsequently ejected. The combination of several dif­
ferent mass analyzers can be used to acquire fragmentation information by isolating 
and fragmenting target ions, and analyzing and detecting the resulting fragments. 
These are called MS/MS analysers or tandem MS. Fragmentation experiments 
important to enable the comparison of experimental fragmentation patterns with 
authentic standards and spectral databases to confirm molecular structure. For 
more details, see [165,166]. In addition, combining different MS techniques together 
increases the amount of detectable metabolites. Platforms that combine technical 
approaches have covered hundreds of metabolites from plant central and secondary 
metabolism [169].
Many MS methods require a sample preparation step that is, however, one of 
the major sources of error in the MS analysis. The steps in the sample preparation 
quenching, cell harvesting, cell lysis and metabolite extraction [170]. Quenching 
to halt the metabolism is usually done through addition of cold methanol or flash­
freezing the biological samples in cold nitrogen. Biological matrix consisting of all 
other biological material than metabolites of interest must be removed from the 
pies. For metabolite extraction, a wide range of solvent systems and temperatures 
can be used. All of these steps in the sample preparation can cause metabolite losses. 
Metabolites may change during the harvest and quenching of the biological material, 
and they may be lost or modified during the preparation of the extracts. Therefore, 
the extracts must be converted into a form in which metabolites are stable and that 
can be applied to the analytic machine. For more information, see [165,166].
The minimum information about a metabolomics (MIAMET) experiment which
the liquid phase. The ESI is based
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should be reported with each study have been introduced [118]. These are sampling, 
sample preparation, sample analysis including metabolite separation and MS detec­
tion, data export and data analysis. Some reporting standards for metabolomics 
analysis have been presented [171-173] and the demands on data quality and vali­
dation discussed [161].
2.4.6 Statistical analysis of the metabolomics data
After the mass analysis and the detection of the fragmented ions, the metabolites are 
identified and quantified. The raw data is usually a subject of several normalization 
and standardization pre-processing methods, for example, to reduce noise and back­
ground, to correct the baseline, and to minimize the impact of variability of high- 
intensity peaks. Mass spectrometric or chromatographic peaks are automatically 
picked and annotated to certain metabolites. MS instrument manufacturers usually 
provide a software for the export of MS data such as LEGO and Micromass [167]. 
Several platform-independent metabolomics softwares have also been developed such 
XCMS [174], MZmine [175], KNApSAck [176] and mslnspect [177]. The data 
used in this thesis was collected using Xcalibur-program. More information about 
the form of data produced by MS can be found in [165,166].
The absolute values of metabolite concentrations can be obtained when in­
ner standards with known concentrations are used to calibrate the MS instru­
ment [165,166]. Sometimes, only few inner standards not necessary including the 
target metabolites can be used to determine the relational levels of metabolites as 
was done to obtain the data analyzed in this thesis.
Statistical analysis methods usually applied to the data matrices obtained from 
the metabolome analysis are the same as for the gene expression data: principal 
ponent analysis (PGA), independent component analysis (IGA) [178], hierarchical 
clustering, self-organizing maps (SOM), and canonical correlation analysis (CCA). 
These unsupervised methods suit for a situation in which the aim is to cluster 
pies of unknown identity, and investigate the metabolites responsible for the cluster 
differences. On the other hand, the sample identity is often known, for example, 
when the aim is to discover characteristic biomarkers. Then supervised methods, 
such as analysis of variance (ANOVA) [179], or partial least squares methods (PLS), 
be applied. PLS methods identify the combinations and weightings of a large 
set of metabolites that provide the best prediction of a target trait such as biomass 
production [180]. One type of PLS method, 02PLS [21,181,182] allows systematic 
predictive variation that links different types of parameters to be separated from 
parameter-specific variation. Examples of applying statistical and modelling meth­
ods to metabolomic data on its own or together with other data types can be found 
in [158,171,171,180,183-192].
Several sources produce variation to the metabolomic data: First, specific pertur­
bations within the underlying network of biochemical reactions, typically 
pression or knock-out of a gene coding for an enzyme, causes changes in metabolite 
levels. Second, global perturbations, such as a circadian clock, and responses to 
temperature and stress induce changes at multiple sites within the metabolic net­
as
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work. Global changes that are brought about by external factors can influence 
a large number of metabolites simultaneously. Third, there is intrinsic variability 
between strongly interrelated variables. Popular method to analyse metabolomics 
data is to study the correlations between the metabolites to find functionally related 
metabolites [193-196]. Correlations are transitive, meaning that given a metabolite 
A which shows a high correlations to metabolite B, as well as to metabolite C, then 
В and C should be correlate as well. However, correlations do not tell much about 
the causal relationships between metabolites.
Metabolites are correlated due to various reasons [196] such as equilibrium be­
tween neighbouring metabolites; mass conservation; diminutive fluctuations within 
the metabolic network which propagate through the system [197-199]; global per­
turbations such as the circadian rhythm; asymmetric control in which 
ters dominates the control of several metabolites; shared biosynthetic enzymes; and 
coordinated regulation of gene expression [21,197,198,200]. Whether two metabo­
lites correlate or not is a combined result of many if not all, biochemical reactions, 
regulatory interactions and the inducing fluctuations that constitute a system. Cor­
relations do not necessarily occur between metabolites that are neighbours on the 
metabolic map but other more subtle mechanisms 
fore, many correlations observed in metabolome data remain unclear, and addi­
tional knowledge than just metabolite and transcript levels is needed to decode the 
regulatory mechanisms of metabolic pathways hidden in the metabolite-metabolite 
correlations [186,201].
Time series data is essential when studying correlations between metabolites and 
to draw conclusions about the regulatory processes [179,202]. Time series experi­
ments can reveal temporal dependencies between parts of metabolite network and 
provide insights into functional dependencies between the metabolites. Further in­
sight brings the combined analysis of gene expression and metabolites. For example, 
integrated time series metabolome and transcriptome analysis on a mutant plant 
of abscisic acid (ABA) biosynthesis under dehydration has been performed. This 
study indicated the ABA-dependent regulation for the formation of branched-chain 
amino acids (sacharopine, proline, polyamines) which presumably play important 
roles in plants’ responses to dehydration stress [203].
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2.5 Regulation of oxidative stress signalling in Arabidopsis 
thaliana
2.5.1 Oxidative stress signalling
Plants are the most consummate and sophisticated chemical systems in the world. 
They use light energy to convert carbon dioxide into carbohydrates in their leaves. 
However, plants cannot move and so they need to cope with chancing environmental 
conditions and various biotic stresses including pathogen attacks, and abiotic stresses 
such as heat, drought, air pollutants and absence of nutrients.
Ozone is a triatomic oxygen molecule protecting life on earth from ultravio­
let radiation in stratosphere. However, when appearing in troposphere, it is an
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atmospheric pollutant and causes oxidative stress to plants. The tropospheric 
centration of ozone has increased two- to five-fold during the past 60 years due to 
human actions [204]. High peaks in ozone concentration cause visible damage in 
sensitive plants by oxidizing and damaging cell membranes [205-207]. During a 
continuous low level of ozone, photosynthesis and growth of a plant are impaired, 
and the senescence occurs earlier, which results in crop losses worth of several million 
dollars annually [207-209]. Therefore, is it important to understand the signalling 
during oxidative stress, for example, to develop stress-tolerant genetically modified 
(GMO) crops.
The events starting from ozone recognition, and resulting in adaptation of a plant 
to a stressful situation or tissue damage are tightly regulated. This oxidative stress 
signalling resembles the hypersensitivity response (HR) of plants to pathogens such 
as bacteria and viruses [206,210,211]. HR is a form of programmed cell death (PCD), 
apoptosis. Apoptosis requires active cellular processes such as energy production, 
signal transduction, ion fluxes, transcription and translation [212].
Under intolerable concentrations of ozone, the oxidative stress signalling leads 
to the PCD and visible tissue damage, lesions. The oxidative stress signalling and 
regulation of the apoptotic lesion formation have six stages: regulation of ozone flux 
to leaves; ozone degradation to reactive oxygen species, and detoxification by 
bate in the apoplast; ozone sensing or perception; ozone-induced active production 
of reactive oxygen species; early activation of mitogen-activated protein kinases by 
ozone; and hormonal regulation of ozone-induced lesion formation. These compo­
nents are presented in Figure 3, and the steps 1 to 11 in this figure are explained in 
the subsequent paragraphs.
The plant cells are surrounded by a free diffusional space called apoplast. It is 
formed by the cell walls of adjacent cells, as well as the extracellular space. The 
apoplast facilitates the transport of water and solutes across a plant tissue or an 
organ. Ozone enters to the plant through small pores in leaves which are used by 
the plant to exchange gases and to evaporate water with the apoplastic space and 
air. The mechanism by which the plant cells sense ozone is not known. Ozone itself 
is not deleterious to the cell plasma membrane, but when it enters to the apoplastic 
fluid, it rapidly degrades into super oxide anion radicals Oj , hydrogen peroxide H2O2, 
hydroxyl radicals OH*, and singlet oxygen. These are called reactive oxygen species, 
ROS (step 1 in Figure 3 ). Although ROS damage the cellular membranes [207], they 
also important regulatory molecules in several stress signalling processes. During 
a substantial or prolonged ozone exposure, ROS signalling eventually initiates a 
programmed cell death of individual cells, or the whole tissue [211]. In apoplast, 
the ROS molecules are scavenged by apoplastic antioxidative molecules such as 
ascorbate. This partly removes the harmful ROS generated from ozone (step 1 in 
Figure 3) [214]. If the apoplastic antioxidants cannot detoxify ROS, ROS level in 
apoplast increases over a threshold which elicits several downstream processes [213].
If apoplastic antioxidative capacity is not enough to remove the ROS formed from 
ozone, the perception of ROS induces a signalling cascade that include endogenous 
signalling, as well as cell-to-cell signalling. Different mechanisms have been proposed 
for ROS sensing [213,215-217] but the whole picture has not emerged. When ROS
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Figure 3: ROS signalling in oxidative stress. The rounded rectangles are individual 
plant cells. ROS, reactive oxygen species; 03, ozone; МАРК, mitogen-activated pro­
tein kinase; Ca2+, calcium-ion; ET, ethylene; a, G-protein a-subunit; /3, G-protein 
Д-subunit; 7, G-protein 7-subunit; Rac, a small GTPase; RBOH, NADH oxidase 
(respiratory burst oxidase homolog); SOD, superoxide dismutase; O2, oxygen; O2 , 
superoxide radical; H2O2, hydrogen peroxide; ETR, ethylene receptor; SA, salicylic 
acid; JA, jasmonate. [213]
perceived by a cell, the cell triggers a signalling pathway which leads the cell 
to produce extracellular ROS. The extracellular ROS are then perceived by the 
neighbouring cells. The neighbouring cells also start an active production of ROS, 
and thus the signal propagates. Various protein-signalling cascades are involved in 
this process, as well as several plant hormones. Hormones regulate especially the 
ROS signalling initiation, propagation and containment. This signalling can lead to 
a programmed cell death. The place where the PCD signalling starts is called lesion 
initiation site.
Various signalling proteins such as guanosine nucleotide-binding proteins (G- 
proteins), NADPH oxidases and mitogen-activated protein kinases (MAP kinases) 
are likely involved in the ozone stress signalling (steps 2, 3, 4 and 6 in Figure 
3) [218-220]. There are two separate chains of events that occur when the ROS 
formed in the apoplastic space. First, somehow ROS production is induced in 
the chloroplasts through the heterotrimeric G-protein (or the G/Fy complex) (steps 2 
and 3 in Figure 3) [221]. In addition, as a result of chloroplastic regulation, there is a 
rapid and coordinated down-regulation of many nuclear genes encoding chloroplast 
proteins, presumably as a result of chloroplast-derived signals [222]. Second, ROS 
production in the cell plasma membrane by NADPH oxidases (RBOH in Figure 
3) is activated in a G-protein a:-subunit-dependent way, possibly through a small 
GTPase Rac (step 4 in Figure 3). For more details, see [213].
Receptor enzymes receiving signals from extracellular and intracellular 
usually initiate a long series of protein-signalling cascades which eventually lead to
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expression of certain genes as a response to the signal. In these cascades, the sig­
nal usually propagates from protein to protein by phosphorylation. MAP kinase 
cascades are an example of such signal transduction. MAP kinase cascades 
tivated within minutes from the beginning of ozone exposure (step 6 in Figure 3). 
The activation of MAP kinases does not require the G-protein, and they do not ap­
pear to be directly involved in the activation of ROS production by NADPH oxidase 
RBOH. The two primary oxidative stress related MAP kinases in Arabidopsi 
AtMPK6 and AtMPKS marked in Figure 4. The Figure 4 shows also the upstream 
MAP kinase kinases, and MAP kinase kinase kinases, and downstream targets of 
which some are transcription factors. The MAP kinases AtMPKG and AtMPKS 
connected to the hormonal responses, especially to the synthesis of plant hormone 
ethylene [213]. The activation of AtMPK6 might results in increased plant hormone 
ethylene synthesis (step 6 in Figure 3 and Figure 4). In addition to ethylene, a 
biosynthesis of another plant hormone, namely salicylic acid (SA) is also induced in 
the beginning of ROS signalling, and it accumulates during lesion spreading (step 
5 in Figure 3) [223,224]. Salicylic acid is also involved in the PCD signalling and 
contributes to the containment of lesion growth [213]. ROS has been shown to be 
involved in the regulation of key steps in SA biosynthesis during pathogen infection.
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Figure 4: MAP kinase cascades and some transcription factors and metabolic 
pathway genes which are affected by them. МАРК, mitogen-activated protein ki­
nase; MAPKK, MAP kinase kinase; MAPKKK, MAP kinase kinase kinase; PR- 
1, pathogen response-1 ; ACS, 1-aminocyclopropane- 1-carboxylic acid synthase, the 
rate-limiting enzyme in ethylene synthesis. [219]
The activation of MAP kinases and NADPH oxidases are both calcium depen­
dent, and indeed calcium influx takes place in the early stages of ROS signal trans­
duction (step 8 in Figure 3). After step 4, when the ozone has been sensed, and the 
G-protein a-subunit has activated the NADPH oxidase (RBOH) in the cell 
brane, the NADPH oxidase produces extracellular ROS to the apoplastic space, and 
ROS production and initiation of the SA-dependent cell death spread to the adjoin-
mem-
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ing cells. This active production of ROS is called an oxidative burst [224-227]. In 
the oxidative burst, apoplastic O2 and H2O2 are produced. Thus, NADPH oxidase 
passes the signal from cell to cell. The ROS produced by the NADPH oxidase in the 
lesion initiation site are perceived by the neighbouring cells, in which G-protein 
trolled activation of ROS-production is induced in several subcellular compartments 
such as chloroplast and mitochondrion.
Hormonal regulation and plant hormones abscisic acid (ABA), salicylic acid 
(SA), ethylene (ET) and jasmonate (JA) are important in determining the de­
gree of plant ozone sensitivity and lesion initiation, propagation and containment 
[212,228-232]. Increase of ethylene concentration is one of the fastest responses of 
plants to ozone (step 7 in Figure 3), and is well correlated with the extent of cell 
death [231,233-238]. Furthermore, ROS production drives the SA-dependent cell 
death (step 5 in Figure 3) [223,239] which continues until the third hormone, JA, 
antagonistic to lesion propagation, contains the enlargement of the lesion lesions 
spread (step 10 in Figure 3). The spread of the ROS signal to the neighbouring 
cells, and the competence of these cells to receive the ROS signal is ethylene de­
pendent (steps 7 and 9 in Figure 3 ). The heterotrimeric G-proteins are involved 
in receiving the signal, and they pass it forward in an ethylene dependent manner 
(step 9 in Figure 3). The repetition of this process along cells is depicted 
self-amplifying loop, i.e an oxidative cell cycle, presented in Figure 5, which results 
in the formation of visible lesions [231, 232, 240]. In this cycle, the endogenous, 
cell-death driving ROS production triggered by ozone is ET and SA dependent and 
repressed by JA [205,231,236,237]. Cell death during the lesion spread creates 
increasing concentration of membrane lipid peroxidation products which 
substrate for jasmonate (JA) biosynthesis. Therefore, when the lesion propagates, 
jasmonates begin to accumulate. Increased JA accumulation reduces ethylene 
sitivity of the cells in the spreading lesion, resulting in a gradual decrease in the 
ethylene-dependent ROS production, and consequently containments the cell death 
(step 10 in Figure 3). The JA signalling is suppressed by SA and ET during the ini­
tial cell death. Abscisic acid (ABA) is still another plant hormone functioning in the 
oxidative stress signalling. The biosynthesis of ABA is increased by ET. Moreover, 
the balance between ABA and ET is maintained through subsequent inhibition of 
ET biosynthesis by ABA and by mutually antagonistic interactions between ABA 
and ET signalling. In addition, ABA is involved in responses to several abiotic 
stresses, and is a regulator of glucose signalling. For more details, see [213].
All steps from 1 to 11 in Figure 3 regulate a set of ozone-induced responses 
including cell death, and the transcription of defence-related genes (step 11). As a 
conclusion, the time development and activation of each process in oxidative stress 
signalling starting from the ozone exposure is shown in Figure 6 [213].
A major part of plant adaptation to abiotic stress is regulated at the level of tran­
scription. Several processes contribute to the stress signalling: post-translational 
activation [241]; selective nuclear import of transcription factors; regulation of DNA 
accessibility by chromatin modifying, and regulation of remodelling enzymes; and co­
operation between two or more TFs in a stress-responsive promoter. Several hundred 
to thousands of genes in plants have been identified with altered response to abiotic
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Figure 5: Oxidative cell cycle. X/XO, xantine/xantine oxidase(oxidative agent); 
SOD, superoxide dismutase; O2, superoxide radical; 03, ozone; DPI, diphenylene 
iodonium(an inhibitor of ROS accumulation) ; RODI, RADICAL INDUCED CELL 
DEATH; JA, jasmonate; JARI, mutant of this gene is JA insensitive ; ACS6, ACC 
synthase 6; ETR, ethylene receptor; NBD, ethylene antagonist; EIN2, mutant of this 
gene is ethylene insensitive; NahG, salicylate hydroxylase; SA, salicylic acid. [231]
12 24 time(h)
Figure 6: Time development of oxidative stress. [213]
stress [242]. To translate the stress exposure into appropriate changes in gene expres­
sion, suitable signalling pathways needs to be activated, ultimately ending up with a 
transcription factor binding at the promoter of the gene to be transcribed. Changes 
in gene expression can be detected within 15-30 min of an applied stress [243] and 
can last for several days. The expressed genes can be classified into three groups: 
early (expressed at 0-3 h after the onset), intermediate (expressed at 3-6 h after
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onset) and late genes (6-10 h or more after the onset). Examples of genes induced 
early are coding pathogen-responsive proteins and an elicitor-induced genes, 
pies of the intermediate genes are 
the late genes include peroxidases and hydroxyproline-rich glycoprotein genes [206].
Arabidopsis genome encodes about 2000 TFs, corresponding to 7 % of the genes 
in this species [244]. The function of about ten of them is known. TFs have an im­
portant role in oxidative stress signalling. In response to oxidative stress signalling, 
some TFs already present in the cytoplasm can be activated by post-transcriptional 
modifications, or they can be transferred to the nucleus. On the other hand,
TF genes are transcribed to produce new regulatory proteins. Many genes with rapid 
changes in gene expression after abiotic stress treatment encode TFs [243,245]. TFs 
be divided into early and late expressed. The early TFs increase the expression 
of a second class of TFs with a role in later and prolonged stress responses. For 
more details, see [246].
In this thesis, the metabolite data contain 19 proteinogenic amino acids: ala­
nine, arginine, asparagine, aspartic acid, glutamate, glutamine, glycine, histidine, 
isoleucine, leucine, lysine, methionine, phenylalanine, proline, serine, threonine, 
tryptophan, tyrosine, valine; 1 polyamine: 7-aminobuturic acid (GABA), 6 
proteinogenic cr-amino acids: citrulline, ornithine, homocysteine, cystathionine, a- 
aminoadipic acid, a-aminobutyric acid; and 2 other organic acids with an amino 
group: /З-aminoisobutyric acid and pipecolic acid. Most of these metabolites 
produced in the chloroplasts where the photosynthesis occurs. In addition to being 
precursors for protein synthesis (proteinogenic amino acids) and secondary metabo­
lites, these metabolites have several other functions in a cell, for example in oxidative 
stress regulation [206].
Chloroplasts-derived metabolites, and especially amino acids, serve as precursors 
for biosynthesis of several plant hormones and other biomolecules that regulate the 
oxidative stress response: cysteine is a precursor of glutathionine (GSH); methionine 
is a precursors of ethylene; phenylalanine is a precursor of SA; tryptophan is a precur- 
of the growth hormone auxin and abscisic acid; arginine is precursor of agmatine, 
a polyamine, whereas ornithine is a precursor of polyamines putrescine, spermidine 
and spermine; and glutamate is a precursor of polyamine gamma-aminobutyric acid.
Aromatic amino acids serving as precursors for the biosynthesis of auxin and 
flavonoids are synthesised in chloroplast via a shikimic acid pathway [247-249]. Be­
sides providing building blocks for protein synthesis, aromatic amino acids also 
as precursors for important secondary metabolites, including tryptophan-derived in­
dole hormones and phenylalanine- and tyrosine-derived flavonoids and lignins (Fig- 
7 ) [247,248]. The shikimate-derived pathways are regulated by complex net­
works, including feedback control by aromatic amino acids and environmental fac­
tors [249]. A proteinogenic, aromatic amino acid phenylalanine is a starting 
pound in the flavonoid biosynthesis. Moreover, together with tyrosine derived from 
phenylalanine, phenylalanine is the precursor of lignin (Figure 7 ). Ozone exposure 
causes increases in the activities of several phenylpropanoid and flavonoid path­
way enzymes [206]. Ozone treatment has been shown to increase the activities of 
PAL and CAD, enzymes controlling respectively the phenylpropanoid, flavonoid and
exam-
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Figure 7: Connections between hormones, secondary metabolites and phenylalanine. 
This graph depicts the stress induction of phenylpropanoid metabolism in plants, 
and induction of various defence reactions by some phenylpropanoid substances. 
Dashed lines indicate known induction of enzyme activity or gene expression. CA, 
cinnamic acid; 4-CA, trans cumarylic acid; CaA, cafeic acid; SA, salicylic acid; CHS, 
chalcone synthase, PAL, phenylalanine-ammonium lyase; CAD, cinnamyl alcohol 
dehudrogenase, 4CL, p-coumarate-CoA ligase. [206]
This biological background to the oxidative stress signalling is given to present 
connections between measured metabolites, and other components participating in 
the signalling. It was recognized that several of the measured metabolites 
cursors of hormones, or other metabolites functioning in the signalling or stress 
adaptation. The results obtained by this thesis are compared to the known reg­
ulation of oxidative stress signalling presented in this chapter. The chapter also 
illustrates the importance of transcriptional and metabolic regulation during the 
oxidative stress signalling.
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2.5.2 Role of the gene RCD1 in oxidative stress signalling
The protein RCD1 (RADICAL-INDUCED CELL DEATH1) mapped to a gene
AT1G32230 has an unknown role in oxidative stress signalling. This protein is 
a member of SRO (Similar to RCD-One) protein family, consisting of 6 members, 
which all contain a certain protein-protein interaction domain. An ozone tolerant 
Arabidopsis thaliana ecotype Col-0, when having a mutation in this gene, gives 
ozone-sensitive phenotype. Mutation disrupts an intron splice site resulting in a 
truncated protein. In addition to ozone sensitivity, the mutant redi has several 
other phenotypes related to growth, development and hormone biology [231,250].
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lignin biosynthesis pathways (Figure 7 ). These pathways play a significant role in 
plant defence responses because they synthesise many potentially protective 
pounds including flavonoids, furanocoumarins and lignin. For more details, see [206].
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The redi is sensitive to condition that leads to the formation of apoplastic ROS but 
it has an increased tolerance to UV-B light [251]. Moreover, the appearance of the 
mutant plant is different; it has smaller, more erect rosettes, altered leaf shape and 
earlier flowering (Figures 8(a) and 8(b)).
Col-0 f (redi-r-
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ferences of the wild ozone exposure. The Col-0 shows no sign of damage, 
type Col-0 and the whereas the redi mutant has produced lesions. [231] 
redi. [231,250]
Figure 8: Arabidopsis thaliana wild type Columbia-0 and redi mutant.
The RCD1 is assumed to interact with another proteins, and likely with tran­
scription factors because the RCD1 protein contains several protein-protein inter­
action domains [252], and domains which localize it into the nucleus. [252]. The 
protein-protein interaction domain in the RCD1 was shown to interact with several 
transcription factors or DNA-binding proteins involved in dehydration or osmotic 
stress responses, such as DREB2A, which is a central transcription factor in the 
ABA-independent responses to osmotic stress [253]. Indeed, one of the target genes 
of DREB2A, namely the RD29A/LT18, had lower steady state transcript levels in 
the redi mutant. It has also been speculated that the RCD1 could function by 
post-transcriptionally modifying its target proteins [213].
The redi is a lesion propagation mutant and hormone-balance -related runaway 
mutant. Its sensitivity to extracellular ROS leads to extensive formation of HR-like 
lesions, and activation of several pathogen defence-related processes in response to 
ROS. Therefore, the RCD1 seems to define a component of the HR related to the role 
of ROS in PCD regulation. The redi appears to be deficient in the control of lesion 
propagation, leading to wide cell-death spreading, whereas in the same conditions, 
the wild type has no visible lesions, although microscopically small lesions 
(Figures 8(a) and 8(b)). The deficiency occurs only transiently in the redi because 
after 24 h (ozone exposure between 0 h and 6 h) the propagation of lesion is brought 
under control. In contrast, in the wild type Col-0, there is lesion initiation but 
propagation.
The mutation in the RCD1 seems to affect mostly hormone-related processes. 
The redi has normal levels of SA and JA under control condition but under 
exposure, the levels of ET, SA and JA are higher compared to the wild type. In 
addition, in a microarray analysis with 6400 oxidative stress related genes, the few 
genes that had changed basal expression level in clean-air grown redi are involved in
dif- (b) The wild type Col-0 and the redi mutant after
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either ethylene-, ABA- or sugar-related processes [250]. Furthermore, the redi shows 
slight insensitivity to ABA, ET and JA in some specific responses to these hormones. 
The redi is described as an ET overproducer and a JA insensitive mutant. It has 
been hypothesized that the RCD1 encodes a protein that most likely is involved in 
interactions between hormonal signalling cascades in abiotic stresses [213,250].
While the redi mutant shows differences in hormone levels and metabolism- 
related processes (sugar metabolism [250]), and some of the metabolites analyzed 
in this work are precursors of the hormones playing a role in the oxidative stress 
signalling, changes in metabolite concentrations between the wild type and the 
tant redi under ozone exposure are expected. The results obtained in this thesis 
investigated in the light of previous knowledge of changes caused by the mutated 
gene during the oxidative stress signalling. The mutated gene very likely interacts 
with the transcription factors, which makes the interpretation of the results hard. 
If under ozone exposure there is a differential expression of some genes (either genes 
coding metabolic enzymes or transcription factors) between genotypes, this implies 
that either the RCD1 directly bounds to the promoter of these genes and regulates 
them, or the RCD1 interacts with the transcription factors regulating these genes. 
In the latter case, one could be interested of the potential motifs at the promoters 
of the differentially expressed genes to find transcription factors which potentially 
interact with the RCD1.
mu-
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3 Probabilistic modelling and mathematical back­
ground
3.1 Probabilistic modelling
Data analysis is a field of study using computational methods to analyse collec­
tions of data including data obtained by measuring natural phenomena. Natural 
data contain always errors and unwanted variation resulting from sources such as 
inaccurate measurement technologies, differences in observed subjects, and human 
errors. The measured phenomenon can also be stochastic by nature. Due to these 
different sources of random errors in the observed data, the exact underlying de­
scription of the phenomenon is unknown. Nevertheless, the underlying model for 
the phenomenon can still be estimated, and a deviance of the estimate from the 
true model determined using probabilistic modelling framework. To understand the 
probabilistic model estimation goal, definitions for some key concepts of statistical 
modelling are presented in this and the following chapters.
A data set is a collection of n observations or samples x each of which is con­
sidered to be an instance of a random variable X. The noise in the individual 
samples is usually considered independent between samples, and to follow the 
distribution if the samples are observations replicated under the same experimental 
conditions. The samples having this property are referred to as independent and 
identically distributed (i.i.d.). Each sample can be a continuous or a discrete single 
value, or a data vector of several values; in that case the instance of a random vari­
able, x, is a multidimensional variable with dimension d. Elements in a data vector 
x are called features. A data set can be represented as a data matrix X in which 
columns correspond to samples and rows correspond to features. In this thesis, two 
multivariate data sets X and Y with paired samples are analyzed. Paired samples 
of the two data sets are co-occurring, i.e. the zth column in data set X is paired 
with the ith column in data set Y. Both data sets have an equal number of n 
samples.
same
Collections of observations can be described using probabilistic models. A model 
describing the data enables the understanding of the underlying phenomenon, and 
the prediction of future observations. A model is usually constructed to describe and 
summarize the process that generated the data; such models are called generative 
models. A model is usually a specific instance of a model family that is a collection 
of all possible models. The model family is usually determined by the assumptions 
made before the model implementation. Assumptions include, for example, the form 
of the probability distribution, and the independency assumptions of the variables.
A specific model within a model family is defined by model parameters. A single 
model is found by estimating the values of the model parameters from the data. 
Parameter values are chosen by optimizing the data description of the model. This 
is called learning or fitting a model. To find the best model, a measure for the 
quality of the model describing the data set is required. The criterion of fit or cost 
function usually used is the likelihood function. The likelihood function defines the 
probability of the observed data given the model parameters. By maximizing the
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likelihood function, a maximum likelihood estimate for the model is obtained.
A good probabilistic model generalizes well to yet unseen data; it predicts future 
observations well, and describes the underlying probability distribution and not just 
the data used in the learning phase. When the model does not generalize to 
observations, overlearning or overfitting has occurred. This implies that the model 
does not only fit to the training data but also models the noise in the training data, 
which is undesirable. Overfitting is likely when the model is complex, i.e. has high 
effective dimensionality of parameters, and when the training data set is small. One 
solution to overfitting is regularization which forces the complex model to a simpler 
one. Regularization can imply reduction of non-linear models towards linear ones, or 
drawing certain model parameters to
new
zero. Regularization is often done by adding a 
separate penalty term to the cost function. Regularization is discussed more detailed 
in Chapters 3.2, 3.3 and 3.5.5.
Machine learning is a field of study in which computational programs are imple­
mented to learn from data [254]. In machine learning, learning methods are roughly 
divided into two groups: supervised learning and unsupervised learning. This thesis 
considers unsupervised learning where the task is to summarize the data, and find 
the probability distribution that represents the distribution of the data. Examples of 
unsupervised learning methods are clustering, density estimation, visualization and 
dimensionality reduction. Exploratory data analysis is a subfield of unsupervised 
data analysis. In exploratory data analysis there is often little prior information of 
the data, and the goal is to extract novel systematic properties from an unknown 
data collection. Properties of the data that are studied by exploratory data anal­
ysis can be complex and largely unknown. Exploratory data analysis can suggest 
novel hypotheses for statistical testing, or suggest what kind of data to collect in 
the future to test these hypotheses. Examples of exploratory data analysis include 
clustering and visualization.
Data fusion is a subfield of data analysis aiming at combining several data 
sources, in order to improve the accuracy of the analysis. Noise in measurements is 
usually reduced by averaging over multiple measurements; thus data fusion can be 
seen as a generalization of averaging over several sets of measurements. In addition, 
the main interest in data analysis can be to find structure visible in several data sets 
with co-occurring observations. In machine learning, multi-view learning is a term 
including methods, for example, which search consensus between the multiple views, 
i.e. multiple data sets. Consensus can be defined in a numerous ways, for example, 
by seeking the variation common to both data sets. A rationale behind multi-view 
learning is that if models learned based on multiple views agree with each other, 
they are likely to generalize better.
In data fusion, co-occurring data sets are thought to supervise each other. Su­
pervision is used to focus fundamentally unsupervised data fusion methods 
relevant findings which in this case are the structure shared in the paired data sets. 
Supervision is provided, for example, through searching for statistical dependencies 
between co-occurring data sets. In Chapter 3.4 statistical dependency between two 
or more data sets is defined and studied more detailed.
This thesis discusses the analysis of high-throughput bioinformatics data sets.
on more
38
Data analysis in bioinformatics is challenging in many ways: Due to the development 
of measurement techniques, one can measure the gene expression of thousands of 
genes at once. However, the data are very noisy, and often the number of samples, 
n, is much smaller than the number of features, p, such as genes. This is called 
large p, small n problem [255]. Large number of features compared to the number 
of samples often impedes the statistical analysis by leading to computational issues, 
inaccurate estimates of the model parameters and results which do no generalize. 
However, when obtaining biological high-throughput measurements, thousands of 
samples from individual humans, animals or other organisms cannot be obtained 
because there are not enough human patients, or it would be too expensive and 
ethically questionable if thousands of laboratory animals were used. In addition to 
the cost of gaining large data sets, there is also cost of learning from large data 
sets. Moreover, the relationships between variables in biological data can be very 
complex. The large number of variables, especially when they are not independent 
of each other and form highly correlated groups, i.e. the variables are multicollinear 
[256,257], the statistical analysis and biological interpretation of the results becomes 
difficult [38]. The large p, small n problem, and the overfitting of the models to a 
data set having the properties mentioned above can be overcome by regularization 
methods, and by finding a low dimensional representation of the data [255].
Nowadays in machine learning and bioinformatics, it is very popular to fuse 
several data sets. In this thesis, the data fusion of gene expression and metabolomics 
data is studied. Hence, the learning scenario is multi-view learning discussed above. 
Multi-view learning is one way to face the large p, small n problem as fusing several 
data sources can be seen as averaging over them. Integrating different types of omics 
data might answer, for example, to the following questions: “Which variables from 
both types of datasets are related to each other?”, and “Which variables are relevant 
and provide more insight into the biological experimental hypotheses?”
3.2 Regularization in statistics
The high dimensionality and small sample size in a data set cause several problems to 
the statistical analysis. When the data set is complex due to the high dimensionality, 
it is tempting to fit complex models with large number of parameters to the data. 
This leads often to overfitting; the observations are modelled perfectly in the training 
data but the fitted model is ambiguous: there are several sets of model parameters 
that explain the data equally well. Overfitted model is also incapable predicting 
future observations. The large p, small n setting causes the model parameters 
learned from the data to be unstable, implying that their variance is very high. 
Therefore, more robust ways to estimate model parameters are needed [255].
Statistical regularization is a class of methods that modify the maximum likeli­
hood of a model to give reasonable answers when overfitting and instability issues 
are very likely, for example, in a large p, small n situation. Regularization is used to 
control the model complexity, and to improve the parameter estimation and the gen­
eralization to future observations. Regularization can be seen as incorporating prior 
information to data analysis to better understand the data, and to make the estima-
Cov(ti>) = ß-\XTX)
E[Lj] = E[(ti> - w)T(w - гу)] - /3-1Тгасе(ХтХ)-1 .
For the mean squared error of the w shown in Equation 5, i.e. E[L^], the following 
inequality holds:
1ЩЦ] > ß -1 (6)Amin(XrX) '
In Equation 6, Amin(XTX) is the smallest eigenvalue of XTX. When XTX devi­
ates from the unit matrix to ill-conditioned or even singular, non-invertible matrix, 
X X has smaller and smaller eigenvalues, and the mean square error for w be­
comes large. In that case, the least squares estimate for w becomes unreliable and 
sensitive to small changes in the data. For more details, see [24,259].
To solve the instability issue of the regression weight vector, Hoerl and Ken- 
nard [24] developed a regularization method called a ridge regression to obtain more
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tion of the parameters robust. Regularization methods often modify the maximum 
likelihood function by introducing additional penalty terms to it. Regularization 
methods are also called shrinking, smoothing and penalizing methods. For 
details, see [258].
Regularization in linear regression was first introduced by Hoerl and Kennard 
[24,259]. A standard model for a multiple linear regression is
more
Y -Xw + e . (2)
In Equation 2, X is n x (p + 1) data matrix of rank p + 1, and w is an unknown 
vector of regression weights of length (p+1). The elements of the regression weight 
vector are marked as w0, Wi, , wv\ w0 is the intercept term, so the first column of 
the matrix X consists of ones. In Equation 2, e is a Gaussian error term having 
mean and precision ß (or variance ß~l). The maximum likelihood, or the ordinary 
least squares estimate for w is
zero
w = (XTX)-xXTY .
In Equation 3, the matrix ХтX needs to be invertible, i.e. nonsingular. If 
the matrix ХтX is not invertible, the equation 3 does not have a solution, or the 
solution is not unique. Moreover, the estimate w is already unstable, i.e. having high 
variance, when the matrix ХтX deviates from the unit matrix. Considering that 
the sample covariance matrix for a zero-mean data is ±XTX, n being the sample 
size, the deviation of ХтX from the unit matrix implies that the variables in the 
data set correlate with each other, i.e. data is not orthogonal and the variables 
multicollinear. If the multicollinearity is considerably high, or the number of 
variables exceeds the number of samples in the data, the matrix ХтX becomes 
singular. Even matrices close of being singular, i.e. ill-conditioned, cause problems. 
To demonstrate the effect of singularity and ill-condition of the matrix ХтX to 
the ML-estimate of m, the covariance matrix Cov, (ú>), and the mean squared error 
E[Lj] of w are considered:
(3)
are
4^
Q
i
40
robust estimates. In ridge regression, the maximum likelihood estimate of the re­
gression weights is
w* = (XTX + kI)~1XTY] k>0.
In Equation 7, non-negative к is called a ridge parameter or a regularization con­
stant. Hoerl and Kennard have shown that the mean squared error for the ridge 
regression estimate w* is smaller than for w [24]. The ridge regression estimate tv* 
is also shorter than the maximum likelihood estimate w: (w*)T(w*) < (w)T(w). 
This implies that the elements in w* are drawn towards zero. The mean squared 
error of the regression weight w* is
(7)
E[Li(fc)] = — w)T(w* — ги)]
= E[(m - E[m])2] + (E[w - tv*])2 
= Var(tv*) + Bias (tv*, tv)2 
p x= e-'Y- Xj 
P ^ (A, + k)
(8)
- + k2w*(XTX + kl)~2w* . (9)
j=i
In Equation 8, Xj is the jth eigenvalue of the matrix ХтX. As can be seen from 
this equation, the mean squared error of the regression weight can be decomposed to 
two terms, the first being the total variance of the regression weight, E[(tv —E[tv])2], 
and the second being the square of the bias, (E[tv - tv*])2, which tells the deviation 
of the estimate from the value of true regression weight. The bias term will be 
when & = 0, leading to the same mean squared error as for the non-regularized 
ML estimate tv. Therefore, the maximum likelihood estimate is called an unbiased 
estimate. As was shown above, the variance of the regression weight can be high in 
data having large p, small n setting and/or multicollinear variables. Ridge regression 
regularization reduces the total variance of the regression weights because к appears 
in the denominator of summed terms in the variance part of Equation 9. This is 
done at the cost of introducing a small bias.
In ridge regression, the optimization function L when minimizing the squared 
distance between the true and predicted target variables is
zero
L = 53^ ~ 53wjxb)2 + kJ2w¿
¿=i 3 j
(10)
The ridge regression estimate for the regression weights is obtained by minimizing 
the penalized mean squared error between observed and predicted values presented 
in Equation 10. In Equation 10, к is the regularization parameter. The rigde regres­
sion, also called 2-norm regularization, ^-penalization, or weight decay, discourages 
the weights to become large by shrinking them towards zero. It can be though as 
introducing a bound prior for w weights. As a result, parameters are less uncertain 
than the ordinary least squares estimates. Moreover, in ridge regression regular­
ization, highly correlated variables get similar weights resulting in grouping of the 
variables. This is reasonable, for example, in the analysis of gene expression data 
which consists of со-expressed and со-regulated genes. However, ridge regression
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regularization does not set some weights completely to zero, which would be desir­
able in certain situations. Pushing some weights completely to zero would improve 
the interpretability of the results because it would remove the irrelevant dimensions 
from the analysis. This would lead to a sparse solution. In ridge regression, one still 
has to analyse all the weights in the end.
In regularized statistical modelling, one has to find the optimal regularization 
parameter k. The regularization parameter can be found using cross-validation 
procedure [254]. In m-fold cross-validation, the data are divided into m parts of 
about equal size. Then one of these sets is used on its turn as model validation data 
and the rest m-1 of these sets are used as training data. The parameter к could be 
defined in some interval that includes all the possible values for the regularization 
parameter. Then for each of the parameter values, a model is learned using the 
training data, and validated using the validation data. The objective function to find 
the optimal regularization parameter could be, for example, the likelihood function 
of the validation data, given the parameters learned using the training data. The 
learning and validation with different sets is performed m times. The final value 
of the object function is the mean of the likelihood function values obtained for m 
validation data sets. Then the regularization parameter giving the best value of the 
object function is chosen. The number of divisions m is usually chosen to be 5 or 
10 leading to 5-fold or 10-fold cross-validation.
3.3 Bayesian data analysis
Until now the classical or frequentisi probabilistic data analysis has been discussed 
in this thesis. The frequentisi data analysis considers the model parameters as fixed 
quantities, and estimates them by maximizing the likelihood function. In contrast, 
this chapter turns to Bayesian data analysis in which in addition to the observed 
random variables, the model parameters are also considered as random variables, 
and the uncertainty of them is represented by probability density functions. In fre­
quentisi data analysis, probability is defined as a ratio of favourable events to all 
trials as the number of trials approaches infinity. However, there are events that 
cannot be repeated infinitely many times or even few times, resulting in difficulties in 
estimating the probabilities. In Bayesian data analysis, the probability is considered 
as a measure of uncertainty, or as a degree of belief which can be quantified using 
numerical values, and manipulated by different rules. An example of a difference 
between frequentisi and Bayesian data analysis is the treatment of error bars or 
confidence intervals that define the uncertainty of estimated model parameters. In 
frequentisi framework, the value of a model parameter is estimated by an estimator, 
and the confidence interval on this estimate is obtained by considering the distri­
bution of all possible data sets; the confidence interval implies that when repeating 
the experiment and gaining a new equal sized data set, the value of a parameter 
estimated from this new data will be within the limits of the confidence interval 
in (1 - a) x 100 % of the repetitions where a is a pre-specified significance level. 
Conversely, in the Bayesian framework where the uncertainty of a model parameter 
is measured as a probability density function, the range where the parameter value
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is with the probability of (1 
density function. This range is called Bayesian credible interval, and it gives the 
uncertainty of a model parameter a clear definition.
Bayesian data analysis fits well for data sets having small number of samples, and 
when there is a risk of overfitting because the Bayesian treatment has an intrinsic 
regularization property. In other words, the models learned by Bayesian inference 
adapt to the correct model complexity during the learning. Therefore, the Bayesian 
models are resistant to overfitting. This is explained more detailed in Chapter 3.3.3. 
Other advantages of the Bayesian framework are easy handling of missing data, and 
natural ways of model comparison.
a) x 100 %, can be directly determined from the
3.3.1 Bayes’ theorem
This chapter presents the components of Bayesian data analysis. The joint probabil­
ity distribution of two random variables a, and ß, namely p(ct, /3), can be presented 
in two different ways using the product rule of probability, and the symmetry prop­
erty of the joint distribution: p(a, ß) = p(ß, a):
p(a, ß) = p(a\ß)p(ß) = p{ß\a)p(oi) = р(/3, а) . (И)
Prom Equation 11 the Bayes’ theorem can be derived as
p(ß\a)p(a)p(a\ß) = (12)P(ß)
The Equation 12 implies that the conditional distribution of a. given ß can be 
obtained when the conditional distribution of ß given a, p(ß\a), and the marginal 
distributions p(a) and p(ß), are known. Keeping in mind the data modelling task, 
a can be considered as the model parameters and ß the observed data. Therefore, 
p(ß\a) is recognized as the likelihood function, and p(ß) is obtained by integrating 
the product of p(ß\a) and p(a) over all model parameters. The distribution p(a) is 
the probability distribution of the model parameters, and p(a|/3) can be considered 
as the probability distribution of the model parameters after the data ß is observed. 
The distribution p(a) is called a prior distribution over the model parameters, and 
it quantifies the uncertainty of the parameters before seeing the data. In contrast, 
the uncertainty of the model parameters after seeing the data, p(a\ß), is called a 
posterior distribution of the model parameters. The normalization constant p{ß) 
guarantees that the posterior distribution is a proper probability distribution, i.e. 
integrates into one. As a result, the model parameters have a probability distribution 
that can be used to assess the parameter uncertainty. Bayes’ theorem can be also 
seen as an update rule for the probability distribution of the parameter values after 
observing a single data point ß. The posterior distribution can then be used as a 
prior for the next sample, and so forth.
The prior distribution makes an assumption of the model parameter values before 
observing the data. It determines the possible parameter values and their probabili­
ties; for example, if a prior assigns zero value to some parameters, then the posterior 
of those parameters will also be zero. One the one hand, prior can be subjective: for
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example, it can be given by an expert of the phenomenon under study; or it can be 
based on a common sense. On the other hand, prior can be uninformative indicat­
ing that it has only some influence on the posterior. When considering the Bayes’ 
theorem as an update rule for the parameter uncertainty, the influence of prior has 
a strong effect when there are only few data points. This prevents the model from 
overfitting to the data. However, when obtaining more data, the likelihood starts to 
dominate over the prior. Therefore, choosing a prior reflecting wrong assumptions 
of the data do not bias the final results when there is much data available. However, 
a strong prior may bias the results when the number of samples is limited.
A posterior distribution is obtained from a prior by gaining new evidence from 
the data. The posterior distribution of the parameters can be investigated as such, 
or single parameters estimates can 
probable parameter values. The most probable parameter values axe called Max­
imum A Posteriori (MAP) estimates. In contrast to estimating single parameter 
values and a single model, and considering that as the right model, the posterior 
gives the probability distribution over several parameter values or models. Instead 
of considering the most probable model, the probability distributions of all of the 
possible models can be investigated, which avoids picking a single solution. For 
example, in predictive analysis, the probability of a new data point given the model 
parameters can be obtained by marginalizing the likelihood function over the model 
parameters, thus avoiding the overfitting issue originating from picking a single, 
most likely overfitted model. The variance of the predictive distribution is the 
of noise in the data, and the uncertainty associated with the model parameters.
be obtained, for example, by picking the most
sum
3.3.2 Conjugate prior distributions
Priors can be informative or uninformative. When an uninformative prior is desir­
able, a uniform prior is chosen. The uniform prior assigns an equal probability for all 
parameter values. Multiplying the likelihood function with the uniform prior does 
not affect the posterior distribution as the introduction of a uniform prior is equal to 
the multiplication of the likelihood function by a constant, and new normalization 
coefficient can be calculated for the posterior. Therefore, using uninformative priors 
leads the MAP estimates to equal the maximum likelihood estimates.
In this thesis, informative or very vague priors are used. Multiplying the likeli­
hood function with any randomly selected prior distribution might lead the posterior 
distribution to be intractable. In that case, the normalization constants axe impos­
sible to derive. Therefore, conjugate priors are usually used to simplify calculations. 
For a given likelihood, a prior can be sought that is conjugate to the likelihood func­
tion, so that the posterior distribution has the same form as the prior distribution. 
In this case the posterior distribution can be easily derived.
If the likelihood function is Bernoulli distribution, then the conjugate prior is 
the beta distribution. If the likelihood is univariate Gaussian, the mean // of this 
distribution has Gaussian conjugate distribution and the variance parameter a2 has 
inverse-Gamma as its conjugate distribution. As a result, the posterior distributions 
of /i and cr2 also follow the Gaussian and inverse-Gamma distributions, respectively.
3.3.3 Model selection and regularization in Bayesian data analysis
Bayesian data analysis provides inherent regularization without the need to opti­
mize the regularization parameters, for example, by computationally tedious 
validation procedures. This can be demonstrated by considering the Bayesian treat­
ment for linear regression model presented in Equation 2. In this case the number of 
featmes in the data set, or the number of elements in the regression vector (p + 1), 
is the measure of the total model complexity. The target variable y is a function of 
x and tv, with additive Gaussian noise £ as shown in Equation 13. The noise s is 
assumed to be normally distributed with zero mean and a precision ß.
cross-
p
Y2 xjWj+e.y(æ, w) = xw + e = (13)
j=o
Now y follows a Gaussian distribution with mean xw and precision ß. The likelihood 
function for the whole data set is
p(y\X,w,ß) = Y\(Vi\xiVi,ß ') . (14)
t=l
A conjugate prior distribution for the weight vector w is given by a Gaussian 
distribution
p(w|oO =AAMO,a 1I) .
The mean of the prior distribution is chosen to be zero and the covariance matrix 
is isotropic with a single precision parameter a.
Using Gaussian conjugate prior for the weight vector w, its posterior distribu­
tion is also a Gaussian, N(w\mN, Sn) where the mean parameter шдг and the 
covariance matrix Sn are
(15)
m,v = ßSNXTt 
S^1 = al + ßXTX .
The logarithm of the posterior distribution is
(16)
— XiW}2 — ~wTw + const. 
¿=1 2
\np(w\y) (17)
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If the likelihood is multivariate Gaussian, then the conjugate prior of the 
rameters is also multivariate Gaussian, whereas the conjugate distribution of the 
covariance matrix is inverse-Wishart distribution. The prior distributions for the 
model parameters also have parameters that define the prior distribution. For ex­
mean pa-
ample, the Gaussian prior for p can be parameterized by mean mo and variance 
4 i260] The values for these hyperparameters can be chosen to reflect the prior
assumptions or knowledge before seeing the data, or they can be learned from the 
data by Empirical Bayes strategy [254], or a prior distribution can be set for them 
as well, leading to hyperpriors and hierarchical Bayesian models.
The usage of different priors leads to different assumptions and regularization 
effects. These issues are considered in the following chapter.
to
l'C
ö
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It can be shown that the Equation 17 equals the Equation 10. Therefore, the 
maximization of the posterior distribution with respect to w is equivalent to the 
minimization of the sum-of-squares error function, or the negative log likelihood 
with the addition of a quadratic regularization term with the regularization param­
eter A; = ! which is the ratio between the precisions of the prior and the likelihood. 
In other words, the MAP estimate of the weight vector equals the ML estimate of 
the penalized likelihood. As a conclusion, the Gaussian prior of the weight vector w 
can be seen as an additional regularization term which leads to the ridge regulariza­
tion. Maximizing the posterior distribution moves the solution towards the prior, 
preventing the model from overfitting.
Usually it is sufficient to set small values for the prior parameters leading to a 
vague prior distribution, and get more accurate estimate during the Bayesian learn­
ing. A proper value of a can also be learned from the data before the Bayesian 
treatment, for example, by Empirical Bayes strategy [254]. However, this can be 
avoided by setting a prior distribution also for the precision parameter a. The prior 
distribution of a is called a hyperprior. Conjugate hyperprior for a precision param­
eter is Gamma distribution with hyperparameters Oq and ßo. These parameters 
be set to make the hyperprior as uninformative as possible. The distribution of the 
precision parameter a, as well as the distribution of the regularization parameter 
f adapt to their optimal values and the correct model complexity during learning. 
Therefore, in the Bayesian framework, the model complexity is learned using all 
available data in contrast to the classical regularization methods where the data 
were divided to training and validation data sets. Moreover, the exact posterior 
distribution of the precision parameter a, and the distribution of the regularization 
parameter к are usually not interesting, so these parameters can be marginalized 
out of the posterior distribution, i.e. the posterior can be averaged over them. The 
averaging over uninterested parameters is an important property of Bayesian data 
analysis.
can
The different priors, for example, for regularization in the Bayesian treatment 
are studied heavily nowadays but are not further considered in this thesis. The 
regularization in the Bayesian framework can 
future data prediction. A prediction of future data instance у given observed x for 
the linear Bayesian model is done by marginalizing over the posterior distribution 
of the weight vector:
be further investigated by considering
J P{y\w, ß)p(w\y, a, ß)dw .P(.y\y,a,ß) (18)
The result of this integration implies that the future observations follow a Gaussian 
distribution
p(y\x,y,a,ß) = N(y\mJíx,a2N(x)) .
The mean the Gaussian distribution in Equation 19 is mJfX, and the variance o^ix) 
is
°n(x) = -ß + xTSNx .
(19)
(20)
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The variables mN and are the posterior mean and variance of the weight vector
respectively, as presented in Equation 16. The first term in Equation 20 is the 
data variance, whereas the second term reflects the uncertainty associated with the 
parameters w. This is a way of the Bayesian data analysis to manage the 
tainty associated with the modelling process itself. The derivation of the predictive 
distribution in Equation 18 can be seen as a weighted averaging over the multiple 
solutions, each having a high variance. This marginalization avoids the overfitting 
because the prediction is obtained by averaging over the whole posterior instead of 
using a single, most likely overfitted model. For more details, see [254].
Bayesian data analysis provides a rigorous formulation to the automatic model 
complexity control, and is thus a proper way to address large p, small n -problem. 
The regularization effect in the Bayesian framework emerges when the prior distri­
bution prefers parameter values leading to simpler models, or to more likely models 
before seeing the data. The model complexity measured as an effective number of the 
parameters, or degrees of freedom, adapts automatically to the size of the data set. 
Moreover, the prior distribution can constrain the solution space, for example, by 
making independence assumptions between the variables. In the previous example 
of Bayesian ridge regression, isotropic Gaussian prior was assumed for the regression 
weight parameters. This indicates that the different elements of the weight vectors 
are assumed independent of each other and to have the same variance. In practise it 
is sometimes difficult to choose a proper prior; the prior needs to be flexible enough 
and enable to constrain the complexity according to the data.
Chapters 3.2 and 3.3 presented regularization applied to linear regression, 
supervised statistical method. However, the work done in this thesis considers ex­
ploratory data analysis. In exploratory data analysis, there is no need to build a 
model for predicting future values, although the model’s capability to generalise to 
future observations is still desirable. In exploratory data analysis, it is more impor­
tant to study learned joint distribution of the model parameters, and investigate the 
relationships between observed features. Moreover, in exploratory data analysis, 
additional data sets are usually provided which could be used to validate the learned 
model. Both classical frequentisi and Bayesian regularization methods can still be 
applied also to unsupervised data analysis methods which are the topics of Chapters 
3.4, 3.5 and 4.
uncer-
an
no
3.3.4 Bayesian inference using variational approximation
For many models of practical interest, it is infeasible to evaluate the posterior dis­
tribution, or to compute expectations with respect to this distribution. This could 
be because of the high dimensionality of the variable space, or because the posterior 
distribution has a highly complex form for which expectations are not analytically 
tractable. In the case of continuous variables, the required integrations may not have 
closed form analytical solutions while the dimensionality of the space and the 
plexity of the integrand may prohibit numerical integrations. The techniques used 
to infer the Bayesian probabilistic models when the posteriors cannot be solved 
alytically include Markov Chain Monte Carlo (MCMC) methods, and a variational
com­
an-
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approximation scheme. The Bayesian model applied in this thesis is inferred by 
a variational approximation method which scales well to large applications. Varia­
tional approximation methods are typically used when the model has a large number 
of unknown parameters because in such situations MCMC methods often become 
computationally prohibitive. Variational approximation methods approximate the 
true posterior distribution using a simpler probability density function that is fac­
torised in a particular way with respect to groups of variables, or has a specific 
parametric form. As such, variational approximation methods never generate exact 
results, which is their weakness.
Variational approximation methods consider optimization of a functional 
a set of functions. A function is a mapping that takes a value of a variable as an 
input and returns the value of the function as an output, whereas a functional can 
be defined as a mapping which takes a function as an input, and returns the value 
of the functional as an output. Entropy presented in Equation 29 is an example 
of a functional; it takes a probability distribution p(x) as an input and returns the 
entropy as an output. A functional derivative corresponds to the derivative of a 
function; the functional derivative expresses the change in value of the functional 
in response to infinitesimal changes in the input function. The optimal function is 
obtained by exploring all possible input functions to find the one that maximizes, 
or minimizes, the functional. For more details, see [254].
Consider a full Bayesian model in which all parameters are given a prior distri­
bution. The set of all model parameters is denoted by Z. The set of all observed 
variables is denoted by X. The probabilistic model specifies the joint distribution 
p(X,Z), and the goal is to find an approximation for the posterior distribution 
p(Z¡X), as well as for the model evidence or marginal data likelihood p(X). For 
any choice of a distribution q(Z), the log marginal likelihood can be decomposed as
over
J q{Z) \np(X)dZ
/<(z)lnwdZ-/?(z)lnT^dZ
C(g) + KLD(q\\v),
KLD{(i\\p) are defined as follows:
/«-Sf-*
Inp(X) (21)
where C(q) and
(22)
KLD(q\\p) = dZ . (23)
In Equations 22 and 23, both £(q) and KLD(q\\p) are functionals of the distribution 
q(Z). КLD(q\\p) is noticed as a Kullback-Leibler divergence between the distribu­
tions p and q. The Kullback-Leibler divergence is considered in more detail in 
Chapter 3.4. In brief, it is a measure of dissimilarity between probability densities p 
and q. The Kullback-Leibler divergence is always non-negative, so lnp(X) > £(q).
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Therefore, £(ç) is a lower bound of the log marginal probability of the likelihood 
function. For more information, see [254].
If distribution q(Z) corresponds to the approximate posterior distribution of the 
model parameters, it can be found by maximizing the C(q) with respect to the dis­
tribution q(Z)', this is equivalent to minimizing the KL divergence, or maximizing 
the expectation of the complete data log likelihood, i.e log(^C, Z). If any possi­
ble choice for q(Z) is allowed, then the maximum of the lower bound occurs when 
the KL divergence vanishes, implying that q(Z) equals the posterior distribution 
p(Z\X). However, as was noted above, the model is usually so complex that work­
ing with the true posterior distribution is intractable. Therefore, a restricted family 
of distributions q(Z) is considered, and the member of this family is sought for 
which the lower bound is maximized. The goal is to restrict the distribution family 
sufficiently that they comprise only tractable distributions, while at the same time 
allowing the family to be sufficiently rich and flexible that it provides a good ap­
proximation to the true posterior distribution. The restriction is imposed purely to 
achieve tractability, and as rich a family of approximation distributions as possible 
should be used. There is no over-fitting associated with highly flexible distribu­
tions because using more flexible approximations simply allows to approach the 
true posterior distribution more closely. Variational methods lead to approximate 
solutions because the range of functionals over which the optimization is performed 
is restricted. For example, one could consider only quadratic functions, or func­
tions composed of a linear combination of fixed basis functions in which only the 
coefficients in the linear combinations can vary. In the case of applications to prob­
abilistic inference, the restriction may, for example, take the form of factorization 
assumptions [254,261,262].
To restrict the family of distributions q(Z), factorised distributions can be used. 
The elements in Z are partitioned into M disjoint groups that are denoted where 
i = 1,..., M. Then it is assumed that the distribution q factorises with respect to 
these groups as shown in Equation 24. This is called a mean field approximation 
[254].
M
4(Z) = X[q,(Z,) . (24)
1=1
No other assumptions are made than the one presented in Equation 24. In partic­
ular, there is no restriction on the functional forms of the individual factors <7¿(Z¿). 
Amongst all distributions q(Z) having the form of Equation 24, the distribution for 
which the lower bound C(q) is largest, is sought. The optimization of C{q) with 
respect to all of the distributions qi(Zi) is done by optimizing with respect to each 
of the factors in turn. To achieve this, the above Equation 24 is substituted into 
the equation of the lower bound (Equation 22), and the dependence on one of the
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factors qi(Zj) denoted simply by Qj is dissected out as shown below:
f Y[qi{]np(X, Z) -Y^lnqi}dZ
i iJ Pj9¿lnp(X, Z)dZ - J ]~[ In QjdZ
i i i
I qj{ J lnp(X,Z)llqidZi}dZj- J qji 
J qj bp(x, Z^dZj — J Qj In qjdZj + const
C(q) = (25)
n qjdZj + const
The distribution p(X, Zj) appearing in Equation 25 is defined as
= Ei#j[lnp(X, Z)] + const = J lnp(X, Z) Д qidZi +lnp(X, Zj) const . (26)
The notation [.] in Equation 26 denotes an expectation with respect to the q 
distributions over all variables for г 7^ j. Now suppose q^j is kept fixed, and C(q) 
is maximized with respect to all possible forms of the distribution ^(Zj). This is 
easily done by recognizing that £(q) is the negative KL divergence between g^Zj) 
and p(X, Zj). Thus maximizing the lower bound is equivalent to minimizing the 
KL divergence. A general expression for the optimal solution q*(Zj) is
Inq*j{Zj) = [Inp(X, Z)] + const .
The form of solution presented in Equation 27 provides the basis for applications 
of variational methods. It implies that the log of the optimal solution for factor q3 
is obtained simply by considering the log of the joint distribution over the data and 
model parameters, and then taking the expectation with respect to all of the other 
factors qi for i ± j. The additive constant in 27 is set by normalizing the distribution 
q*j{Zj). Thus if an exponential is taken on both sides and the distribution normalized
exp(Ej^j[lnp(X, Z)])
/ехр(Е^[1пр(Х, Z)})dZj '
In practise, the form in Equation 27 is more convenient to work with, and so normal­
ization constant is reinstated where required. The set of Equations for j = 1,..., M 
represent a set of consistency conditions for the maximum of the lower bound subject 
to the factorization constraint. However, they do not represent an explicit solution 
because the expression on the right-hand side for the optimum q*{Zj) depends on ex­
pectations computed with respect to the other factors g*(Z¿) for г ф j. A consistent 
solution is found by first initializing all of the factors g*(Z¿) appropriately and then 
cycling through the factors and replacing each in turn with a revised estimate given 
the current estimates for all of the other factors. Convergence is guaranteed because 
the lower bound is convex with respect to each of the factors g*(Z2) [254,263].
(27)
<№) (28)
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There are several sources of inaccuracy when applying factorised approximation 
methods. First, there might be interesting dependencies between model parameters 
which are, however, lost in the factorization of the parameters to independent sets. 
For example, when applying variational approximation to multivariate Gaussian 
data, and the posterior of the features are assumed to be independent of each other, 
the mean can be correctly captured but the variance of the factorised distributions 
controlled by the direction of smallest variance of the true parameters, and the 
other variances are significantly under-estimated. In addition, the covariance matrix 
of the data will be isotropic. Second, factorised variational approximation tends to 
give approximations to the posterior distribution that are too compact. Third, if 
there are multiple modes in the true posterior distribution, maximization of the 
lower bound ends up to one of the local optima. For more discussion, see [254].
are
3.4 Modelling dependencies
Until now, Chapter 3 has considered only analysis of one set of random variables. 
From now on, the fusion of several sets of variables is discussed. Modelling depen­
dencies between several data sets is one way to formulate a data fusion approach. It 
is an unsupervised, exploratory method for data integration. Often the dependency 
between different data sets is considered to be the interesting and relevant part in 
the data sets. In this chapter, the term dependency is defined and its properties 
examined.
Statistical dependency is an antonym to a more familiar term, statistical inde­
pendency. Independency can be defined for random variables. Two random variables 
x and y are statistically independent if and only if their joint probability distribu­
tion p(z, y) is the product of the marginal probability distribution of the variables: 
p(x, y) = p(x)p(y) for all x and y. Thus, the joint density factorises into a product 
of the marginal terms if the variables are independent. Independency is essentially 
binary; either two variables are independent or they are not. Dependency refers 
to a deviation from independency. It is a continuous quantity, and in addition to 
knowing that some variables are dependent, the strength of the dependency can be 
assessed.
Determining dependency requires understanding of the concepts of information 
theory. Function that represents the information content of a continuous random 
variable x is denoted as entropy H(x)
J p{x) logp(x)dzH{X) (29)
Entropy is dependent of the probability density function of x, p(x). It is the average 
amount of uncertainty or randomness that an unobserved random variable has. 
Entropy tells how much information is received on average when a random variable 
is observed. For more details, see [264].
An average additional information required to specify the value of x using den­
sity function ç(x), instead of the true density function p(x), can be measured by
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Kullback-Leibler divergence KLD(p||g)
p(x)= f p{x) logKLd(pIIq) dx . (30)q(x)
The Kullback-Leibler divergence is 
densities q{x) and p(x). It can
a measure of dissimilarity between probability 
be interpreted as the average inefficiency of assuming 
that the distribution of x is q{x) when the true distribution in reality is p{x) [264].
The Kullback-Leibler (KL) divergence between the joint density function p(x, y) 
and the product of the marginal density functions p{x)p(y) can be used to measure 
the dependency between the two random variables x and y. In this case, the KL- 
divergence measures the deviance of the joint distribution from the product of the 
marginal distributions; hence it measures the deviance from the independency. This 
measure is called mutual information I(X, Y) [264]
P(z,p)- uI(X,Y) X, y)log dxdy . (31)p(x)p(p)
The mutual information measures the information shared by random variables 
X and Y. It is a measure describing how much knowing one of the variables reduces 
the uncertainty about the other. The mutual information can be seen as a decrease 
in the entropy of one variable when the value of the other variable is known. If X 
and Y are independent of each other the mutual information is zero. If the variables 
identical, the mutual information equals the entropy of X or Y. In that case, if 
the value of X is known, the entropy of Y reduces to
The mutual information is regarded as the standard definition for the strength of 
the statistical dependency. However, mutual information needs the joint distribution 
of the random variables to obtain an exact and accurate characterization of the 
dependency. In practise, only the data sets, X and Y are available. Therefore, 
a dependency measure defined for the data sets is needed. A classical measure of 
association or dependency between two univariate variables x and y is the Pearson’s 
correlation [265,266] defined as
are
zero.
E[(z - M)fa - E[ÿ])] 
\/(E((x-E[x]])2)y(E([¡,-E[í,]])2) ■ (32)
Pxy —
Pearson correlation pxy measures the linear dependency between random variables 
x and y. In Equation 32, E[.] denotes the expectation over the joint probability 
distribution p(x,y). In practise, the expectations are often replaced by population 
means when estimating the correlation, giving the sample correlation coefficient rxy
ELi(£. - x){yi - у)
(33)rxy — (тт l)S3;Sy
In Equation 33, x and у are the sample mean of X and Y, respectively, n is sample 
size, and sx and sy are 
Values of correlation range from -1 to 1. The sign measures the nature, and the
the sample standard deviations of X and Y, respectively.
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absolute value measures the strength of the dependency. Correlation is zero for 
statistically independent variables. However, the converse is not generally true. For 
the special case of multivariate normal distribution, a zero correlation also implies 
independence.
Mutual information has a strong connection with multivariate normal distribu­
tion. It can be shown that for jointly normally distributed random variables x and 
y, the correlation and mutual information are related [267]: the mutual information 
between x and y can be presented as
1
-log(l - p2xy) .
In Equation 34, pxy is the Pearson correlation between the variables. This implies 
that for jointly normal variables we can use correlation as a dependency measure 
without loss of generality.
One way to perform a data fusion task is to combine the data sources so that 
the variation in common between them is emphasized. The relevant and interesting 
thing is often the information shared by two or more data sources. The shared 
information in this thesis refers to a shared variation in the data sets or statistical 
dependencies. More accurate results might be obtained when concentrating only 
information present, in all of the data sets and ignore variation specific to individual 
data sets. This enables to find information that could only accidentally be revealed 
by looking at any of the single sources only. One might also be interested in the 
variation remaining in data sets after extracting the dependencies. In the later 
chapters, generative models are presented that have representation for both the 
dependencies and the data set-specific variation; the residual variation in the data 
sets after extracting dependencies can therefore be easily obtained.
The models that are used in this work are based on maximizing the dependency 
between the two data sets. Modelling the data by seeking linear projective transfor­
mations of the data sets, such that the correlations between the lower dimensional 
representations of the data are maximized leads to canonical correlation analysis 
which is a traditional method to fuse several data sets, and to perform dependency 
modelling.
7(Х,У) (34)
on
3.5 Canonical correlation analysis
3.5.1 Classical canonical correlation analysis
Canonical correlation analysis (CCA) 
component analysis (PCA) [254] because the vocabulary and computation of these 
two methods are similar. Both are also linear methods. Principal component anal­
ysis is a popular method for dimensionality reduction and visualization of the data. 
PCA is defined as an orthogonal projection of the data onto a lower-dimensional 
linear subspace denoted as a principal subspace, such that the variance of the pro­
jected data is maximized [268]. PCA seeks a single low dimensional representation 
of a single data set, whereas CCA considers two data sets and seeks a lower dimen­
sional representation for both of them, so that the correlation between the separate
be partly understood through principalcan
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presentations is maximized. CCA is a traditional method to seek dependencies be­
tween two data sets. It can be used to determine whether two sets of variables 
statistically independent of each other in a linear sense, or conversely, to determine 
the magnitude of the relationship between the two sets. CCA aims to find linear 
projections of the variables in the first set that are associated with the linear pro­
jections of the variables in the other set when the variables in both sets have been 
observed on the same experimental units. The association is found by maximizing 
the correlation between the linear projections of the two data sets.
CCA can be seen as the most general version of the traditional least-squares 
method for the analysis of data sets. The roles of the two sets of variables in CCA 
are symmetric; it is not known a priori if variation of the features in the first data set 
imply variation of the features in the other set, or vice versa. In other words, neither 
of the data sources is considered as a target variable set or as a predictor variable 
set. Nevertheless, using the results obtained by CCA, the values of variables in 
data set can be predicted using the values of the variables in the other data set, 
and vice versa. When studying gene expression and metabolomics changes, 
metric analysis is reasonable; changes in gene expression cause changes in metabolic 
pathway activities, which ultimately affect the metabolite concentrations, but it is 
known that the metabolites also affect the expression of genes. As a result from 
CCA, we find out which variables from gene expression and metabolomics data 
related to each other, and which variables are relevant in providing more insight into 
the biological experimental hypotheses. The nature of relationships between the two 
data sets is explained by measuring the relative contribution of each variable to the 
canonical relationships obtained.
The model family in CCA is linear projections, data are assumed normally dis­
tributed, and the dependency measure is Pearson’s sample correlation coefficient. 
Let us consider again two sets of random variables X and T and their correspond­
ing data matrices X and Y. The data matrices are assumed standardized implying 
that the means of the features equal zero and the variances equal one. In the data 
matrices, rows correspond to variables and columns correspond to samples. The 
dimension of the variable X is p and the dimension of the variable Y is q. It is also 
assumed that p < q. The columns of the data matrices are paired and there are n 
samples. The sample covariance matrices for the variables X and Y are S 
Syy, respectively. The covariance matrix for the concatenated set of variables is
_ Sxx SXy
° ~ G C )
«-'yæ ‘-'y y
where Sxy and Syx are the between-sets covariance matrices.
CCA is formulated by denoting the directions corresponding to the first dimen­
sion of the lower dimensional projections of the data sets X and Y as щ and vu 
respectively. These are called the first pair of canonical variates or canonical com­
ponents. The task in canonical correlation analysis is to determine the canonical 
variates Ui — aJX and Vi = bjY which are maximally correlated. The vectors 
°i and hi correspond to the first projection vectors for data sets X and Y, re­
spectively. The dimension of the canonical variate vectors щ and iq, is the sample
are
one
sym­
are
and,/\r
size n, so there is one element of a canonical variate corresponding to one sample. 
The maximization of the correlation between the canonical variate pair leads to 
optimization problem
an
Sxyb,maximize (35)\/®i Sxx o, i\jb i Syyb\ 
SXXO'1 1
6j Syyb\ = 1 ,
subject to
where the canonical correlation is maximized subject to the constraint that the 
length of the canonical variates equals one. In practice, one needs to maximize only 
the numerator of the canonical correlation, aJSxybi. To maximize the correlation, 
a Lagrangian function L
(a^Sxxai - 1) - föSyyb! - 1)
is defined. The parameters Л and д are Lagrangian multipliers.
Differentiation of the Equation 36 with respect to Л and ц gives A = /¿ and 
eigenvalue problem shown below:
L dj SXybi (36)
an
&XX SxySyy Syxai
Syy SyXSxx Sxybi
= A2oi
= A20! •
The eigenvectors of the solution to this eigenvalue problem define the linear projec­
tion vectors Oi and bi that form the first pair of canonical variates. The square root 
of the eigenvalue, i.e. A, is the canonical correlation between Ui and V\. The second 
canonical variate pair and v2 is found by maximizing the canonical correlation 
between them with the unit length constraints for it2 and u2, and orthogonality 
constraints between the subsequent canonical variates: afSxzo2 = 0, b\Syyb2 = 0, 
and ajSxyb2 = 0. It can be shown that p pairs of canonical variates corresponding 
to the rows of matrices U and V can 
eigenvalue problem
be determined by solving the generalized
s;is,ys^syiA =Л2А
Syy SyxSxx SxyB — A2В
As a solution to the above eigenvalue problem, p pairs of canonical variates U = 
A X and V = BTY are obtained having p rows corresponding to the dimensions 
of the canonical variates and n columns corresponding to samples. The matrix A is 
a pxp matrix and the matrix В is a qxp matrix in which the columns correspond 
to the projection vectors a¿ and ò„ respectively. The matrices A and В are called 
projection matrices. Canonical variate pairs have the properties that the 
ical variates Uj and have the correlation A¿, all us are uncorrelated with each 
other, all vs are uncorrelated with each other and Ui, and Vj are uncorrelated if 
This orthogonality property of subsequent canonical components implies that 
different canonical variate pairs represent different relationships between the two 
sets of variables.
canon-
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3.5.2 Significance of the canonical correlations
Canonical correlation Ri between the ¿th canonical variate pair is obtained 
square of the eigenvalues of the generalized eigenvalue problem. Canonical 
lation measures the strength of the overall relationship between the corresponding 
canonical variate pair, and is always at least as large as the largest correlation be­
tween any pair of variables of the two sets. There are at most p canonical variate 
pairs and canonical correlations if p = min(p, q). The squared canonical correlation 
R2 is an estimate of the amount of shared variance between the canonical variates. 
It expresses the proportion of variance in a canonical variate that is related to the 
other variate of the same pair. Squared canonical correlation cannot however be 
interpreted as the degree of relation between the sets of variables. Squared 
ical correlation of 0.5 means that the pair of canonical variates share 50 % of their 
variance, not that the sets of variables share 50 % of their variance.
When there is a large number of variables in the data sets, and thus a large 
number of canonical correlations, the probability that a canonical correlation is 
nonzero just by change, is considerably high. Therefore, only those canonical variates 
are analyzed whose corresponding canonical correlation coefficients are statistically 
significant at some preselected level, for example, 0.05. The classical test to estimate 
significance of canonical correlation is Bartlett’s test [269]. The test assumes that 
the sample population is multivariate normal, and the sample size is reasonably 
large. The requirement of large sample size renders the Bartlett’s test unsuitable 
for the data analysis of this work, so an alternative significance test is used in this 
thesis. More suitable methods to assess the significance of a canonical correlation 
permutation tests [270]. In a permutation test, the observed value of a test 
statistic, for example, a canonical correlation, is compared to the distribution of 
values obtained from a random sample. For CCA, a meaningful random sample is 
one that is normally distributed with the same variance as the original variables but 
with no dependencies between variables. In this work, a permutation test for CCA 
presented in the master’s thesis of Tapio Rinnet is used to assess the significance of 
canonical correlations [271]. In this permutation test, the data is randomized in a 
Gaussian way. The test proceeds as follows:
1. Divide the data set X into X
as a
corre-
canon-
are
and Xtest, and similarly for Y.
and Ytrain, and calculate the canonical correlation 
Ri between the canonical variates in the test data.
train
2. Perform CCA for X train
3. Create random samples Xrand from multivariate normal distribution with a 
diagonal covariance matrix in which the values in the diagonals equal to the 
columnwise variances of X and similarly for Y.train i
4. Perform CCA for X and Yrand, and calculate the correlation Riband there 
is between the canonical variates in the original test data.
rand
5. Compare Ri to the distribution of A, ,.
Vi are deemed significant where the is significantly larger than Rl<rand at 
the 5 % confidence level.
Those canonical variates (7¿ and
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3.5.3 Limitations of the classical canonical correlation analysis
Canonical correlation analysis is sensitive to small changes in the data sets, and 
it overfits badly when the data dimensionality is close to the sample size, and/or 
when there are many correlating variables in the data sets. In that case, canonical 
correlation analysis detects artificially high canonical correlations. Overfitting is 
especially harmful in exploratory data analysis when the aim is to form hypotheses 
on data. When the data dimensionality is higher than the sample size, the traditional 
canonical correlation analysis cannot be performed at all as the data-specific sample 
covariance matrices become singular, and their inverses cannot be determined. The 
solutions to these problems are studied in Chapters 3.5.5 and 3.5.7. The probabilistic 
formulation of CCA presented in Chapter 3.5.7 as such does not solve the problems 
but makes possible the Bayesian treatment with all the necessary tools. One of the 
cons of canonical correlation analysis also is the difficulty to interpret the results 
which is discussed in the next chapter.
3.5.4 Interpretation of the results of canonical correlation analysis
The contents of the canonical variates are defined by the canonical projections or 
weights A and ß. They can be interpreted in a similar way as multivariate regression 
weights or factor score coefficients in factor analysis; canonical projections reflect the 
independent or unique contributions of each variable to each canonical variate. The 
values for the weights are unbounded, so their relative magnitudes for a particulate 
variate are informative. If the weights are reported for standardized data having 
mean and unit variance, the weights are comparable within a canonical component, 
as well as between different canonical variate pairs. However, if the variables in 
the data are multicollinear, the interpretation of the weights becomes difficult. The 
multicollinearity might be due to co-expressed and со-regulated genes in the gene 
expression data, for example. A variable may receive a small weight simply because 
it is highly correlated with another variable in the same set, even though both 
variables have high correlations with the variate. In this situation, is becomes less 
clear where the observed effects originate. Therefore, when the variables within a 
data set are correlated, the weights do not reveal the variable’s variance accounted 
for the variates. For more details, see [272].
Instead of canonical weights, canonical loadings, i.e. canonical structure coef­
ficients, can be investigated. Canonical loadings denote to the correlations of the 
original variables in either of the two data sets and either canonical variate in a 
given canonical variate pair. They are commonly used to interpret the results of 
canonical correlation analysis as they pertain to the overall correlation of the respec­
tive variables and canonical variates [273-275]. The canonical loadings are bounded 
from above by 1 and from below by -1. Moreover, they are standardized across the 
canonical variates and can be compared between variates. The values of canonical 
loadings drop off quickly for the later, less highly correlated variates. The canonical 
loadings provide information about the relative contributions of variables to each 
independent canonical relationship. The variables in each set contributing heavily to 
the shared variance between variables and canonical variates are said to be related
zero
57
to each other. Some significance tests for weights and canonical loadings have been 
proposed [276] but they are not further considered in this thesis.
Canonical loadings can be calculated by considering the relations of the ob­
served variables in one data set with the canonical variates in either set. When the 
correlations of observed variables in the first (second) set are calculated with the 
canonical variates of the first (second) set, the loadings are called intraset loadings. 
The squared intraset loadings give the proportions of each variable’s variance that is 
accounted for a canonical variate in the same set. When the correlations of observed 
variables in the first (second) set are calculated with the canonical variates of the 
second (first) set, the loadings are 
loadings give the proportions of each variable’s variance that is accounted for by a 
canonical variate of the other set. For more details, see [277].
In addition to investigating the significance of canonical correlations, it is useful 
to determine the amount of variation in the data sets explained by each canonical 
variate pair. It is possible that despite having found very strong and significant 
relations between two data sets, they represent insignificant variation in the original 
data sets. Therefore, it is important to quantify how strongly a canonical variate 
interacts with its own data set. A useful measure for this is the squared intraset 
loading. Squared canonical intraset loading equals variable’s variance shared with 
the corresponding canonical variate. For both canonical variates in a canonical
called interset loadings. The squared interset
cor-
component, an average proportion of the variance extracted by them can be cal­
culated as a mean of canonical intraset loadings of individual variables. These 
be further summed to have a single measure of the extent to which the canonical 
variates account for the variation in their respective sets. For more information, 
see [272,278].
Another measure to assess the variance in the data sets accounted for canonical 
variate pairs is redundancy. Redundancy describes the actual variability in one set 
of variables explained by the other. Redundancy depicts how redundant one set of 
variables is given the other set of variables. In other words, redundancy can be used 
to determine the amount of variance shared by two sets of variables. Together with 
the average squared canonical intraset loadings, redundancies also reveal the data set 
that has more relevant (shared) information. Redundancy is analogous to multiple 
regression’s R2 statistics, the square of the correlation coefficient. Redundancy 
measure
can
is obtained when the squared canonical correlation coefficient is multiplied 
by the variance extracted, i.e. the average of squared canonical intraset loadings over 
variables. Redundancies of canonical variates in relation to the corresponding data 
sets are presented in Equation 37. Redundancies can also be summed or averaged 
the significant canonical variate pairs to obtain a single index of redundancy. 
Redundancy is also useful in assessing practical significance of canonical correlation 
coefficients. For more details, see [272,279].
over
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Graphical representations and visualization are crucial to help interpreting the 
results obtained by CCA. Scatter plots of the canonical variates in two dimensions 
reveal the separation of the samples to clusters based on their characteristics. The 
features responsible for the clustering of the samples can be revealed by investigating 
the canonical loadings of individual variables. The canonical loadings can be visu­
alized using so called correlation circles where the coordinates of the variables 
determined by the canonical loadings corresponding, for example, two given 
ical variates. In a correlation circle, all variables end up inside a circle of radius 1. 
Correlation circles help revealing the correlations between two sets of variables, and 
indicate clusters of highly correlating variables. Furthermore, because the 
ical variate vectors are orthogonal, there is a small degree of overlap between the 
variables contributing to the differences in samples modelled by different dimension 
of canonical variates. Thus each canonical variate pair focuses on a specific aspect 
of the data set. The canonical variates and correlation circles can be plotted either 
by using the canonical variates corresponding to the data set X or the data set 
Y\ If the canonical correlation is high for the corresponding canonical variates, the 
plots obtained using either set should be almost similar. In addition, a visualization 
tool called eye diagram is used in this thesis to represent the content of canonical 
components [280].
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3.5.5 Regularized canonical correlation analysis
Classical canonical correlation analysis can be applied only to data having 
samples than variables. In that case the data matrices are of full column rank, i.e. 
the rank of the data matrices equals the data set dimensions, p and q, respectively, 
and the sample covariance matrices are nonsingular. When the number of variables 
increases, greatest canonical correlations are nearly 1 due to overfitting. Therefore, 
a standard condition where CCA can be reliably perform isn>p + ç + l [281]. 
Multicollinearity of the variables within the data sets also causes data matrices X 
and Y not to be of full rank. As a result, the covariance matrices can be singular. 
Singular and ill-conditioned covariance matrices cannot be inverted, or their inverses 
are at least unstable, i.e. they have a high variance. To overcome these drawbacks of 
aPPlying CCA to high dimensional and multicollinear data, regularization methods 
presented in the context of regression in Chapter 3.2 can be applied to canonical 
correlation analysis.
Ridge regression regularization for canonical correlation analysis was first intro­
duced by Vinod [25] and further developed in [282]. In the ridge regularization 
framework for CCA, the sample covariance matrices Sxx and Syy are replaced by
more
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matrices Y¡xx(ki) and Y,yy(k2), respectively, defined as
Sxx + k\Ip and Yjyy(k,2) = Syy + k2¡q . (38)
The values for regularization parameters ki and k2 are chosen so that the gener­
alization ability of the model is maximized. This can be done using cross-validation 
or bootstrapping -methods [283,284]. In this thesis, cross-validation procedure is 
used. The possible values of the regularization parameters are defined in a two- 
dimensional grid, and for every combination of the regularization parameters, 10-fold 
cross-validation is performed to obtain the average value of the optimization func­
tion. The regularization parameters maximizing the objective function are finally 
chosen to be the regularization parameters of the final analysis.
In cross-validation, the objective function used to maximize the generalization 
performance of the validation data is usually the data likelihood. In addition to likeli­
hood function, several other objective functions can be used for canonical correlation 
analysis, such as mutual information, or the sum of all canonical correlations, which 
are maximized [38]. In this thesis, the maximization of the mutual information of 
the validation data is used. Other object functions could also be considered such 
as minimizing the mean difference between the canonical correlation in the train­
ing and validation data [36,285], or minimizing the mean squared prediction 
(MSPE) of the canonical variates [286]. The performance of the different object 
functions is somewhat covered in [36,38,285,286] but a comprehensive comparison 
of these methods in optimizing the regularization parameters in canonical correla­
tion analysis has not been conducted. This issue is not further considered in this 
thesis.
error
Ridge regression shrinks the canonical weights by imposing a penalty on their 
size. The diagonal of the covariance matrices are penalized such that they become 
nonsingular and give unique estimates for the model parameters. To perform the 
regularized canonical correlation analysis properly, the regularization parameters 
ki and k2 should not be considered equal for each row of the covariance matrix 
but unequal. However, in this case the optimization of the regularization param­
eters would become computationally very tedious. Practically, the regularization 
parameters can be considered equal for all rows. In regularized canonical correla­
tion analysis developed and implemented by González et al. [26,27,287], an equal 
regularization parameter is considered, and it is optimized using cross-validation by 
maximizing only the first canonical correlation for the validation data. The method 
has been applied, for example, to analyse gene expression measures of 120 genes, 
and gas chromatography mass spectrometric measurements of 21 fatty acids in the 
liver cells of 40 mice [287-289]. The goal of this research was to investigate the effect 
of the genotypes (mutant and wild type), and five different oil diets 
sion and fatty acid levels in liver cells. Regularized canonical correlation analysis 
was shown to yield the same results obtained by classical multivariate data analysis 
methods, such as hierarchical clustering and principal component analysis applied to 
the two data sets separately but, in addition, the regularized CCA revealed findings 
not visible in single data set analysis. In different experimental conditions, multiple 
metabolite levels were seen to correlate with the expression of genes coding enzymes
on gene exprès-
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of the fatty acid metabolites and with the expression of some transcriptional fac­
tors. The authors in [287] hypothesized regulatory relationships between correlated 
metabolites and genes, and proposed a link between a certain fatty acid and the 
tivity of a certain transcriptional factor pathway which will be target of the future 
validating experiments.
Jozefczuk et al. [290] have applied ridge regression regularized CCA to integrate 
metabolite data together with gene expression to provide an insight into system level 
stress adjustments of E. Coli. The authors obtained transcriptomics and metabolite 
responses to five different perturbations of the standard growing conditions (cold, 
heat, oxidative stress, lactose diauxie and stationary phase). The data 
sured in several time points during the fermentation. The analysis consisted on 188 
metabolites and 288 genes, whereas the total sample number was more than 550. 
Canonical correlation analysis was performed for the metabolite and transcriptomics 
data on each perturbation separately but the number of samples obtained from 
each perturbation experiment was not mentioned. Nevertheless, the analysis iden­
tified a number of significant condition-dependent associations between metabolites 
and transcripts; authors found groups of correlating metabolites, metabolite genes 
and transcriptional factors which are known to regulate or potentially regulate the 
metabolic processes. The co-occurrence of metabolic and transcript responses for 
functionally related genes and metabolites was proposed to be an effect of strong 
co-regulation on both levels of responses. These associations were found for previ­
ously known specific pathway regulations, as well as potential new ones that will be 
targets for future research. In conclusion, according to the authors, CCA is 
cessful explorative tool to display associations between genes and metabolites that 
are less prominent by means of direct linear relationships (e.g. Pearson correlation) 
in the initial data [287,290].
Applying the classical ridge regression regularization technique to canonical 
relation requires the optimization of the regularization parameters using 
lidation procedure. However, optimizing the regularization parameters can be un­
ambiguous and computationally very tedious. In the studies of [26,27,287,290] the 
number of features was not comparable to the number usually obtained from the 
high-throughput bioinformatics studies or the number of samples was very large. 
Therefore, it is questionable, whether the ridge regression regularized CCA general­
izes well to large-scale data sets without overfitting.
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3.5.6 Generative latent factor model for canonical correlation analysis
This section presents a visualization tool for probabilistic models called a plate di­
agram. The plate diagrams can be used to understand the probabilistic canonical 
correlation analysis presented in Chapter 3.5.7, and the models derived from that. 
A plate diagram is a visual representation of a joint probability distribution of a 
probabilistic generative model. It shows the form and properties of the distribution 
through a diagrammatic representation. This visualization eases especially the un­
derstanding of very complex probabilistic model structures. The structure of the 
graph is called generative because it reflects the process whereby the observed data
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has been arisen. The generative graph is composed of nodes and edges connecting 
the nodes. A node corresponds to a random variable, and is associated with the 
corresponding conditional probability distribution. An edge connecting two nodes 
can have a direction denoted by an arrow, and if cycles formed by the edges are not 
allowed, the graph is called directed acyclic graph. A directional edge corresponds 
to a conditional dependency of the variables it connects; for example, if there is 
edge from node A to node B, then the probability distribution of В is conditioned 
on the values of A. Moreover, A is called a parent node and В is a child node. For 
more details, see [254].
A generative model and its plate diagram can consist of three types of random 
variables: observed variables corresponding to the observed data, model parameters, 
and latent or hidden variables. Observed variables are shaded in the plate diagram, 
and if there are several observations of the same random variable, a plate (rectangle) 
is drawn around the corresponding node, and the sample size N is marked to the 
right bottom corner of the plate. In contrast, the model parameters are not observed 
but estimated from the data. The model parameters are usually of interest because 
their values depict the underlying process being modelled. Moreover, the latent 
variables are also not observed but are sometimes introduced to allow construction 
of complex joint distributions of the observed variables and model parameters from 
simpler components, i.e. the conditional distributions. The latent variables are not 
necessarily interesting, and they might have no interpretation. They can be also 
considered as generating the data through an unknown mapping determined by the 
model parameters. For more details, see [254].
Consider a plate diagram for a generative latent variable model shown in Figure 
9 [31]. A plate is drawn around the graph implying that there are N instances of 
X, Y and Z. Generally, the generative graph determines the joint distribution of 
all random variables in the model, and the factorization of the joint distribution 
to a product of conditional distributions. The joint distribution p(X, Y, Z) of the 
model in Figure 9 factorises as follows:
an
p(X, У, Z) = p(X)p(X\Z)p(Y\Z) .
The joint distribution is a product of the conditional distributions associated with 
the graph nodes. It is notable that the variables X and Y are independent of each 
other given the value of the latent parameter Z.
The edges in the plate diagram show the conditional dependence and inde­
pendence properties of the random variables. Therefore, the edges can be con­
sidered to express the probabilistic and causal relationships between the random 
variables [254]. Particularly, the absence of edges between the nodes usually 
veys interesting information about the properties of the distribution that the graph 
represents. Moreover, the number of model parameters can be reduced by dropping 
the edges in the graph; this leads to restriction of the possible distributions that 
the graph can encompass. An alternative way to reduce the number of independent 
model parameters is by sharing them. This is also denoted as tying the parame­
ters. An example of tying of parameters is seen in Figure 9 where the conditional 
distributions of X and У share the latent variable Z.
(39)
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Figure 9: Probabilistic graphical model for canonical correlation analysis. [31]
Plate diagrams have various advantages and applications: they can be used to 
design and motivate new probabilistic models; they show the conditional indepen­
dence properties of the variables; and their structure tells how synthetic data points 
can be sampled from the model. Sampling is started from the nodes with 
ents by drawing random samples from their corresponding probability distributions. 
This process continues by sampling the values of other nodes from their conditional 
distribution given the earlier sampled parent values. This method is called ancestral 
sampling. For more discussion, see [254].
A plate diagram in Figure 9 is for a generative latent variable model correspond­
ing to the probabilistic canonical correlation analysis, formulated in [29]. The nodes 
X and Y correspond to the two data sets and Z is a shared latent variable between 
X and Y. For each pair of X and Y there is a shared instance Z.
no par-
3.5.7 Probabilistic canonical correlation analysis
In addition to the graph structure giving the conditional independence assumptions 
for the random variables, probability distributions for each node are needed to de­
termine the full model. Following [29], the nodes in the graph presented in Figure 
9 could have the following probability distributions:
z ~ A/\0, /)
x\z ~ U(Wxz + iix, tyx), Wx 6 Rpxdz 
y\z ~ U{Wyz + Aty, Фу), Wy G Rqxdz .
(40)
In Equation 40, z follows a zero mean Gaussian distribution with identity covariance 
matrix. The dimensionality of z, dz, is equal to p, the minimum dimensionality of the 
two data sets. The mean of x consists of an overall mean /xx, and a linear function of 
the shared variable z through a transformation matrix W^. The covariance matrix 
of æ is Фа,. Similar distributions can be set to the random variable у corresponding 
to the data set Y.
In classical canonical correlations analysis, no probabilistic treatment of the 
learned parameters is usually performed. Nevertheless, Bach and Jordan [29] showed
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that the maximum likelihood solution for the model having the structure presented 
in Figure 9 and the probability distributions presented in Equation 40 corresponds 
to the classical canonical correlation analysis. Theorem 2 in [29] states that the 
maximum likelihood estimates for the model parameters are
Wx ^‘xxU XI (41)
Wy — JlyyUyMy,
= - WXWTX
Vy = Vyy - WyWTy .
In Equation 41, Ux and Uy denote the CCA projection or weight matrices. 
The matrices Mx and My are arbitrary matrices with spectral norms smaller than 
one, such that MxMy — P where P is a diagonal matrix having the canonical 
correlation on its diagonal. The expectations of z given x or y, E(z\x) and E(z|y), 
lie on the CCA projection space, i.e. the subspace that corresponds to the space 
spanned by the CCA projections [29]. However, the solution presented in 41 has 
a rotational ambiguity caused by Mx and My implying that the true canonical 
components corresponding to the classical solution are not revealed. [291] presents a 
method to solve this ambiguity and to find the actual CCA projections. The CCA 
projection matrices corresponding to the classical CCA results are
, Uxd = 'Z^Wx(Id-B^)-hRx,
\ Uyd = Y,yyWy{Id - B-'yiRy.
Here Bx — Wx Wx + Id and By = W"y íí>yWy + Id. The matrix Rx contains 
the eigenvectors of (Id - B-l)\{Id - B~l){Id - B;1)! and the matrix Ry contains 
the eigenvectors of {Id - Byi)i2(Id - B"1)^ - В~1)1. For more details, see [291].
In [29], Bach and Jordan also derive the minimum of the negative log likelihood 
for the probabilistic canonical correlation analysis shown below:
(P t9h/oy27re + ^oy|¿$:r| + rLiog\tyy\ + ^ ¿ log(l-pl) . (42)min{—log L} =
¿=i
The last term of the minimum of the negative likelihood is the negative mutual 
information. Thus, minimizing of the negative log likelihood with respect to the 
canonical correlation corresponds to maximizing the mutual information between 
the two data sets X and Y. Hence using the mutual information as a optimization 
function when determining the regularization parameters for ridge regression CCA 
using cross-validation is reasonable.
Klami and Kaski [30, 31] have introduced another generative model that also 
corresponds to the classical canonical correlation analysis. The plate diagram for 
this model is shown in Figure 10. In addition to the shared latent variable Z, the 
model includes also latent variables specific to the two data sets, Zx and Zy. The
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Figure 10: Probabilistic graphical model for canonical correlation analysis including 
data set-specific latent variables [30,31].
conditional probability distributions for this model
z,zx,zy ~ A/"(0, /) 
x\z, zx ~ M(Wxz + Bxzx + nx, all), Wx G Rpxd2 Bæ g Rpxd^ 
y\z, zy ~ Y(tyyz + Byzy + a2yI), Wy G R9Xdz By G Rpxdzv .
are
(43)
Note that in.Equation 43, Bx and By are different from the Bx and By shown in 
equations above.
The data set-specific latent variable Zx (and corresponding Zy) accounts for the 
variation existing only in data set X (Y). Variation in either data set can have its 
characteristic ways of producing noise and irrelevant information to the 
spending data set. In a generative sense, for example, the data X is generated from 
the shared source of variation, and the data-specific variation as a linear function 
through the matrices Wx and Bx. Moreover, the non-shared variation may be also 
of interest and it can be modelled using the above model. However, the shared vari­
ation is often considered more 
The data set-specific latent variables can be considered as nuisance parameters, and 
their modelling is avoided by marginalizing them out of the model. When the data 
set-specific variation has a full dimensionality denoting that the dimensionality of 
the data set-specific latent variables match the corresponding data dimensionality, 
<4* +1 = P and dZy + l = Ç, and the data set-specific latent variables are marginalized 
out, the model in Figure 10 corresponds also to the classical canonical correlation 
analysis [30,31]. Then the covariance matrix for data set X, can be presented 
as BXBX + all which is a covariance matrix of rank dZx +1. The corresponding fact 
is true for the covariance matrix of y. If the data set-specific latent variables are of 
full dimensionality, then the residual variances al and a^ are both zero. As a result 
this leads to the same model as proposed in the work of Bach and Jordan [29].
Several things support the marginalization of the data set-specific latent variables 
from the model: First, if they are included in the modelling, the computation would 
be inefficient comparing to the situation when they are integrated out. Second, the
own corre-
relevant, and the data-specific variation is ignored.
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marginalization is a crucial step to find the correct shared latent signal; the model 
including the data set-specific latent signals is very flexible, and there would be a 
serious risk of overfitting these less interesting signals. In that case, the data set- 
specific latent signals could prefer modelling also some of the shared signal and the 
dependencies would not be detected correctly. By introducing the data set-specific 
latent variable which correspond to the marginal densities of the data sets, and 
integrating them out allows to use likelihood more generally as a score function for 
fitting dependency seeking models. For more discussion, see [30,31].
The data set-specific latent variables can be found as a pre-processing step after 
the model parameters Wx, Wy, Фх and Фх have been learned. The covariance 
matrix Фх can be factorised by learning the model
Xj 'r4j Af {BxzXj,
In Equation 44, zXj is the data set-specific latent variable and £x = WTXWX is the 
variation already explained by the shared latent variable. This model is essentially 
same as the probabilistic principal component analysis [292].
The probabilistic canonical correlation analysis has several advantages and appli­
cations: it deepens the understanding of CCA; it enables the use of local canonical 
correlation models as components of larger hierarchical probabilistic models; and it 
suggests generalization of CCA to members of the exponential family other than the 
Gaussian distribution [29,30,293]. However, the probabilistic canonical correlation 
analysis cannot be applied when the dimensionality of the variables is higher than 
the sample size, the same problem encountered by classical canonical correlation 
analysis. The overfitting in both cases is serious, or the method cannot be applied 
at all. The problem resides especially in the estimation of the large 
trices of the data sets having large p but small n. Nevertheless, the probabilistic 
framework enables the usage of Bayesian probabilistic modelling tools discussed in 
Chapter 3.3. The Bayesian treatment makes possible the use of priors which regu­
larize the model, and applying Bayesian regularization can be more straightforward 
and efficient than the classical regularization methods. In addition, the probabilistic 
canonical correlation analysis could have less parameters to learn if a compromise 
relating to the dimensionality of the data set-specific latent variables (i.e. the 
ber of columns in matrix Bx) is made. This leads to the constraining of the data 
covariance matrices by decreasing the rank of the covariance matrix Фд.. However, 
when the data set-specific latent variables are not of full dimensionality, they begin 
to also model the shared variation, and the shared latent variable begins to model 
the data set-specific variation as noted above. Nevertheless, in this case the model 
could still detect some of the shared variation right and perform better with data 
sets having small n and large p. A model that utilize is approach is discussed in a 
section 4.
Sx + a2xI) . (44)
covariance ma-
num-
3.5.8 Bayesian canonical correlation analysis
Probabilistic canonical correlation analysis presented in Chapter 3.5.7 can be readily 
extended to the Bayesian framework where prior distributions are defined for the
~ N (O, I)
~ AÍ(Wz + fi, Ф), W G R(p+<?)x^ .
(45)
In Equation 45, fi is the concatenation of fix and fiy, W is the concatenation of the 
matrices Wx Wy, W = [Wz, y], and Ф is a block diagonal matrix having Фт 
and Фу on its diagonal.
Z
—®
N
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Figure 11: Probabilistic graphical model for Bayesian canonical correlation analysis.
The prior distribution for the parameters in the model 45
At ~ A/"(0, er2/),
Фх,Фу ~ IW(S0,^o),
Wi ~ Л[(0,Рг1),
ßi ~ TQ(a0,ßo)
For N > A a relative non-informative prior for Ф can be specified by setting t/0 to a 
small value, indicating a small number of virtual prior data. However, for scenarios 
with N æ D, the posteriors of the Ф becomes improper, and tricks like increasing 
the virtual sample count in the prior are required. This, in turn, makes the Wishart 
prior relatively strong, severely biasing the whole posterior.
In Equation 46, denotes the column of W with a isotropic variance /3,/■ A 
hyperprior distribution for is also determined. TÇ and TW are abbreviations 
for inverse-Gamma distribution and inverse-Wishart distribution, respectively. The 
priors for fi and for the covariance matrices Фх and Фу are conjugate priors. The 
prior for the projection matrix W is the so-called automatic relevance determination 
prior (ARD) [34]. It has been used for example in Bayesian Principal Component 
analysis [295] to determine the number of retained principal components automat­
ically. Using values «о = 0.1, ß0 = 0.1, z/0 = p + 1, S0 = / and a2 = 1 for the prior
are
(46)
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model parameters. Consider model in Figure 11, in which in addition to the observed 
and latent variables, the nodes corresponding to model parameters are added. Before 
introducing the prior distributions, a feature-wise concatenation of the data V —
on this concatenation [294].[Х;У] is performed, and the model is written based 
The CCA model can then be written
N
 ^
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and hyperprior parameters gives reasonably vague priors for a workable Bayesian 
data analysis.
The purpose of the ARD prior is to find low dimensional subspace for the canoni­
cal components. The number of canonical correlations is usually set to the minimum 
of the dimensionality of the two data sources. All of the canonical correlations 
not significantly different from zero, so using ARD the true underlying dimension­
ality is found. The variance parameter ßi controls the magnitude of wt. If the 
dimensionality of the canonical subspace is less than the full dimensionality, the 
prior variance parameters for some columns of W go towards zero as do the actual 
elements of the vectors. The prior for the matrix W as a whole is not conjugate 
given ARD so the values need to be obtained component by component.
are
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4 A new variant of Bayesian canonical correlation 
analysis to fuse gene expression and metabolomics 
data
4.1 Implementing group sparsity constraints into Bayesian 
canonical correlation analysis
The Bayesian probabilistic canonical correlation (BCCA) analysis presented in 
tion 3.5.8 still has difficulties in modelling data sets having large p and small n. The 
standard BCCA model requires full rank covariance matrices, which prevents it from 
working with data sets having small number of samples compared to the number of 
variables. Existing Bayesian canonical correlation analysis have shown an improved 
performance on data sets with small sample size but they are still limited to small 
scale problems; in the experiments of several studies, the data dimensionality h 
been at most 10 [294, 296-298]. The difficulty arises from the full-rank 
matrices having an inverse-Wishart prior because the estimation of these covariance 
matrices requires D(D+l)/2 parameter values to learn, D being the data dimen­
sionality. For increasing D and fixed sample size N, the amount of data per element 
reduces rapidly, and inference slows down because the cost is cubic as a function 
of D. Inferring such large covariance matrices can be done by introducing 
strong prior assumptions such as restricting the covariance matrices to be diagonal. 
However, this would in turn produce serious bias in the results. In this section, a 
new Bayesian dependency model is introduced in which the covariance matrices for 
the data sets are estimated by matrices having a low rank [33]. The low rank matrix 
is constructed as an inner product of a matrix having a low number of columns. 
In contrast, some studies have proposed CCA variants that assume full sparsity 
for the projections/transformation matrices, thus decreasing the efficient number of 
parameters learned in the model [294,297]. The former introduces sparsity to the 
transformation matrices via sparsity-inducing priors, and the latter by constructing 
an Indian Buffer process (IBP) prior for choosing the active elements [299]. The 
former approach still lacks the solution for identifying the shared and non-shared 
components, and the authors provide no empirical experiments with the full CCA 
model. The IBP-based model, in turn, retains the full-rank noise covariance, pre­
venting efficient and robust inference for high-dimensional data [300,301]. Another 
problem in the standard BCCA formulation is the lack of identifiability; the solution 
is found only up to an unknown rotation.
This chapter presents a new
sec­
as
covariance
a very
variant of Bayesian canonical correlation analysis 
which implements group sparsity constraints to the sample covariance matrices of 
the data sets [33]. The new model is similar to the model presented in Figure 
10 which includes the data set-specific latent variables. Now the latent variables 
are not integrated out, which leads to a generative model having a plate diagram 
shown in Figure 12. If the data sets assumed to be standardized, the probabilityare
~ А/(О, /)
~ N(Wz, Ф), w e R(p+<?)xd2 .
(48)
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distributions assigned to the nodes
~ AA(0, /)
Xj ~ UiWxZj, BXBTX + (T^/)
y, ~ A^(Wyz,,BX + S2/)-
Actually, in Equation 47, it seems that the data set-specific latent variables have 
been integrated out. However, the covariance matrix of the feature-wise concatena­
tion of the data, Ф, is a block diagonal matrix having BxB^.-\-all and ВуВ1у + a21 
on its diagonal, and the data set-specific latent variables are needed to be included 
into the modelling to get estimates of the matrices Bx and By.
If the data and the projection matrices Wx and Wy are concatenated as in 
Equation 45 and the covariance matrix Ф is a block diagonal matrix having BxBl 
a2I and ByBy + a21 on it’s diagonal, the model in Equation 47 can again be 
presented in a simpler form:
are
(47)
+
Figure 12: Probabilistic graphical model for canonical correlation analysis when 
introducing group sparsity constrains.
Priors for the model parameters are
Wi ~ Л/ХО, ßnl)
ßu ~ X£(<*io,Ao)
Ъхк ~ Af(0, ßixkl)
ßixk ~ ^G(oi20, /З20)
byi ~ ß2ylI)
ß2yl ~ («20, /З20)
al’al ~ ZG((*o,ßo) ■
In Equation 48, bxk is the kth column of Bx, and byi is the Ah column of By. The 
priors for Wj, bxk and byi are all ARD priors. Virtanen et al. [33] present this model
(49)
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Wxw = Wy
This method is called the group-sparsity Bayesian canonical correlation analysis 
(gsCCA). The Bayesian canonical correlation analysis has reduced to a simplified 
factor analysis model with specific form of sparse structure for the linear projections 
W. By inspecting the columns of W, each column is either dense or has a very 
specific sparsity structure: either the elements corresponding to the first p rows of 
the matrix W, the elements corresponding to the last q rows of the matrix W, or 
both are zero. The last case 
shared nor data set-specific, i.e. is pruned out.
The model structure presented above enables the learning of the covariance 
trices in large p, small n setting, by automatically learning the low-rank structure 
of the covariance matrices Фх and Фу. The automatic learning of the 
structure is done by introducing automatic relevance determination priors [302,303] 
for the columns of the projection matrix W. By integrating out the data set-specific 
latent variables, the model can be shown to be equivalent to imposing a low-rank 
assumption Фх = BXB! + for the covariance matrices. This allows decreasing 
the computational demand and increases the amount of data per model 
ter. However, the number of latent variables is increased three-fold. Nevertheless, 
this has the advantage that instead of merely capturing the correlation between the 
data sources, it produces a full factorization of the variation in data into shared 
and non-shared components. All this makes inferring the number of components in 
the model more difficult. For example, trying to simultaneously learn three compo­
nent numbers with three separate ARD, and hence the structure of the matrix W, 
is extremely sensitive to initialization. Correctly identifying the shared and 
shared components becomes tricky since the non-shared components can always be 
represented as the shared ones with an equal likelihood. The only information for 
identifying the components comes from the prior. For more discussion, see [33].
In contrast to the previous models, here the matrices Wx and Wy are modelled
implies a situation where the component is neither
ma-
covariance
parame-
non-
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in a following way: Feature-wise concatenation v = [x,y\ leads to factorised CCA 
model presented in Equation 50. Instead of explicitly specifying three different sets 
of latent variables, namely one shared and two data set-specific components, a single 
set of components is used.
Z ~ A7(0,/), 
v ~ N{WZ,4f)
In Equation 50, Z includes the shared latent variable, as well as the data set-specific 
latent variables. The dimensionality oi Z is Kc = К + Kx +Ky and Ф is a diagonal 
matrix that contains only the variances and о* on the diagonal in p and q copies. 
The structure of the transformation matrix VF is as follows:
(50)
to
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i
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row-wise, i.e. the ARD prior is determined for the rows of the projection matrices:
P{WX) = X[N(wxd\0,ßI)
d=l 
dz
P(P) = nietolQo.A) •
(51)
t—1
Actually, Equation 51 still implies that each column of W has the corresponding 
precision ß. Small values of qq and ßo in a hyperprior for /3, shown in Equation 
51, result in an ARD prior automatically driving unnecessary components to 
If two grouped columns in the learned matrix corresponding to different data sets 
have a small ß parameter, this component is completely pruned out of the model. 
If both groups have a high /3, then this component is a shared component. If the 
ß corresponding to one data set is large, and the ß corresponding to other data is 
small, then the component is specific to either data set.
The prior distribution for W is
zero.
P q
p(W) = П U(wdl[0,ß,l) f] M(wd,\0,ß2I) . (52)
di=l «¿2 = 1
In Equation 52, w¿i is one of the p first rows of W and is one of the last q rows 
of W.
gsCCA is inferred by a variational approximation method using formulas derived 
for a Bayesian PCA and Bayesian CCA where applicable [298,302]. The factorised 
approximation of the posterior is presented in Equation 53. All model parameters 
are included in ©. The different factors of the posterior are learned by updating 
them in cycles [33].
p+q kc n
q(Z, 0) = q(<7¡)q(a¡)q(Z) J] q(wd) Д q^Mß^) Д q(zn) (53)
Í¿=1 k=l 71=1
The underlying projection corresponding to the classical CCA solution can be 
identified for a Bayesian CCA with a post-processing step proposed by [291] and 
presented in Chapter 3.5.7. However, this extra step is essentially equivalent to 
solving the classical CCA problem, and hence many of the advantages of Bayesian 
treatment are lost. While the transformation can easily be applied to the maximum 
likelihood solution, it is unclear how the transformation works for the full posterior 
distribution. Virtanen et al have solved this unidentifiability problem by explicitly 
optimizing a variational lower bound with respect to an unknown rotation [33]. 
This procedure is similar to the approach presented by Luttinen et al which has 
dramatically improved convergence of variational approximation in factor analysis 
model [304]. Luttinen et al have achieved the speed up of the optimization by 
using proper parameterization of the posterior approximation, which allows joint 
optimization of its individual factors. For CCA, this approach does not only result 
in increase in computational speed of variational approximation; the optimization of
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the rotation gives also the correct CCA projections, and helps separating the shared 
components from those specific to either data set [33,304].
The trick that solves the rotational ambiguity comes after each round of varia­
tional updates. The variational approximation includes a separate parameter matrix 
R which is a linear transformation applied to W. On the other hand, if z is multi­
plied by the inverse of R, W*z* = (WR^R-'z) = Wz, the likelihood is invariant 
to R. The rotation is inferred by maximizing the variational lower bound with re­
spect to R, or equivalently by minimizing the Kullback-Leibler divergence between 
the approximation q(Z, 0) and the prior Po(Z, 0), shown in Equation 54. In Equa­
tion 54, the expectation is taken with respect to the transformed approximation 
q*(Z, 0). For details of this optimization, see [304] and [33].
arg min (InR
Given a fixed likelihood, the only way the variational bound can improve is by 
rotating the components so that the posterior p(Z, 0) better matches the facto­
rial approximation q(Z, 0). Hence, maximizing the lower bound with respect to R 
equals forcing the model to find components that are a posteriori maximally inde­
pendent of each other. This is analogous to the classical CCA solution requiring 
orthogonality of the components in the latent space. Hence, the maximasing R not 
only provides a deterministic choice for the rotation but also does it in a meaningful 
sense. For more discussion, see [33].
The gsCCA method has several good properties. It is computationally efficient 
and works for high dimensional data. In addition, the model separates the latent sig­
nals into shared and data set-specific. Virtanen et al have compared the performance 
of the original Bayesian CCA to gsCCA in finding the true shared components when 
varying the data dimensionality. The authors observed that the models have equal 
performance on low dimensional data but with high-dimensional data, the standard 
BCCA does not find the shared components correctly. The standard BCCA would 
require a full-rank covariance matrix, which is possible only in large n, small p set­
tings. The new model, gsCCA, is able to extract the underlying model structure 
and is independent of the data dimensionality. Moreover, gsCCA was applied to 
neuroinformatics data set including 137 samples, 274 features in the other data set, 
and 28 features in the other data set. The gsCCA method applied to this data 
outperformed the standard multiple output linear regression model in the sense of 
mean-squared prediction error. One shortcoming of the model is that the rotation 
maximizes independence of the whole posterior approximations, which implies inde­
pendence of both the latent variables z and the projection vectors. Ideally, a CCA 
model would only require independence over the latent variables. For more details, 
see [33].
In Chapter 3.2, it was shown how the regularization stabilizes the model param­
eters but introduces a small bias. Regularization in the Bayesian framework and 
using priors also biases the results. Priors are heavily used in gsCCA, so a question 
of the bias introduced by them rises. Inverse-Wishart priors for data covariance 
matrices in the standard Bayesian CCA are so called hard priors which biases the
q*(Z,e)
>*, (54)Po{Z,Q))
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results strongly if they are very informative. On contrast, the ARD prior is so called 
soft prior which adapts to the data complexity, and do not bias the results heavily.
4.2' Data for studying the role of the gene RCD1 in Ara- 
bidopsis thaliana oxidative stress signalling
4.2.1 Description of the data
In the study of the role of the gene RCD1 in Arabidopsis thaliana oxidative stress 
response, gene expression and metabolite data were measured in two genotypes: 
in the wild type Col-0 and in the mutant redi. Both genotypes were exposed to 
ozone starting at time point 0 h, and ending at time point 6 h. The data 
measured at six time points starting from the ozone exposure: 0 h, 1 h, 2 h, 4 h,
8 h and 24 h. In addition to ozone treated plants, plants kept in clean air, i.e. 
in the control condition, were subjected to measurements as well. The experiment 
was performed three times, so there are 3 different measurement batches. The three 
different batches were measured during different seasons, so there might the variation 
due to that and other factors. In each batch and in each combination of genotype, 
treatment and time, 5-7 plants were analyzed. Separate MS measurements 
obtained for each individual plant, but to obtain gene expression data, the biological 
material from all these 5-7 plants were pooled to get enough RNA material.
Gene expression was measured by custom made cDNA microarrays. In the gene 
expression analysis, common reference design [305] was used; to obtain a common 
reference, all biological material obtained in the experiment were pooled. Com­
mon reference and the sample of interest were labelled with the different dyes and 
hybridized on the same microarray slide. Dye-swap was performed thus giving two 
repetitions. For the MS experiment, the samples were prepared, and the amino acids 
derivatised using EZ-faast kit [306]. MS data were measures using Thermo Finni­
gen s LC-LTQ high-resolution MS instrument. Metabolites were identified using 
their retention time, mass and fragmentation pattern. The relative concentrations 
of amino acids were obtained by comparing their concentrations to three known 
inner standards. The data was collected using Xcalibur -program. The data 
normalized with respect to the fresh weight of the samples. The relational metabolite 
levels for individual plants were averaged, as well as the repetitions obtained from 
the dye-swap. Together this gives 3(batches)x2(genotypes)x2(treatments)x6(ti 
points)=72 paired samples. A logarithmic transformation was applied to the metabolic 
data. Before logarithmic transformation, 1 was added to all metabolite data values 
to ascertain that after the logarithmic transformation, zero will be still zero. Log­
arithm transformation of the metabolite data takes away the effect that variance 
increases as the measurement level increases. One metabolite, ornithine, 
moved from the data because it does not show any variance. As a result, the data 
include 27 metabolites.
The gene expression data were received as already pre-processed and normalized, 
so then relative intensity values were used as such. Recent reconstruction of Ara­
bidopsis thaliana metabolic network built from the known reactions in the AraCyc
was
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data base [307,308], and the experimental data about the (ir)reversibility of the 
reactions was used to select a subset of genes among about 12500 genes analyzed in 
the microarray experiment [309]. Linear programming have been used to show that 
the model is capable of producing amino acids, nucleotides, starch, cellulose and 
lipids in the ratio needed for growth of heterotrophic Arabidopsis thaliana cell cul­
tures [309]. All metabolite and reaction names in this metabolic model are AraCyc 
unique identifiers. The used model, however, did not include the names of the genes 
associated with the reactions, so those were queried from AraCyc database based 
on the reaction names using pathway tools using Common Lisp interface [310].
1164 genes associated with the reactions of Poolman’s Arameta model were the 
basis of the gene subset selected for the analysis. This set includes genes related 
to the biological processes where the metabolites analyzed in this thesis participate 
[309]. In addition, 52 transcription factors which show differential expression at time 
points 1 h and 2 h in redi compared to the Col-0 either in control condition or under 
ozone exposure were included to the data set. The gene RCD1 (AT1G32230) 
also added. Together this makes 1217 genes. When choosing only those genes that 
in the data, the number of genes decreases further. Moreover, only those genes 
having absolute fold change equal or larger than one, were included in the model. 
Finally there are 489 genes in the subset. Of the expression data of these
was
are
genes,
1 % of the values were missing, so missing-value imputation was performed by an 
iterative version of principal component analysis. The method is called Non Linear 
Estimation by Iterative Partial Least Squares (NIPALS) [311]. This method has 
been the origin of partial least squares, and it allows performing PCA with missing 
data. NIPALS is implemented for example in the R package ade4 [312]. Finally the 
data was standardized to have zero mean and variance of one.
Pre-processing of gene expression and metabolite data using linear 
mixed effect models
Metabolite and gene expression data were both analyzed and pre-processed by li 
mixed-effects models. The mixed-effects models were also used to address the sig­
nificantly differential concentration levels of metabolites. The mixed-effects models 
resemble ANOVA type of methods in which the observed variance of a particular 
variable is partitioned into components attributable to different sources of varia­
tion. These different sources of variation are referred to as covariates, and in this 
work they are the genotype, treatment and time. Mixed-effects models contain 
both fixed effects and random effects. Fixed effects are covariates associated with 
entire population, or with certain repeatable levels of experimental factors. On 
the other hand, random effects are associated with individual experimental units 
drawn at random from population. In other words, fixed effects assume that the 
data come from populations which may differ only in their means, whereas random 
effects describe a hierarchical structure of the data where the difference of different 
populations are constrained by the hierarchy. Random effects are additional error 
terms that account for correlation among observations within the same predefined 
group of samples. If there are more than one source of random variation, the model
4.2.2
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is called a hierarchical model. For more details, see [313].
The linear mixed-effects model finds the differences in gene expression and metabo­
lite levels due to genotype, treatment and time but it can also be used to remove the 
random effects such as the dye effect in gene expression studies, as well as the dif­
ferences in three different measurement batches. For metabolite data, the unwanted 
random variation in different plants, or variation due to the MS technique could be 
modelled. There random effects are usually not of interest, and one would want to 
remove them from the data. For more details, see [313].
In linear mixed-effect models, both fixed and random effects are assumed linear. 
A linear mixed-effects model having a single level of grouping is presented as [313]
Vi = X-iß + ZA + e¿ г = 1,..., M, 
bi ~ A^(0,S) 
e¿ ~ N(0,al) .
In Equation 55, n, dimensional observation vector yl in group i is a linear function 
of p dimensional fixed effects vector ßu and òj is a q dimensional random effects 
vector. Matrices -X"¿ (щ x p) and Zt (n¿ x q) are known fixed effects and random- 
effects regressor or contrast matrices, respectively. Gaussian error term e¿ has the 
dimension щ and models the within-group error. The random effects 6¿ and the 
within-group errors are assumed to be independent for different groups, and to 
be independent of each other in the same group. In that case, the covariance matrix 
£ of Gaussian random effects is diagonal.
Among the three measurement batches, replicates of the measurements for a 
given metabolite behave in a similar way but there is a shift in the overall con­
centrations. This is to be taken into account in a linear mixed effect model and, 
therefore, a random effect term bv (v = 1,2,3) for each measurement batch is added 
to the model. Also random effects for different plants are included, denoted as bvi 
(г = 1,..., 5). The random effects are assumed to be independent of each other. 
The fixed effects include genotype, treatment and time and all combinations of these. 
The model is presented in Equation 56 for each metabolite. In this equation, C is 
the intercept term, ak denotes treatment (k=l,2), ßg denotes genotype, (g = 1,2), 
and 7t denotes time (t = 1,... ,6). The bv is normally distributed with a diago­
nal covariance matrix, bv ~ N(0,af), as well as bvi, bm ~ N(0,a¡). The £ is the 
Gaussian error term; Egktdvi ~ Ar(0, a2).
Vgktvi = С + ak + ßg+ъ + ak~/t + akßg + ßg^t + afcßs7t 
bvi T Egktvi
Linear mixed-effects model for expression of a gene is presented in Equation 57 
where C, ak, ßg and 7¿ are same as in the Equation 56, and Sd, d = 1,2 denotes a 
fixed dye-swap effect. The ¿v, n = 1, 2, 3, is the batch effect.
Vgktdvi = C + ak + ßg + It + Olklt + Oikßg + ßglt + Oikßg^t + àd 
T Egktdvi
(55)
(56)
(57)
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The mixed effect model can be fitted using the maximum likelihood method. The 
fitted linear mixed effect model can and should be examined using graphical and 
numerical summaries. One graphical summary that should be examined routinely is 
the plot of the standardized residuals e versus the fitted responses of the model. This 
plot is used to assess the assumption of constant variance of the residual error term. 
This plot is investigated to see whether there are systematic reduction or increase 
in the variance of e as the level of the response decreases or increases. In addition, 
hypothesis test can be performed on 
effects model, and confidence intervals for the parameters can be calculated. The 
precision of fit and the significance of various terms in the model can be assessed, 
and the fitting of two different models to the data can be compared. A general 
method for comparing fit of the nested models is the likelihood ratio test [314]. A 
statistical model is called to be nested within another model if it represents a special 
case of another model. If Т2 is the likelihood of the more general model, and Li 
the likelihood of the restricted model, and the more general model fist better to the 
data, L2 > Lx and correspondingly log L2 > log h holds. The likelihood ratio test 
statistic (LRT) defined in Equation 58 will be positive in this
the parameters learned by the linear mixed-
case.
21og([2) = 2[log(L2)-log(L1)l 
-^1
(58)
The linear mixed-effects models were fitted to the data, and models analyzed 
using R-package nlme [315]. The raw metabolite data were pre-processed using 
linear mixed-effects models. Linear mixed-effects model was fitted to the data and 
P values corresponding to the differences of metabolites due to genotype, treatment 
and time were obtained. Problems in multiple comparison were avoided by adjusting 
the p values with Benjamini-Hochberg correction [67]. Finally, the metabolite data 
were normalized to have zero mean and unit variance.
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5 Results
5.1 Correcting batch effect in the metabolite data by linear 
mixed-effects model
The linear mixed-effect model (Equation 56) was fitted to the metabolite data. The
assessed by investigating the distribution of residuals, 
i.e. the differences between the measured and predicted metabolite concentration 
levels. The residuals were normally distributed around zero in a similar way for all 
metabolites except serine. The model in Equation 56 was compared to a simpler 
model lacking the term bvi. The likelihood ratio test indicated the more detailed 
model fitting better to the data, except for a metabolite pipecolic acid.
The random effects learned by the model (Equation 56) were subtracted from 
the original data. The effect of this pre-processing can be seen in Appendix A in 
Figure Al where concentration levels for metabolite asparagine are plotted as a 
function of time for all combinations of genotype and treatment. Different colours 
red, blue and green correspond to different measurement batches. As can be seen, 
before pre-processing the measurements from different batches differ, whereas after 
pre-processing, they are more similar. However, the metabolite data are still very 
noisy.
model fit to the data was
5.2 Metabolites showing differential concentration levels due 
to genotype, treatment and time
The significantly differential concentration levels of metabolites due to genotype, 
treatment and time are obtained as a result from fitting the linear mixed effect 
del (Equation 56) to the metabolite data. The metabolites showing statistically 
significant (adjusted p value < 0.05) differential concentration levels in the wild type 
Col-0 between control and ozone treatment are highlighted in Figure 13. Red colour 
indicates up-regulation, and green colour indicates down-regulation. The values in 
the table are logarithmic fold changse of the metabolite levels between compared 
conditions. As can be seen, the concentration levels of citrulline, cystathionine, 
glutamine and methionine are decreased at certain time points, whereas most of 
the metabolite levels increase from time point 2 h onwards. The levels of aromatic 
amino acids phenylalanine, tryptophan, and tyrosine increase due to ozone exposure. 
Valine, leucine, isoleucine, and lysine synthesised by the same metabolic pathway 
also show increased concentration in wild type plants due to ozone treatment.
The metabolites showing statistically significant differential concentration levels 
in the mutant redi between control condition and ozone exposure are shown in 
Figure 14. Citrulline and methionine show similar decreased concentration levels as 
the wild type. Moreover, the concentration levels of a-aminoadipid acid, glutamine, 
and methionine show similar differences in the mutant as in the wild type. Also the 
levels of arginine, histidine, isoleucine, leucine, phenylalanine, tryptophan, tyrosine 
and valine show similar higher expression but the fold changes are larger, and the 
higher levels occur earlier in the redi than in the wild type (isoleucine, leucine,
mo
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phenylalanine, glycine). Four additional metabolites show increased concentration 
in the redi compared to the wild type: a-aminobutyric acid, /3-aminoisobutyric 
acid, 7-aminobutyric acid and pipecolic acid. Glycine does not show decrease at 
time point 2 h in the mutant plant as was observed for the wild type.
time
metabolite Oh 1 h 2 h 4 h 8 h 24 h
alpha-aminoadipic acid 0.917
arginine 1.041
citrulline -0.431
cystathionine -0.302
glutamine 0.436
glycine -0.753 0.906
histidine
isoleucine
leucine
0708
0.8630.528
methionine -0.344 -0.568 -0.481 
0.5651 07081 0.765phenylalanine 0.803
0.615threonine 0.381
tryptophan 0.831 1.046 0.972
tyrosine 0.484 0.688 1,332 
0.2811 0.348| 0.382
1.160
valine 0.416
Figure 13: The statistically significant differences in metabolite concentration levels 
due to ozone exposure in the wild type Col-0 (adjusted p value < 0.05). The 
significantly up-regulated metabolites are highlighted red and the significantly d 
regulated metabolites are highlighted green.
The changes of metabolite concentration levels between genotypes in control 
dition are shown in Figure 15. Several metabolite levels are differentially regulated 
in the mutant plant already in the control condition, and the differences change dur­
ing the day. The metabolites a-aminoadipic acid, citrulline, glycine, phenylalanine 
and pipecolic acid show down-regulation, whereas alanine, arginine, glutamate, glu­
tamine, lysine, proline and valine show up-regulation. Especially the proline levels 
are higher in the mutant plant in control condition than in the wild type.
The differential levels of metabolite concentrations between genotypes under 
ozone exposure are shown in Figure 16. The column corresponding to the time 
point 0 h is same as the corresponding column in Figure 15 because that is the 
sample obtained just before initiating the ozone exposure. Under ozone exposure 
the metabolites show differential expression from time point 2 h onwards. Citrulline 
is down-regulated at time point 24 h, later than in other comparisons. All other 
differentially regulated metabolites are up-regulated: a-aminobutyric acid, arginine, 
7-aminobutyric acid, glycine, histidine, isoleucine, leucine, lysine, phenylalanine, 
proline, threonine, tryptophan, tyrosine and valine have all more elevated levels in 
the mutant redi than in the wild type under ozone exposure.
It is difficult to draw conclusion from the tables presented in Figures 13, 14, 15, 
and 16. They just show the significant differences in the metabolite concentration
own-
con-
79
time
metabolite Oh 1 h 2 h 4 h 8 h 24 h
alpha-aminoadipic acid 1.258
alpha-aminobutyric acid 0.466
arginine 1.844
beta-aminoisobutyric acid 0Л73|
citrulline -0.427
gamma-aminobutyric acid 1.2003 1.0323 0.981 
Ó.450glutamine
glycine 0.5547 1.584
1.190histidine
isoleucine 0.4105
0.4631
0.6143 1.0290 
0.6300 1.4936
1.896
2.134leucine
lysine 0.4239 0.922
methionine -0.366 -0.584 -0.491
phenylalanine 0.320 0.6384 1.3979 1.5242 1.959
0.835
pipecolic acid 1.5127
0.3187threonine
tryptophan 1.0428 1.2623 2.122
tyrosine 0.4787 1.3237 1.7821 
0.6565 0.7831
2.507
1.176valine 0.2883
Figure 14: The statistically significant differences in metabolite concentration levels 
due to ozone exposure in the mutant redi (adjusted p value < 0.05). The sig­
nificantly up-regulated metabolites are highlighted red and the significantly down- 
regulated metabolites are highlighted green.
levels. The lists become more interesting when introducing to the analysis the 
expression values of genes associated with enzymes synthesizing and degrading these 
metabolites, as well as the transcription factors potentially regulating the expression 
of metabolism associated genes.
5.3 Significance of canonical correlations
5.3.1 Canonical correlations obtained by rrCCA
The significance of canonical correlations obtained by the ridge regression regular­
ized CCA (rrCCA) were investigated using the test presented in Section 3.5.2. The 
training and test data were obtained by dividing the whole data into half. This di­
vision was performed 1000 times. For each division, 100 random samples X 
Yrand were sampled from multivariate normal distribution with diagonal 
matrix. Finally, this test resulted in 24 significant canonical correlations out of 27. 
This result is very likely overoptimistic.
The values of canonical correlations obtained by the rrCCA method are shown 
left in Figure 17. It can be seen that there is a clear gap between canonical 
relations for canonical variate pair 5 and 6; between canonical variate pair 10 and 
11; and between canonical variate pair 12 and 13. As suggested by Gonzalez et
and 
covariance
rand
cor-
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time
metabolite Oh 1 h 2 h 4 h 8 h 24 h
alanine 0.3119
alpha-aminoadipic acid -0.783
0.3059arginine 0.397
citrulline -0.584
glutamate 0.3884
0.2934glutamine
glycine -0.700 -0.651
lysine 0.4008
phenylalanine -0.367
pipecolic acid -1.059
proline 0.6307 0.6646 0.706 0.43560.5926 0.668
0.373valine 0.3920 0.311
Figure 15: The statistically significant differences in metabolite concentration levels 
in the redi in control condition compared to the Col-0 (adjusted p value < 0.05). 
The significantly up-regulated metabolites are highlighted red and the significantly 
down-regulated metabolites are highlighted green.
al. [26,27], the intrinsic dimensionality of the data set could be chosen to be 5, 10 
or 12. As seen in the leftmost Figure of 17, the rrCCA method overfits badly as the 
smallest canonical correlations are not approaching zero as is expected.
5.3.2 Canonical correlations obtained by gsCCA
For the gsCCA method, the total number of shared and data set-specific 
nents need to be set before training the model. To choose the correct number of 
components, gsCCA was run by varying the number of components between 2 and 
50. The total number of components giving highest value for the lower bound 
chosen. The lower-bound as a function of total number of components is shown in 
Figure 18. The highest lower bound is obtained using 19 components. The divi­
sion of the components to shared and data set-specific components, and the final 
order of the shared components vary according to the initialization of the gsCCA 
algorithm; the results analyzed in this thesis consist of 13 shared components 
component specific to metabolite data, and 5 components specific to gene expres­
sion. The values of the canonical correlations for the 13 canonical variate pair 
shown right in Figure 17. Because the initialization affects the results of gsCCA, 10 
random initializations were performed with fixed number of components (19), and 
the solution giving the highest lower bound was chosen.
The significance of the canonical correlations obtained by gsCCA were addressed 
by investigating the posterior distribution of the canonical correlations. By using 
ancestral sampling, 500 samples from the model presented in Figure 12 were sampled.
compo-
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time
Oh Ih
JU12
metabolite 2 h 4h 8 h 24 h
alanine
alpha-aminoadipic acid -0.783
alpha-aminobutyric acid 0.674
0.306arginine 0.692 1.199
-0.452citrulline
gamma-amino-butyric acid 
glutamate
0.891 0.795 0.714
0.3881
glutamine 0.293
glycine 0.625
0.798histidine
isoleucine 0.465 0.741 1.367
leucine 0.334 0.693 1.022 1.555 
0.838
0.494 0.473 1.114
lysine 0.401
phenylalanine
pipecolic acid -1.059
proline 0.631 0.500 0.825 0.559 0.631
threonine 0.347
tryptophan 1.268
tyrosine 0.620| 0.495 
0.479 0.510
1.445
valine 0.392 0.318 1.133
Figure 16: The statistically significant differences in metabolite concentration levels 
in the mutant redi under ozone exposure compared to the Col-0 (adjusted p value 
< 0.05). The significantly up-regulated metabolites are highlighted red and the 
significantly down-regulated metabolites are highlighted green.
The histograms of the canonical correlations are shown in Appendix В in Figures 
B1 and B2. The canonical correlations are higher than zero with probability 0.95 for 
all canonical variate pairs except for the two last ones, the 12th and 13th canonical 
components. Therefore, the 11 highest canonical correlations were chosen as targets 
of further analysis.
5.4 Comparing performance between rrCCA and gsCCA
The performance of rrCCA and gsCCA were compared by investigating the 
ical correlations obtained from the training and non-permuted validation data, as 
well as from permuted validation data using cross-validation. Moreover, the effect 
of optimization of the regularization parameters on the results obtained by rrCCA, 
or the optimization of the total number of components on gsCCA were addressed. 
The results of this comparison are shown in Figure 19. When using rrCCA, the 
non-permuted validation data canonical correlation coincide with the training data 
canonical correlation for the first canonical correlation (left in Figure 19). Some of 
the non-permuted validation set canonical correlations from fourth canonical 
lation onwards are much lower than the training data canonical correlation, and the 
permuted and non-permuted validation data canonical correlations are around zero
canon-
corre-
Dimension
гтССА: canonical correlations gsCCA: canonical correlations
__
1 3 5 7 9 11 13
Dimension
Lower bound as a function of total number of components
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Figure 17: Canonical correlations obtained by the rrCCA and gsCCA methods.
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for the l\th canonical component. Therefore, the canonical correlations from the 
component 11 onwards are likely not significantly different from
When the same experiment is performed using the gsCCA method, the 
lations in the training data and non-permuted validation data are similar for the 
four highest canonical correlations, the fourth canonical correlation being equal in 
both training and validation data sets (right in Figure 19). The 7th, 8th and 9th
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Figure 19: Training and validation set canonical correlations obtained by rrCCA 
and gsCCA when the model complexities are optimized.
canonical correlations between training and non-permuted validation data are also 
close to each other. However, the permuted validation data canonical correlation is 
higher than non-permuted canonical correlation already for the 5 th canonical vari­
ate pair. Also the 12th and 13th permuted validation data canonical correlations 
are higher than non-permuted canonical correlations. From these figures and the 
results presented in the previous chapter, it can be concluded that the significance of 
the canonical correlations is better addressed by gsCCA than by rrCCA. Otherwise, 
there seems not to be much difference between the methods in obtaining the most 
highest canonical correlations. The results shown in Figure 19 are of course affected 
by the random division of the data into training and validation sets. In contrast to 
plotting only the means of canonical correlations of к training and validation data, 
the distribution of the canonical correlations could be better assessed by plotting 
also the distributions of the canonical correlations.
5.5 The amount of shared variance in data sets explained 
by canonical components
5.5.1 Variance explained by rrCCA
The variation in the data sets accounted for by the canonical components is inves­
tigated using squared intraset and interset canonical loadings. The average squared 
canonical loadings for the rrCCA method are shown in Figure 20. The first five 
components explain most of the variation in the data, although components 14 and 
20 explain also decent amount of variation in the metabolite data. The intraset 
loadings in general are larger than interset loadings. The first five canonical compo­
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Figure 20: The proportion of variance in both data sets explained by the canonical 
variates obtained by rrCCA.
5.5.2 Variance explained by gsCCA
The average squared canonical intraset and interset loadings obtained for the gsCCA 
method in Figure 24 are somewhat different in comparison to values obtained using
The amount of variation in the data explained by each canonical component
о
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nents, except the third one, explain more variation in the gene expression data; the 
third component explains more variation in the metabolite data. This plot clearly 
states that only the first five canonical components should be investigated 
carefully. The cumulative distribution for the average squared canonical loadings 
presented in Figure 21. The five first canonical components explain 62 % of the 
variation in the metabolite data and 70 % of the variation in the gene expression 
data based on the intraset squared canonical loadings.
The redundancy of the canonical variates obtained by the rrCCA method, i.e. 
the amount of shared variance between the two sets of variables in each canonical 
component, and the cumulative sum of redundancies over canonical components are 
shown in Figures 22 and 23, respectively. These figures result in similar conclusions 
as Figures 20 and 21. The cumulative sum of the redundancies of the first five 
ical components is 0.54 for the canonical variates corresponding to the metabolite 
data, and 0.60 for the canonical variates corresponding to the gene expression data.
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Figure 21: The cumulative sum of the proportion of variance in both data sets 
explained by the canonical variates obtained by rrCCA.
rrCCA. For gsCCA, the components 1, 2, 3, 4 and 8 include most of the variation, 
and component 5 explains still quite much variation in the metabolite data. Com­
ponents 1 and 2 explain more variation in the metabolite data, whereas components 
3, 4 and 8 explain more variation in the gene expression data. The Results indicate 
that the components 1, 2, 3, 4 and 8 should be studied more closely. The cumulative 
sum (Figure 25) of the average squared intraset canonical loadings for these compo­
nents are 0.82 for both metabolite data and gene expression. The redundancies and 
the cumulative sum of redundancies are shown in Figures 26 and 27, respectively. 
The cumulative sum of the redundancies for components 1, 2, 3, 4 and 8 is 0.67 
for the canonical variates corresponding to the metabolite data, and 0.62 for the 
canonical variates corresponding to the gene expression data.
When comparing the cumulative sums of the average squared canonical loadings 
and redundancies for the two methods, it can be concluded that the components 
obtained using gsCCA extract more variation from the two data sets, and the shared 
variation is also higher than obtained using rrCCA. High variation extracted from 
the metabolite data is a desirable property because in that case gene expression data 
with more variables does not dominate too much, and metabolism related shared 
processes are likely extracted better.
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The cumulative sum of the average squared canonical loadings over the canonical components
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Figure 22: The redundancies of each canonical variate pair obtained by rrCCA.
Biological interpretation of canonical components
5.6.1 Interpretation of canonical components obtained by rrCCA
The samples analyzed by canonical correlation analysis can be projected onto the 
canonical components. For example, two dimensions of either canonical variate 
vectors can be chosen, and the samples can be projected on these two dimensions. 
In Figure 28, the samples projected on the first two dimensions of the canonical 
variate corresponding to the metabolite data obtained by the rrCCA method 
plotted. Blue colour corresponds to the wild type and red colour corresponds to 
the redi. The labels control and 03 indicate the control and ozone treatment, 
respectively, and time point is marked at the end of the sample name. Figure 28 
shows the ozone treated samples deviating from the control samples in the direction 
of negative x-axis corresponding to the first canonical component. Therefore, the 
first component likely contains the variation in the data caused by oxidative stress 
signalling: The ozone treated samples deviate from control until time point 8 h, and 
at time point 24 h the wild type returns close to the control state. However, the 
ozone treated mutant plants at time point 24 h still lie far away from the control 
samples.
In Figure 28, the second canonical component separates time points in control 
for both genotypes. This time dependent behaviour in control samples could be 
due to a circadian clock, a time-keeping mechanism that affects gene expression, 
and several regulatory mechanisms in plants such as environmental responsiveness
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Figure 23: The cumulative sum of redundancies over the canonical variate pairs 
obtained by rrCCA.
to anticipate daily functions including light and temperature. To check whether 
the second component indeed models the circadian rhythm, the genes having a 
high canonical loading on any canonical components were compared to the list of 
circadian clock regulated genes reported in the work of Covington et al [316]. When 
investigating the percentage of differentially expressed genes having a high absolute 
canonical loading on components 1, 2, 3, 4 and 5, and belonging to the circadian 
rhythm regulated genes, the percentages were 29 %, 64 %, 7 %, 36 % and 0 %, 
respectively. The second component contains the highest percentage of the circadian 
rhythm regulated genes, so this component very likely models the circadian rhythm. 
As seen in Figure 28, in ozone treated plants, this rhythm is turned off while the plant 
starts to cope with the stress. However, the circadian clock affects also very likely 
the regulation of oxidative stress signalling, causing mixing of these two processes.
The samples projected on 
using rrCCA are shown in Appendix C in Figure Cl. The third component separates 
genotypes both in the control condition, as well as under ozone exposure. The figures 
of canonical variate pairs from 1 to 5 were investigated to assess the clustering and 
separation of the samples by the canonical components. The results are listed below 
for rrCCA method.
1. The first component separates ozone treated samples from control samples at
the first and third canonical components obtained
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The amount of variation in the data explained by each canonical component
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Figure 24: The proportion of variance in both data sets explained by the canonical 
variates obtained by gsCCA.
time points 2 h, 4 h, 8 h and 24 h. There is also a difference between genotypes 
in ozone at time points 8 h and 24 h. Time point 24 h for the redi in 
is more deviated from control samples than for the wild type.
2. The second component clusters different time points of control samples. The 
variation in control samples is likely due to the circadian rhythm regulated 
genes.
3. The third component separates genotypes, both in control and under ozone 
exposure. This component also separates time point 1 h in ozone from control 
samples for the redi.
4. The fourth component separates ozone treated samples at time points 2 h and 
4 h from time points 8 h and 24 h (early versus late regulation). There is also 
a slight difference between genotypes in ozone at time point 4 h.
5. The fifth component separates time points 1 h, 2 h, and 24 h from time points 
4 h and 8 h under ozone exposure. Time point 1 h is more deviated from 
control samples for the redi than for the Col-0.
ozone
5.6.2 Interpretation of canonical components obtained by gsCCA
The samples projected on the first three dimensions of canonical variates obtained 
by the gsCCA method are shown in Appendix D in Figures D2 and D2. The sep-
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Figure 25: The cumulative sum of the proportion of variance in both data sets 
explained by the canonical variates obtained by gsCCA.
aration and clustering of samples by canonical components were studied, and the 
descriptions are listed below for the five interesting components. The percentages 
of circadian clock regulated genes on components were again investigated; the per­
centages were 25 %, 6 %, 29 %, 67 % and 17 % for the components 1, 2, 3, 4 and 8, 
respectively. Thus, the component 4 very likely models the circadian rhythm.
1. The first component separates ozone treated samples obtained at time points 
8 h and 24 h from other samples. There is also a slight different between 
genotypes.
2. The second component separates genotypes. There is a slight difference be­
tween genotypes already at early time points in ozone. Samples for the redi 
in ozone at time point 24 h are clustered far away from the samples at time 
point zero, whereas for Col, the state of the plant at time points 0 h and 24 h 
is almost the same.
3. The third component separates ozone treated time points starting at time 
point 1 h from other samples.
4. The fourth component explains regulation of gene expression and metabolite
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The cumulative sum of the average squared canonical loadings over the canonical components
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Figure 26: The redundancies of each canonical variate pair obtained by gsCCA
levels in control samples. This is likely due to the circadian rhythm regulated 
genes.
8. The Uh component separates time points 1 h and 2 h from time points 0 h,
ozone treatment for both genotypes. However, time 
point 8 h for the redi in ozone does not fit to the pattern.
4 h, 8 h and 24 h under
5.7 Genes and metabolites explaining the variation in canon­
ical components
5.7.1 Results obtained by rrCCA
The genes and metabolites responsible for the clustering and separation of samples 
seen in Figures 28 and Cl can be addressed by investigating the canonical loadings. 
Canonical loadings can be visualized by canonical loadings plots; a canonical load­
ings plot showing the canonical loadings corresponding to the first two dimensions 
of canonical variates obtained by the rrCCA method is shown in Appendix E in 
Figure El. In this plot, the coordinates for individual genes and metabolites are 
correlations between the original variables and the first two dimensions of canonical 
variates associated with the metabolite data set. In Figure 28, the first component 
separates the ozone treated samples from the control samples. Therefore, the ge 
and metabolites shown in Figure El having high or very low canonical loading on the 
first canonical component are
nos
responsible for the oxidative stress regulation. Only
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Figure 27: The cumulative sum of redundancies over the canonical variate pairs 
obtained by gsCCA
the genes and metabolites, whose distance from the origin of the figure is larger than 
0.5, are plotted. This figure is difficult to read due to the large number of genes 
but the genes having high positive loading on the first component, in the right side 
of the plot,
first component, in the left side of the plot, are up-regulated during oxidative stress 
signalling. The side in which the up-regulated and down-regulated genes reside, 
needs to be checked each time.
Instead of plotting individual genes into correlation plots, the significantly 
riched gene sets among high absolute canonical loadings can be plotted. This is 
shown for the first component of rrCCA in Appendix F in Figure FI which plots 
metabolites, enriched biological processes gene sets, and transcription factors hav­
ing a high canonical loading on the first and third component. In Figure FI, the 
metabolites and genes having high positive canonical loading on component 1 are up- 
regulated. In Figure FI, several amino acids, and a GO biological process class cellu­
lar amino acid and derivative metabolic process have a high canonical loading on the 
first component. This process is also associated with the third, fourth and fifth 
ponent (Figure J1 in Appendix J). The cellular amino acid and derivative metabolic 
process class includes genes that code enzymes which are involved, for example, in 
tryptophan, phenylalanine, proline, aspartic acid, methionine and flavonoid biosyn-
down-regulated, and the genes having high negative loading on theare
en-
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Figure 28: Samples projected on the first two dimensions of canonical variates corre­
sponding to the metabolite data set. Canonical variates are obtained using rrCCA.
thesis and degradation pathways. The metabolites tryptophan, phenylalanine, 
line, aspartic acid and methionine all have high canonical loading on component 1, 
as well as associations to other components (Figure Jl). The genes belonging to 
the GO class cellular amino acid and derivative metabolic process, and involved in 
phenylalanine biosynthesis are plotted together with metabolite phenylalanine under 
ozone exposure in Appendix G in Figure Gl. In this Figure, the up-regulated genes 
are up already at time point 2 h, and they return to their 0 h state latest at 24 h. 
The genes AT1G22410, AT1G48850, AT1G62960 and AT5G22630 are examples of 
early regulation explained by the fourth component. There are some differences in 
the gene expression between genotypes which could explain the difference in pheny­
lalanine concentration observed between genotypes: 3-deoxy-7-phosphoheptulonate
pro-
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synthase and arogenate dehydratase (AT5G22630) genes are up-regulated in the 
mutant redi at time points 4 h and 2 h, 4 h and 8 h, respectively, compared to the 
Col-О. Moreover, aspartate transaminase degrading phenylalanine is down-regulated 
at time point 4 h in the redi which could also explain more elevated phenylalanine 
levels in the mutant plant. 3-deoxy-7-phosphoheptulonate synthase, chrorismate 
synthase and aspartate transaminase are also involved in tyrosine, tryprophan and 
salicylic acid metabolism, so they might explain the differences in the levels of these 
metabolites between genotypes. Transcription factors shown in Figure FI, such as 
WRKY70, WRKY18 and NAP, having a high absolute canonical loading 
ponent 1 could be up-regulating the genes belonging to the GO classes having high 
canonical loading on component 1. Despite the fact that several metabolic pro­
cesses are up-regulated and/or down-regulated, the transcription factors are mainly 
up-regulated do to ozone exposure.
Chapter 2.5.1 presented metabolic pathways functioning in the oxidative stress 
signalling and producing various protective compounds against oxidative damage 
(Figure 7). The phenylalanine is the starting compound in many of these pathways. 
The first canoninical component obtained by rrCCA is associated to phenylalanine 
and genes metabolising it, thus validating that the first canonical component ob­
tained by rrCCA models the oxidative stress signalling. Moreover, the biological 
process GO classes phenylpropanoid biosynthetic process, phenylpropanoid biosyn­
thetic process and, as well as lignin biosynthetic process and lignin biosynthetic 
process are enriched in the forth and/or fifth canonical components, so these com­
ponent very likely also model some aspects of the oxidative stress signalling
on com-
5.7.2 Results obtained by gsCCA
Correlation circles obtained for gsCCA are shown for components 2, 3 and 4 in Ap­
pendix H in Figures HI and H2. The most interesting regulation between genotypes 
in ozone occurs at time points 1 h and 2 h. Therefore, the 8th component obtained 
using gsCCA was analyzed. As seen in Appendix I in Figure II, the components 2 
and 8 separate the genotypes from each other, as well as the time points 1 h and 2 
h in ozone from the other time points. For the mutant redi, the samples obtained 
at time point 1 h under ozone exposure are more deviated from the control samples 
than the corresponding samples of the wild type.
The genes and metabolites having high absolute canonical loadings on compo­
nents 2 and 8 are shown in a correlation circle presented in Appendix I in Figure 
12. The metabolites having high negative canonical loadings on the 8th component 
are serine and aspartic acid. However, these metabolites do not show statistical 
significant difference in any of the comparisons (Figures 13, 14, 15, and 16). Ob­
serving genes related to serine or aspartic acid metabolism having similar expression 
pattern as the concentration pattern of the metabolites could bring more statistical 
strength to the pattern observed for these metabolites. The biological process GO 
classes enriched on the 8 th component are shown in Figure 13. It can be seen that 
a GO class cellular process is enriched in this component. The genes belonging 
to this class together with a metabolite aspartic acid are plotted in Figure 14 un-
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der ozone exposure. These four genes are strongly up-regulated at time points 1 h 
and 2 h, but return after that to their initial state (except gene AT4G14880 which 
is down-regulated at time point 8 h). The aspartic acid concentration levels are 
slightly up at time points 1 h and 2 h in the Col-0, a pattern that is missing in the 
redi. In contrast, aspartic acid levels in the redi degrease at time point 8 h. The 
genes AT3G23250 and AT4G14680 also have differences in their expression profiles 
between genotypes, which might explain the changes in aspartic acid concentration 
levels.
5.8 Visualization of the gene sets associated with the canon­
ical components by eye diagrams
5.8.1 Eye diagrams for the results obtained by rrCCA
Significantly differentially expressed gene sets associated with different canonical 
components are further visualized using eye-diagrams. The significantly differen­
tially expressed gene sets were determined based on the canonical loadings of the 
corresponding genes. The enrichment was tested based on area under precision-recall 
curve. The p values indicating the statistically significant gene sets were adjusted 
using Benjamini-Hochberg method. Gene sets having adjusted p value > 0.05 are 
considered significant, except for the biological functions GO classes significance 
level 0.01 is used to restrict the number of enriched gene sets.
The eye diagram shown in Appendix J in Figure Jl, Zl, Z3, Z4 and Z5 denote 
canonical components obtained by the rrCCA method. The second component as­
sociated with the circadian rhythm-regulated genes is not included because it would 
introduce too many enriched classes. The metabolites having high absolute 
ical loading on the components are connected to the components by colour-coded 
curves. The width of the curve reflects the strength of the association. In Figure 
Jl on the right, significantly enriched GO classes belonging to the GO category bi­
ological processes on the different components are visualized. Figures J2, J3 and J4 
show the metabolic functions and cellular compartmentalization GO categories and 
AraCyc pathways, respectively. Gene set names coloured by red indicate that most 
of the genes belonging to that gene set have positive canonical loading, whereas blue 
gene sets include genes having mostly negative canonical loadings. If two canonical 
components are associated with a particular gene set, and the signs of the average 
canonical loadings are different in different components, the name is coloured green.
The first component obtained by rrCCA separates ozone treated samples from 
control samples. As was stated in the previous chapter, the down-regulated pro­
cesses during ozone stress signalling have a high positive average canonical loading 
on the first component, so their names are coloured red in Figure Jl. The gene 
sets having high negative canonical loading on average are up-regulated, and their 
names are coloured blue. Several gene sets having a positive average canonical 
loading on the component 1 are associated with chloroplast and plastid, and 
therefore down-regulated (green gene sets in Figure J3. Chapter 2.5.1 mentioned 
that the photosynthetic processes occurring in chloroplast are down-regulated due
canon-
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to ozone-signalling. Thus, the first component correctly finds oxidative stress sig­
nalling related processes. Figure Jl shows that the first component is also associated 
with several amino acid and organic acid related pathways. The gene sets associated 
with the first component contain very many genes, and usually some of them are 
up-regulated whereas others are down-regulated due to ozone exposure. Therefore, 
the colour of the gene set name is not always very informative.
The third component separates genotypes, both in control condition and under 
ozone exposme. Processes having average positive canonical loading on this compo­
nent in Figure Jl are up-regulated in the mutant. This component includes several 
transcriptional regulatory and response processes, as well as metabolic and develop­
mental processes. In addition to metabolism related cellular compartments enriched 
in this component, there is also nucleus (Figure J3); this implies that several tran­
scription factors are responsible for the differences depicted by the third component. 
This can be also seen in Figure J2 where metabolic functions nucleic acid binding, 
transcription factor activity, DNA binding and transcription regulator activity 
enriched and up-regulated. Figure J4 shows that AraCyc pathways glycolysis I and 
II and gluconeogenesis are associated with the third component. Of the metabolites, 
proline has a high canonical loading on this component.
The fourth component separates time points 2 h and 4 h and from time points 8 h 
and 24 h under ozone exposure. In Figure Jl, the gene sets having negative canonical 
loading on average (blue colour) on the fourth component are up-regulated at time 
points 2 h and 4 h (sometimes also at time point 8 h) and gene sets having positive 
canonical loading on average (red colour) are down-regulated at time points 2 h 
and 4 h. This component contains metabolic processes, several response processes, 
developmental processes, transferase activity and membrane associated processes 
(Figures Jl, J2 and J3). The regulation of these processes occurs at time points 2 
h and 4 h. Of the metabolites, alanine, a-aminoadipic acid and /3-aminoisobutyric 
acid are highly associated with this component.
The fifth component separates time points 1 h, 2 h and 24 h hours from time 
points 4 h and 8 h under ozone exposure. The gene sets having positive canonical 
loading on average (red colour) on the fifth component in Figure Jl are up-regulated 
at time points 1 h and 2 h, and the expression goes to zero at time points 4 h and 
slightly increases again at time point 24 h. The gene sets belonging to this group 
are various responses to stimulus and lignin, as well as phenylpropanoid biosynthetic 
process. The component is highly associated with the metabolite glutamate.
Several components are associated with the same gene sets, especially the metabolic 
processes associated with the first component. The gene sets associated with several 
components, one of them being the third component separating the genotypes, might 
be of interest. In Figure Jl, for example, cellular aromatic compound metabolic pro­
cess, responses to various stresses, and regulation of processes are associated with 
both the third and the fifth component. By investigating these shared gene sets, it 
might be found, how genotypes are differently regulated at time points 1 and 2 h.
are
96
5.8.2 Eye diagrams for the results obtained by gsCCA
Eye diagrams were also used to visualize the results obtained by gsCCA. The first 
component obtained by gsCCA separates ozone treated samples from others at late 
time points. The eye diagram of biological processes in shown in Appendix К in 
Figure Kl. The gene sets associated with the first component with a negative 
canonical loading on average are up-regulated at time points 4 h, 8 h and 24 h, 
and gene sets with a positive canonical loading on average are down-regulated at 
the same time points. This component is associated with very many biological 
processes GO classes such as amino acid and organic acid metabolism, signalling, 
responses to various stresses and hormone biosynthesis and response processes, and 
it is associated with all enriched cellular compartments GO classes (Figure КЗ). Of 
AraCyc pathways, the first component is associated with glyoxylate cycle and TCA 
cycle (Figure K4). It can be concluded that the late ozone response is very dominant 
in the data.
The second component obtained by gsCCA separates genotypes. The gene sets 
having high average positive canonical loading are up-regulated in the mutant plant, 
sometimes already in the control condition. The second component is very similar 
to the third component obtained by rrCCA, with GO classes including regulatory 
and response processes. Also other eye diagrams (Figures K2, КЗ, K4) show the 
enriched gene sets for the second component are very similar to those associated 
with the third component obtained by rrCCA.
The third component separates ozone treated time points starting at time point 
1 h. In Figure Kl, the gene sets having positive average canonical loading on the 
third component are up-regulated due to ozone exposure, whereas gene sets having 
negative canonical loading are down-regulated. This component is associated with 
amino acid metabolism, especially histidine biosynthesis process, and heterocycle 
biosynthetic process, as well as some stress responses. AraCyc pathways in Figure 
K4 shows that glycolysis I and II are down-regulated, as well as sucrose degradation 
to ethanol and lactate. The third component is somewhat similar to the first com­
ponent obtained by the rrCCA method but it includes stress responses and specific 
amino acid related process (histidine biosynthesis).
The 8 th component separates time points 1 and 2 from other time points in 
ozone. In the eye diagrams, the gene sets having positive average canonical loading 
on the 8 th component are up-regulated at time points 1 and 2 h. This is the 
early ozone response, and includes regulation and biosynthetic processes, as well 
as responses to chitin, carbohydrate and organic substance stimulus. Metabolic 
functions shown in Figure K2 include, for example, increased transcription factor 
activity. The component is, however, not associated with cellular compartment 
nucleus (Figure КЗ).
In eye the diagrams obtained for the results obtained by gsCCA, the associations 
of components to metabolites are stronger, which can be seen from the width of the 
curves connected to metabolites. Again the shared gene sets between genotype 
separating component 2, and components 3 or 8 are the most interesting results.
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6 Conclusion and future work
In bioinformatics and systems biology, high-dimensional data sets obtained by high- 
throughput techniques pose several challenges to data analysis. Fusing the different 
types of omics data sets observed on the same experimental units has gained wide 
interest. Data fusion could be performed by seeking the variation that is common 
to several data sets. This can be done using canonical correlation analysis. In this 
thesis, the performance of a new variant of Bayesian canonical correlation, BCCA 
with group sparsity (gsCCA), is compared to the performance of the classical ridge 
regression regularized canonical correlation analysis (rrCCA). The gsCCA method 
is claimed to be the first applicable version of Bayesian CCA to data having a high 
dimensionality but a small sample size, so it is expected to perform better than 
rrCCA. The suitability of the methods to find regulatory relationships between 
transcripts and metabolites was addressed by applying them to data from a study 
of plant oxidative stress signalling where Arabidopsis thaliana was exposed to ozone, 
and paired time series gene expression and metabolite data were obtained both under 
ozone exposure and in control condition. The performance of the both methods is 
very similar; rrCCA and gsCCA both are able to find large and significant canonical 
correlations between the data sets, and the canonical components corresponding 
to these canonical correlations explain interesting biological variation. The gsCCA 
method was shown to explain more shared variation between the data sources than 
rrCCA, especially the variation in the metabolite data. The biological interpretation 
of the canonical components obtained differ, so gsCCA may find additional shared 
variation in the data sets that rrCCA is not able to find. Both methods are shown 
to find interesting relationships between transcripts and metabolites.
The gsCCA method has some desirable properties compared to rrCCA: First, 
the optimization of the regularization parameters for rrCCA takes several days, 
whereas the gsCCA algorithm is run on few minutes. Moreover, the optimization 
of the regularization parameters gives different results when the optimization is re­
peated. This is due to the random division of the data into training and validation 
set in the cross-validation procedure. The gsCCA method has the advantage that 
all data is used to learn the complexity of the model. Second, assessing the signif­
icance of canonical correlations is more straightforward when using gsCCA. Third, 
canonical components obtained using gsCCA explain more shared variation in the 
data sets than those obtained by rrCCA. Therefore, gsCCA is an attractive method 
for high-throughput data fusion. However, the analyses presented in this thesis have 
several limitations. The real biological data was very noisy, especially the metabolite 
data. Moreover, the difference between the dimensions in metabolite data and gene 
expression data was quite large. It was observed that gsCCA also overfits to the 
data. The effect of the noise level in the data, the unbalanced number of features, 
and the dimensionality of the data sets on the performance of the methods could 
be addressed using toy data. Better visualization methods of the results are needed 
as, for example, the canonical loadings plots are difficult to read if the data contain 
hundreds of variables. The selection of the subset of genes for the analysis based on 
metabolic network model introduces genes that are not related to the metabolites
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analyzed in the work, and which just bring additional non-relevant variation to the 
data set and increase the number of false positives. The subset of genes could have 
been selected based on other metabolic network models, or by a detailed knowledge 
of the biological processes under study. Also the set of transcription factors included 
in data could have been chosen better. The first canonical component obtained by 
gsCCA separates the time points 8 h and 24 h between genotypes under 
posure. This component probably models the programmed cell death. However, the 
TFs showing differential expression at time points 1 h and 2 h were selected to the 
analysis. The TFs showing differential expression at time points 4 h and 8 h could 
explain the variation seen in the first canonical component obtained by gsCCA.
There are some problems associated with the canonical loadings. Canonical 
commonality analysis has been suggested to be used for the interpretation of the 
canonical components. It was not used in this thesis as the calculation of canoni­
cal commonalities is tedious, and existing software packages perform commonality 
analysis only for the non-regularized classical canonical correlation analysis. The 
gsCCA method could be developed further. One potential improvement could be 
the introduction of variable selection [317-319] using LASSO [37,320,321], or even 
better, Elastic-net regularization [36,38,286,322-324]. These regularization meth­
ods would prune out the variables which do not contribute to the relevant variation 
among the samples. This would lead to sparse transformation matrices, and make 
the interpretation and visualization of the results much easier as there would be 
no need to investigate the parameter values corresponding to all features. Priors 
corresponding to LASSO or elastic-net has been introduced [325,326], and might 
be introduced to the Bayesian gsCCA. The gsCCA method could be extended so 
that it can be applied to more than two data sets. For example, CCA applicable 
to four data sets could fuse data on different levels of biological regulation such as 
expression of transcription factors, expression of metabolism related genes, protein 
levels, and metabolite levels. The method should be applicable also to discrete data, 
for example SNP profiles. This could be achieved using optimal scaling of the vari­
ables [327-330], leading to non-linear canonical correlation analysis [331]. gsCCA 
should be applicable to data obtained by next-generation sequencing techniques as 
it is and will be one of the main high-throughput method used. Biological processes 
which change due to the genotype effect, as well as the ozone stress effect could be 
better found by the BCCA developed by Huopaniemi et al which forces the model 
to find particularly interaction effects of two covariates [32]. Including this property 
into gsCCA could also be one way to develop gsCCA further.
The modelling and visualization of the results could be performed in the context 
of biological background information. There are methods which can simultane­
ously visualize gene expression and metabolites in the context of biological path­
ways [170,183,332-335] but no method exists which can visualize canonical loadings 
in the context of biological pathways. Nevertheless, rrCCA and gsCCA were able 
to find potential interesting regulatory relationships between genes and metabolites. 
It is notable that there are no protein degradation processes among enriched gene 
sets because the changes in amino acid levels may result from degradation of pro­
teins to amino acids. When adapting to the stress, the plant needs to synthesise
ozone ex-
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proteins and the amino acids required for the synthesis may be obtained from 
other less necessary proteins by degrading them leading to increased concentration 
of amino acids. The situation is quite an opposite; several metabolic processes di­
rectly producing and consuming metabolites analysed in this work are enriched. Of 
course, the results obtained using current methods could be further investigated to 
find more interesting relationships between metabolites and genes. For example, 
one could easily project the genes not included in the analysis described in this 
thesis to the canonical components obtained by the two methods, and perform gene 
set enrichment analysis on them to find more enriched biological processes asso­
ciated with the components. One of the future directions would also be to find 
common sequence motifs at the promoters of the gene sets enriched to find potential 
transcription factors regulating the genes, and inteacting with the mutated protein 
RCD1.
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Canonical variate pair 1 Canonical variate pair 2
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Appendix J
Figure Jl: Enriched biological processes GO classes associated with canonical 
ponents 1, 3, 4 and 5 obtained by rrCCA. Names of the gene sets including 
genes with positive canonical loading are coloured red, and names of the gene sets 
including more genes with negative canonical loading are coloured blue. If a gene 
set is associated with two or more canonical components, and the sign of the average 
gene set loading is different on different components, the gene set name is coloured 
green.
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Figure J2: Enriched metabolic functions GO classes associated with canonical 
ponents 1, 3, 4 and 5 obtained by rrCCA. Names of the gene sets including 
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Figure J3: Enriched cellular compartment GO classes associated with canonical 
components 1, 3, 4 and 5 obtained by rrCCA. Names of the gene sets including 
more genes with positive canonical loading are coloured red, and names of the gene 
sets including more genes with negative canonical loading are coloured blue. If a 
gene set is associated with two or more canonical components, and the sign of the 
average gene set loading is different on different components, the gene set name is 
coloured green.
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Appendix К
Figure Kl: Enriched biological processes GO classes associated with canonical 
ponents 1, 2, 3 and 8 obtained by gsCCA. Names of the gene sets including 
genes with positive canonical loading are coloured red, and names of the gene sets 
including more genes with negative canonical loading are coloured blue. If a gene 
set is associated with two or more canonical components, and the sign of the average 
gene set loading is different on different components, the gene set name is coloured 
green.
com-
more
—
—
'H
v*
,,
■-’X
,
\ v
'
и
/
lU
 il
l/
\ к А
 А
 л *
 *
/
z у
Щ
Ж
Ш
'
•c
ef
íS
r п
вр
Ш
оп
Ьу
 O
X
ld
a,
IO
n Ы
 o
r9
an
ic
 co
m
po
un
ds
i
A
8
a
у
i\\\3 \ \
entine
homocysl^oe 4
/XJ
z/y
I
ii
i i s g? ? X f
f ¿ I I # í-? i# #iJf/ffa g /
1| ##//%% 
Ш/Ш. X Ü®»0
ей%:«ZI
s^a^9'OUÍ,etovo*09
„anste«“19
«rt*
ude«60®
adlvW-
phOSP«0'11tá«6^
Petes-
^oxtíwahictese activity, acting on CH-ОН group of donors72
•kinase activity
Че4Г **'**■ *««,,_ ^9,yco^
s groupsZ3
Groups
n0'DeP^öon(
Z8
•4,0,
X*
lXi X ч»
s3
Ì \\ 15
%1 \ X
%
9.4
Mapping GO classes and metabolites 
Left metabolites 
Middle: Shared components 
Right: Metabolic functions
Figure K2: Enriched metabolic functions GO classes associated with canonical 
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Figure КЗ: Enriched cellular compartment GO classes associated with canonical 
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average gene set loading is different on different components, the gene set name is 
coloured green.
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Figure K4: Enriched AraCyc pathways associated with canonical components 1, 2, 3, 
and 8 obtained by gsCCA. Names of the gene sets including more genes with positive 
canonical loading are coloured red, and names of the gene sets including more genes 
with negative canonical loading are coloured blue. If a gene set is associated with 
two or more canonical components, and the sign of the average gene set loading is 
different on different components, the gene set name is coloured green.
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Mapping Aracyc pathways and metabolites
Left: metabolites
Middle: Shared components
Right: Aracyc pathways
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